<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 1.1?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Pathogens</journal-id><journal-id journal-id-type="iso-abbrev">Pathogens</journal-id><journal-id journal-id-type="publisher-id">pathogens</journal-id><journal-title-group><journal-title>Pathogens</journal-title></journal-title-group><issn pub-type="epub">2076-0817</issn><publisher><publisher-name>MDPI</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">7589794</article-id><article-id pub-id-type="doi">10.3390/pathogens9100856</article-id><article-id pub-id-type="publisher-id">pathogens-09-00856</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review</subject></subj-group></article-categories><title-group><article-title>Hepatitis E Virus Infection: Circulation, Molecular Epidemiology, and Impact on Global Health</article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0003-1669-1515</contrib-id><name><surname>Pallerla</surname><given-names>Srinivas Reddy</given-names></name><xref ref-type="aff" rid="af1-pathogens-09-00856">1</xref><xref ref-type="aff" rid="af2-pathogens-09-00856">2</xref><xref ref-type="author-notes" rid="fn1-pathogens-09-00856">&#x02020;</xref></contrib><contrib contrib-type="author"><name><surname>Harms</surname><given-names>Dominik</given-names></name><xref ref-type="aff" rid="af3-pathogens-09-00856">3</xref><xref ref-type="author-notes" rid="fn1-pathogens-09-00856">&#x02020;</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0001-9597-6724</contrib-id><name><surname>Johne</surname><given-names>Reimar</given-names></name><xref ref-type="aff" rid="af4-pathogens-09-00856">4</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-3564-1014</contrib-id><name><surname>Todt</surname><given-names>Daniel</given-names></name><xref ref-type="aff" rid="af5-pathogens-09-00856">5</xref><xref ref-type="aff" rid="af6-pathogens-09-00856">6</xref></contrib><contrib contrib-type="author"><name><surname>Steinmann</surname><given-names>Eike</given-names></name><xref ref-type="aff" rid="af5-pathogens-09-00856">5</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0003-3782-8226</contrib-id><name><surname>Schemmerer</surname><given-names>Mathias</given-names></name><xref ref-type="aff" rid="af7-pathogens-09-00856">7</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0001-8422-6581</contrib-id><name><surname>Wenzel</surname><given-names>J&#x000fc;rgen J.</given-names></name><xref ref-type="aff" rid="af7-pathogens-09-00856">7</xref></contrib><contrib contrib-type="author"><name><surname>Hofmann</surname><given-names>J&#x000f6;rg</given-names></name><xref ref-type="aff" rid="af8-pathogens-09-00856">8</xref></contrib><contrib contrib-type="author"><name><surname>Shih</surname><given-names>James Wai Kuo</given-names></name><xref ref-type="aff" rid="af9-pathogens-09-00856">9</xref></contrib><contrib contrib-type="author"><name><surname>Wedemeyer</surname><given-names>Heiner</given-names></name><xref ref-type="aff" rid="af10-pathogens-09-00856">10</xref><xref ref-type="aff" rid="af11-pathogens-09-00856">11</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-2773-486X</contrib-id><name><surname>Bock</surname><given-names>C.-Thomas</given-names></name><xref ref-type="aff" rid="af1-pathogens-09-00856">1</xref><xref ref-type="aff" rid="af3-pathogens-09-00856">3</xref><xref rid="c1-pathogens-09-00856" ref-type="corresp">*</xref><xref ref-type="author-notes" rid="fn2-pathogens-09-00856">&#x02021;</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-9809-9883</contrib-id><name><surname>Velavan</surname><given-names>Thirumalaisamy P.</given-names></name><xref ref-type="aff" rid="af1-pathogens-09-00856">1</xref><xref ref-type="aff" rid="af2-pathogens-09-00856">2</xref><xref ref-type="aff" rid="af12-pathogens-09-00856">12</xref><xref ref-type="author-notes" rid="fn2-pathogens-09-00856">&#x02021;</xref></contrib></contrib-group><aff id="af1-pathogens-09-00856"><label>1</label>Institute of Tropical Medicine, University of T&#x000fc;bingen, 72074 T&#x000fc;bingen, Germany; <email>srinivas-reddy.pallerla@uni-tuebingen.de</email> (S.R.P.); <email>velavan@medizin.uni-tuebingen.de</email> (T.P.V.)</aff><aff id="af2-pathogens-09-00856"><label>2</label>Vietnamese-German Center for Medical Research (VG-CARE), Hanoi 100000, Vietnam</aff><aff id="af3-pathogens-09-00856"><label>3</label>Division of Viral Gastroenteritis and Hepatitis Pathogens and Enteroviruses, Department of Infectious Diseases, Robert Koch Institute, 13353 Berlin, Germany; <email>HarmsD@rki.de</email></aff><aff id="af4-pathogens-09-00856"><label>4</label>Unit Viruses in Food, Department Biological Safety, German Federal Institute for Risk Assessment, 10589 Berlin, Germany; <email>Reimar.Johne@bfr.bund.de</email></aff><aff id="af5-pathogens-09-00856"><label>5</label>Department of Molecular and Medical Virology, Ruhr University Bochum, 44801 Bochum, Germany; <email>daniel.todt@ruhr-uni-bochum.de</email> (D.T.); <email>eike.steinmann@ruhr-uni-bochum.de</email> (E.S.)</aff><aff id="af6-pathogens-09-00856"><label>6</label>European Virus Bioinformatics Center (EVBC), 07743 Jena, Germany</aff><aff id="af7-pathogens-09-00856"><label>7</label>Institute of Clinical Microbiology and Hygiene, National Consultant Laboratory for HAV and HEV, University Medical Center Regensburg, 93053 Regensburg, Germany; <email>Mathias.Schemmerer@klinik.uni-regensburg.de</email> (M.S.); <email>juergen.wenzel@klinik.uni-regensburg.de</email> (J.J.W.)</aff><aff id="af8-pathogens-09-00856"><label>8</label>Institute of Virology, Charit&#x000e9; Universit&#x000e4;tsmedizin Berlin, Labor Berlin-Charit&#x000e9;-Vivantes GmbH, 13353 Berlin, Germany; <email>Joerg.Hofmann@laborberlin.com</email></aff><aff id="af9-pathogens-09-00856"><label>9</label>Xiamen Innovax Biotech Co., Ltd., Haicang, Xiamen 361022, China; <email>jwshih@innovax.cn</email></aff><aff id="af10-pathogens-09-00856"><label>10</label>Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, 30623 Hannover, Germany; <email>Wedemeyer.heiner@mh-hannover.de</email></aff><aff id="af11-pathogens-09-00856"><label>11</label>German Center for Infection Research, Partner Hannover-Braunschweig, 38124 Braunschweig, Germany</aff><aff id="af12-pathogens-09-00856"><label>12</label>Faculty of Medicine, Duy Tan University, Da Nang 550000, Vietnam</aff><author-notes><corresp id="c1-pathogens-09-00856"><label>*</label>Correspondence: <email>BockC@rki.de</email>; Tel.: +49-30-18754-2617</corresp><fn id="fn1-pathogens-09-00856"><label>&#x02020;</label><p>S.R.P. and D.H. contributed equally to the work and thus share first authorship.</p></fn><fn id="fn2-pathogens-09-00856"><label>&#x02021;</label><p>C.-T.B. and T.P.V. contributed equally to the work and thus share last authorship.</p></fn></author-notes><pub-date pub-type="epub"><day>20</day><month>10</month><year>2020</year></pub-date><pub-date pub-type="collection"><month>10</month><year>2020</year></pub-date><volume>9</volume><issue>10</issue><elocation-id>856</elocation-id><history><date date-type="received"><day>22</day><month>9</month><year>2020</year></date><date date-type="accepted"><day>16</day><month>10</month><year>2020</year></date></history><permissions><copyright-statement>&#x000a9; 2020 by the authors.</copyright-statement><copyright-year>2020</copyright-year><license license-type="open-access"><license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><abstract><p>Infection with hepatitis E virus (HEV) represents the most common source of viral hepatitis globally. Although infecting over 20 million people annually in endemic regions, with major outbreaks described since the 1950s, hepatitis E remains an underestimated disease. This review gives a current view of the global circulation and epidemiology of this emerging virus. The history of HEV, from the first reported enteric non-A non-B hepatitis outbreaks, to the discovery of the viral agent and the molecular characterization of the different human pathogenic genotypes, is discussed. Furthermore, the current state of research regarding the virology of HEV is critically assessed, and the challenges towards prevention and diagnosis, as well as clinical risks of the disease described. Together, these points aim to underline the significant impact of hepatitis E on global health and the need for further in-depth research to better understand the pathophysiology and its role in the complex disease manifestations of HEV infection.</p></abstract><kwd-group><kwd>hepatitis E</kwd><kwd>infection</kwd><kwd>outbreak</kwd><kwd>epidemiology</kwd><kwd>global health</kwd></kwd-group></article-meta></front><body><sec sec-type="intro" id="sec1-pathogens-09-00856"><title>1. Introduction</title><p>Hepatitis E virus (HEV) is a quasi-enveloped, positive strand RNA virus belonging to the family <italic>Hepeviridae</italic> [<xref rid="B1-pathogens-09-00856" ref-type="bibr">1</xref>]. HEV is the causative agent of Hepatitis E, the most common cause of acute viral hepatitis both in resource poor and developed countries. Hepatitis E presents as a mostly asymptomatic or acute self-limiting disease with a mortality rate up to 3% in young adults [<xref rid="B2-pathogens-09-00856" ref-type="bibr">2</xref>]. However the mortality rate may reach 30% in pregnant women [<xref rid="B3-pathogens-09-00856" ref-type="bibr">3</xref>]. Furthermore, chronic hepatitis E infections may occur in high-risk groups such as immunocompromised individuals (e.g., transplant recipients), those with pre-existing liver disease, HIV-positive persons, and cancer patients [<xref rid="B4-pathogens-09-00856" ref-type="bibr">4</xref>,<xref rid="B5-pathogens-09-00856" ref-type="bibr">5</xref>,<xref rid="B6-pathogens-09-00856" ref-type="bibr">6</xref>,<xref rid="B7-pathogens-09-00856" ref-type="bibr">7</xref>]. A recent study estimates that 939 million people worldwide have been infected with HEV in the past and that 15&#x02013;110 million people have recent or ongoing infections [<xref rid="B8-pathogens-09-00856" ref-type="bibr">8</xref>]. According to the WHO, an estimated 3.3 million symptomatic hepatitis E cases occur each year in endemic areas with 44,000 related deaths [<xref rid="B9-pathogens-09-00856" ref-type="bibr">9</xref>]. </p><p>HEV belongs to the genus <italic>Orthohepevirus</italic>, containing four species, namely <italic>Orthohepevirus A, B, C,</italic> and <italic>D</italic> with <italic>A</italic> containing the genotypes HEV-1 to HEV-8 [<xref rid="B10-pathogens-09-00856" ref-type="bibr">10</xref>]. The genotypes that infect humans include HEV-1 to -4, -7, and <italic>Orthohepevirus C</italic>, casually termed rat HEV [<xref rid="B10-pathogens-09-00856" ref-type="bibr">10</xref>,<xref rid="B11-pathogens-09-00856" ref-type="bibr">11</xref>,<xref rid="B12-pathogens-09-00856" ref-type="bibr">12</xref>,<xref rid="B13-pathogens-09-00856" ref-type="bibr">13</xref>]. HEV-1 and -2 infect only humans and cause large waterborne outbreaks due to contaminated drinking water in endemic regions of South and Southeast Asia, Africa, and Mexico [<xref rid="B14-pathogens-09-00856" ref-type="bibr">14</xref>]. HEV-3 and -4 infect both humans and animals, cause sporadic cases in developed countries, and are mainly spread through consumption or close contact with contaminated animal products [<xref rid="B14-pathogens-09-00856" ref-type="bibr">14</xref>,<xref rid="B15-pathogens-09-00856" ref-type="bibr">15</xref>]. HEV-7 and rat HEV infections are rarely reported. HEV-1 is mainly transmitted via the fecal&#x02013;oral route, but also by vertical transmission from mother to child, from person to person, and by blood transfusions [<xref rid="B14-pathogens-09-00856" ref-type="bibr">14</xref>,<xref rid="B16-pathogens-09-00856" ref-type="bibr">16</xref>]. HEV-2 is transmitted via the fecal&#x02013;oral route and human-to-human [<xref rid="B14-pathogens-09-00856" ref-type="bibr">14</xref>]. In contrast, HEV-3 and -4 are transmitted by transfusion of contaminated blood products, consuming contaminated shellfish, contact with infected animals, environmental contamination by animal manure run-off, and consumption of raw or undercooked meat [<xref rid="B14-pathogens-09-00856" ref-type="bibr">14</xref>,<xref rid="B16-pathogens-09-00856" ref-type="bibr">16</xref>]. Hepatitis E is not a sole health burden of the developing world, however, with numbers of reported sporadic cases increasing in industrialized nations, where the virus is spread primarily through zoonotic transmission.</p><p>Although usually a self-limiting disease in immunocompetent persons, hepatitis E can cause serious complications in at-risk populations such as pregnant women [<xref rid="B17-pathogens-09-00856" ref-type="bibr">17</xref>] and organ transplant recipients [<xref rid="B5-pathogens-09-00856" ref-type="bibr">5</xref>,<xref rid="B18-pathogens-09-00856" ref-type="bibr">18</xref>,<xref rid="B19-pathogens-09-00856" ref-type="bibr">19</xref>]. Treatment options remain limited, and only one vaccine has been developed so far with its use limited to China [<xref rid="B20-pathogens-09-00856" ref-type="bibr">20</xref>].</p><p>This review focuses on the history and discovery of the hepatitis E virus and discusses reported outbreaks in order to share new aspects and insights into its epidemiology and global circulation. Furthermore, it explores studies on the virology of HEV to portray a detailed picture of the known stages of the viral life cycle. Finally, it briefly summarizes the clinical aspects to underline the significant need for further research into the viral pathophysiology contributing to this underrated emerging infectious disease.</p></sec><sec id="sec2-pathogens-09-00856"><title>2. Discovery and History</title><p>An epidemic of HEV was reported in 1955 in Delhi, India, with about 29,000 cases of icteric hepatitis [<xref rid="B21-pathogens-09-00856" ref-type="bibr">21</xref>]. After this epidemic, several waterborne outbreaks were reported throughout India, and most of these cases were non-A and non-B, leading the disease to be described as enteric non-A non-B hepatitis (ENANBH) [<xref rid="B21-pathogens-09-00856" ref-type="bibr">21</xref>]. In addition, a major water-related epidemic outbreak in the Kashmir Valley was reported at the end of 1978, with 52,000 cases and 1700 deaths [<xref rid="B22-pathogens-09-00856" ref-type="bibr">22</xref>,<xref rid="B23-pathogens-09-00856" ref-type="bibr">23</xref>]. The symptoms of these cases were similar to hepatitis A but were negative for both hepatitis A and hepatitis B and were therefore confirmed as ENANBH [<xref rid="B22-pathogens-09-00856" ref-type="bibr">22</xref>]. In 1981, hepatitis occurred in a Soviet military camp in Afghanistan. To investigate this situation, a doctor in the Russian army, Mikhail Balayan, voluntarily ingested a pooled filtrate of stool samples from the infected soldiers, and he subsequently developed acute hepatitis [<xref rid="B24-pathogens-09-00856" ref-type="bibr">24</xref>]. The serum of Dr. Balayan was negative for hepatitis A virus (HAV) and hepatitis B virus (HBV), suggesting that a new pathogen was responsible for this infection. Immunoelectron microscopy identified 20&#x02013;30 nm non-enveloped virus-like particles in stool, confirming a novel ENANBH virus [<xref rid="B24-pathogens-09-00856" ref-type="bibr">24</xref>]. In 1990, this novel ENANBH was partially cloned and sequenced and was henceforth called the hepatitis E virus (HEV) [<xref rid="B25-pathogens-09-00856" ref-type="bibr">25</xref>,<xref rid="B26-pathogens-09-00856" ref-type="bibr">26</xref>]. It was initially indicated that hepatitis E infection spreads via contaminated water and is limited to resource poor countries. Later, however, increasing reports of sporadic cases emerged in non-endemic industrialized countries with high seroprevalence in a few areas of the United States [<xref rid="B27-pathogens-09-00856" ref-type="bibr">27</xref>]. The reason for this high prevalence was not understood, and it was speculated that undetected non-pathogenic or less pathogenic HEV strains were circulating. In 1998, genome sequences confirmed that human HEV were similar to that of HEV in pigs, suggesting zoonotic transmission pathways [<xref rid="B28-pathogens-09-00856" ref-type="bibr">28</xref>,<xref rid="B29-pathogens-09-00856" ref-type="bibr">29</xref>]. Overall, these studies led to the identification of a broad spectrum of HEV strains that are either restricted to humans, animals, or infect both.</p></sec><sec id="sec3-pathogens-09-00856"><title>3. Virology</title><p>HEV particles have an icosahedral shape, are non-enveloped, and form virions with a diameter of about 27&#x02013;34 nm [<xref rid="B30-pathogens-09-00856" ref-type="bibr">30</xref>]. The HEV genome is about 7.2 kb in size and consists of a 5&#x02032; UTR capped with 7-methylguanosine (M<sup>7</sup>G), followed by three open reading frames (ORF1, ORF2, and ORF3). The 3&#x02032; UTR ends with a poly(A) tail (A<sub>n</sub>) like the eukaryotic mRNA structure. Viral replication starts with the translation of the ORF1-encoded non-structural polyprotein. An RNA-dependent RNA polymerase (RdRp) subsequently transcribes the full-length negative-sense RNA. This RNA serves as a template for the synthesis of two viral positive-sense RNAs in infected cells, a full-length genomic RNA, and a subgenomic RNA containing the capsid protein-encoding ORF2 and polyfunctional protein (PP)-encoding ORF3 [<xref rid="B31-pathogens-09-00856" ref-type="bibr">31</xref>]. The genomic arrangement and the stages of viral genome replication and protein synthesis are visualized in <xref ref-type="fig" rid="pathogens-09-00856-f001">Figure 1</xref>.</p><p>ORF1 encodes a non-structural polyprotein of varying length that consists of seven domains comprising a methyl transferase (Met), X and Y domains, a papain-like cysteine protease (PCP), a proline-rich hypervariable region (HVR), RNA helicase (Hel), and RNA-dependent RNA polymerase (RdRp) [<xref rid="B32-pathogens-09-00856" ref-type="bibr">32</xref>]. Of these seven, only the Met, Hel, and RdRp have been functionally well characterized [<xref rid="B33-pathogens-09-00856" ref-type="bibr">33</xref>,<xref rid="B34-pathogens-09-00856" ref-type="bibr">34</xref>,<xref rid="B35-pathogens-09-00856" ref-type="bibr">35</xref>,<xref rid="B36-pathogens-09-00856" ref-type="bibr">36</xref>]. The complete function of all ORF1 domains is still not fully understood. In addition, whether it functions as a multi-domain polyprotein like a &#x0201c;Swiss army knife&#x0201d; or whether it needs to be cleaved for functional activity [<xref rid="B37-pathogens-09-00856" ref-type="bibr">37</xref>] is under debate and there is still no conclusive evidence that PCP has a protease function [<xref rid="B38-pathogens-09-00856" ref-type="bibr">38</xref>]. Although ORF1 is essential for HEV replication, its HVR displays considerable sequence divergence even between isolates of the same virus genotype [<xref rid="B39-pathogens-09-00856" ref-type="bibr">39</xref>]. Size differences between different HEV genomes can be primarily attributed to the HVR region. Analysis of different patient derived HEV isolates revealed various strains that harbor insertions from other regions of the viral genome, or from human genes, within the HVR [<xref rid="B40-pathogens-09-00856" ref-type="bibr">40</xref>].</p><p>The ORF2 encodes for the capsid protein. Its N-terminal signal peptide shuttles it to the extracellular compartment. The ORF2 protein contains three potential <italic>N</italic>-glycosylation sites [<xref rid="B41-pathogens-09-00856" ref-type="bibr">41</xref>,<xref rid="B42-pathogens-09-00856" ref-type="bibr">42</xref>,<xref rid="B43-pathogens-09-00856" ref-type="bibr">43</xref>], and is the main immunogenic target of neutralizing antibodies [<xref rid="B41-pathogens-09-00856" ref-type="bibr">41</xref>,<xref rid="B44-pathogens-09-00856" ref-type="bibr">44</xref>]. The full-length ORF2 encodes 660aa; however, recent reports suggested that ORF2 protein is processed into at least two forms, including one or two forms of secreted glycoproteins that are not associated with infectious particles, and one unglycosylated form which is the structural component of infectious particles [<xref rid="B45-pathogens-09-00856" ref-type="bibr">45</xref>,<xref rid="B46-pathogens-09-00856" ref-type="bibr">46</xref>]. ORF2 has been well characterized for its usefulness in diagnostics and vaccines, including the vaccine Hecolin<sup>&#x000ae;</sup> p239, which is currently only approved in China.</p><p>The ORF3 protein is a polyfunctional 13-kDa protein of 113 (genotype 3) or 114aa (genotypes 1, 2, and 4). Computational homology scans did not reveal any domains comparable to other known viral proteins. It has been shown to bind to microtubules and be involved in particle assembly and egress by interaction with the tumor susceptibility gene 101 protein (TSG101), a key protein involved in the endosomal sorting complexes of the ESCRT (endosomal sorting complexes required to transport) transport pathway and involved in the budding of the viruses [<xref rid="B47-pathogens-09-00856" ref-type="bibr">47</xref>,<xref rid="B48-pathogens-09-00856" ref-type="bibr">48</xref>,<xref rid="B49-pathogens-09-00856" ref-type="bibr">49</xref>,<xref rid="B50-pathogens-09-00856" ref-type="bibr">50</xref>]. Furthermore, it may play a role in infectious particle secretion via its palmitoylation and membrane association [<xref rid="B51-pathogens-09-00856" ref-type="bibr">51</xref>]. Additionally, there are also reports of its role in intracellular transduction pathways, the potential to reduce host immune responses, and protection of virus-infected cells [<xref rid="B52-pathogens-09-00856" ref-type="bibr">52</xref>,<xref rid="B53-pathogens-09-00856" ref-type="bibr">53</xref>,<xref rid="B54-pathogens-09-00856" ref-type="bibr">54</xref>]. A recent article reports that ORF3 is a functional ion channel required for release of infectious particles [<xref rid="B55-pathogens-09-00856" ref-type="bibr">55</xref>]. </p><p>HEV exists as quasi-enveloped viral particles in blood and cell culture supernatant and as non-enveloped virions in bile and feces [<xref rid="B56-pathogens-09-00856" ref-type="bibr">56</xref>]. When they are shed into the environment, non-enveloped naked virions are enterically transmitted through contaminated water or food. So far, it is not well understood how HEV virions overcome the intestinal barrier and reach the liver. However, it is assumed that the virions first infect the enterocytes, where they multiply, and are excreted as quasi-enveloped virus particles into blood circulation, thus infecting hepatocytes [<xref rid="B57-pathogens-09-00856" ref-type="bibr">57</xref>]. On their way through the bile duct, the envelope is stripped off and naked, and more infectious virions are again released via the stool [<xref rid="B56-pathogens-09-00856" ref-type="bibr">56</xref>,<xref rid="B58-pathogens-09-00856" ref-type="bibr">58</xref>].</p><p>Naked HEV particles possibly attach to target cells via heparin sulfate proteoglycans (HSGPs) [<xref rid="B59-pathogens-09-00856" ref-type="bibr">59</xref>] and heat shock cognate protein 70 (HSC70) [<xref rid="B60-pathogens-09-00856" ref-type="bibr">60</xref>]. Integrin &#x003b1;3 has been described recently [<xref rid="B61-pathogens-09-00856" ref-type="bibr">61</xref>] as a candidate receptor to mediate entry into the cells by dynamin-dependent, clathrin-mediated endocytosis, supported by the GTPases Ras-related proteins Rab5A (RAB5) and Rab7a (RAB7), which are necessary for quasi-enveloped particle internalization [<xref rid="B59-pathogens-09-00856" ref-type="bibr">59</xref>,<xref rid="B62-pathogens-09-00856" ref-type="bibr">62</xref>,<xref rid="B63-pathogens-09-00856" ref-type="bibr">63</xref>]. Quasi-enveloped particles attach less efficiently to cells and likely enter the cell in a manner similar to exosomes [<xref rid="B63-pathogens-09-00856" ref-type="bibr">63</xref>]. Not requiring HSGPs allows attachment in a non-cell-specific manner, possibly explaining HEV&#x02019;s capacity to infect extrahepatic tissues [<xref rid="B63-pathogens-09-00856" ref-type="bibr">63</xref>]. Following this, lysosomal degradation of the lipid membrane (in the case of enveloped particles) and subsequent viral capsid uncoating take place, followed by release of the genomic HEV positive strand RNA into the cytoplasm [<xref rid="B63-pathogens-09-00856" ref-type="bibr">63</xref>]. The host cellular transcriptional machinery translates ORF1 polyprotein containing RdRp from HEV RNA. The polymerase transcribes the full-length negative-sense HEV RNA. From this negative strand, two RNAs are transcribed by RNA helicases and RdRp to form a full-length genomic RNA and a 2.2 kb bicistronic subgenomic RNA. These two capped and polyadenylated RNAs serve as templates for the translation of non-structural ORF1 polyproteins, ORF2 capsid proteins, and polyfunctional ORF3 proteins [<xref rid="B64-pathogens-09-00856" ref-type="bibr">64</xref>].</p><p>The subsequent steps are viral assembly and release. ORF2 and ORF3 and positive-sense genomic HEV RNA are known to form a complex in the ER&#x02013;Golgi intermediate compartment and produce viral progeny particles [<xref rid="B65-pathogens-09-00856" ref-type="bibr">65</xref>,<xref rid="B66-pathogens-09-00856" ref-type="bibr">66</xref>]. The particles of the progeny virus bind to the TSG101 protein and are secreted in a presumably basal fashion as enveloped particles [<xref rid="B47-pathogens-09-00856" ref-type="bibr">47</xref>,<xref rid="B48-pathogens-09-00856" ref-type="bibr">48</xref>]. When leaving hepatocytes from the apical part, the envelope is stripped as described above [<xref rid="B56-pathogens-09-00856" ref-type="bibr">56</xref>,<xref rid="B58-pathogens-09-00856" ref-type="bibr">58</xref>]. There are many significant gaps in the understanding of the HEV life cycle and virus&#x02013;host cell interactions [<xref rid="B67-pathogens-09-00856" ref-type="bibr">67</xref>], and further studies are urgently needed. Several in vitro systems exist to study the virus. Reverse genetics models based on infectious cDNA clones have been described for several genotypes. The most commonly used are the Sar-55-related genotype 1 clone [<xref rid="B68-pathogens-09-00856" ref-type="bibr">68</xref>], the genotype 3a and 3c Kernow-C1- [<xref rid="B69-pathogens-09-00856" ref-type="bibr">69</xref>], and 47832-related [<xref rid="B70-pathogens-09-00856" ref-type="bibr">70</xref>] clones, respectively, both of which contain insertions in the HVR, and the genotype 4 TW6196 clone [<xref rid="B71-pathogens-09-00856" ref-type="bibr">71</xref>]. A recent presentation of a novel in vitro method to produce high viral titers, allowing study of the full HEV replication cycle in cell culture, has additionally created confidence that we may overcome our limited understanding of HEV pathophysiology [<xref rid="B72-pathogens-09-00856" ref-type="bibr">72</xref>]. Although these systems are most commonly used in conventional cell culture systems, several animal infection models have been developed. Rhesus monkeys have been shown to be susceptible to HEV-1 through -4 [<xref rid="B28-pathogens-09-00856" ref-type="bibr">28</xref>,<xref rid="B73-pathogens-09-00856" ref-type="bibr">73</xref>], while cynomolgous monkeys and chimpanzees have been used as models for HEV-1 and -2 [<xref rid="B68-pathogens-09-00856" ref-type="bibr">68</xref>,<xref rid="B74-pathogens-09-00856" ref-type="bibr">74</xref>]. As natural hosts for HEV-3 and -4, pigs can be readily infected by strains of these genotypes [<xref rid="B75-pathogens-09-00856" ref-type="bibr">75</xref>,<xref rid="B76-pathogens-09-00856" ref-type="bibr">76</xref>]. Recent reports have also described successful infection of human liver chimeric mice with HEV-1 and -3 strains [<xref rid="B77-pathogens-09-00856" ref-type="bibr">77</xref>,<xref rid="B78-pathogens-09-00856" ref-type="bibr">78</xref>]. Moreover, small animal and avian models exist for the study of animal HEV. Although animal infection models provide more physiological conditions than cell culture systems, limitations are also present. Neither non-human primates nor mice represent natural hosts of HEV, while pigs can only be infected with HEV-3 and -4. Experiments with primates also raise ethical concerns.</p></sec><sec id="sec4-pathogens-09-00856"><title>4. Outbreaks</title><p>HEV outbreaks occur mainly in resource poor countries, due to waterborne infections caused by HEV-1 and possibly HEV-2 [<xref rid="B79-pathogens-09-00856" ref-type="bibr">79</xref>], often during the monsoon season. The outbreaks are caused mainly by consumption and use of contaminated water where sanitary and hygienic conditions are poor [<xref rid="B14-pathogens-09-00856" ref-type="bibr">14</xref>]. The first laboratory confirmed HEV outbreak was reported in Delhi in 1955, and since then several outbreaks have been reported in tropical and subtropical regions of the world, especially in Asian and African countries. Reported outbreaks are summarized in <xref rid="pathogens-09-00856-t001" ref-type="table">Table 1</xref>. </p><p>The largest outbreaks involved 79,000 ENANBH cases in Kanpur, India, between 1990 and 1991, and 119,000 cases in China between 1986 and 1988 [<xref rid="B93-pathogens-09-00856" ref-type="bibr">93</xref>,<xref rid="B94-pathogens-09-00856" ref-type="bibr">94</xref>,<xref rid="B95-pathogens-09-00856" ref-type="bibr">95</xref>]. Sporadic outbreaks have also occurred in recent years in Asian and African countries, but with a low number of reported cases [<xref rid="B133-pathogens-09-00856" ref-type="bibr">133</xref>,<xref rid="B134-pathogens-09-00856" ref-type="bibr">134</xref>,<xref rid="B135-pathogens-09-00856" ref-type="bibr">135</xref>,<xref rid="B136-pathogens-09-00856" ref-type="bibr">136</xref>,<xref rid="B137-pathogens-09-00856" ref-type="bibr">137</xref>]. Using modelling approaches, a recent study describes the ecologically most suitable hotspots for HEV viruses: the Ganges Valley in India and Pakistan [<xref rid="B138-pathogens-09-00856" ref-type="bibr">138</xref>]. Important factors contributing to water-related outbreaks of HEV are population density, socio-economic conditions, the level of sanitation, and access to drinking water [<xref rid="B14-pathogens-09-00856" ref-type="bibr">14</xref>,<xref rid="B138-pathogens-09-00856" ref-type="bibr">138</xref>]. There are also frequent outbreaks in refugee camps, military camps, and emergency shelters in conflict- and catastrophe-affected regions [<xref rid="B127-pathogens-09-00856" ref-type="bibr">127</xref>,<xref rid="B139-pathogens-09-00856" ref-type="bibr">139</xref>,<xref rid="B140-pathogens-09-00856" ref-type="bibr">140</xref>,<xref rid="B141-pathogens-09-00856" ref-type="bibr">141</xref>,<xref rid="B142-pathogens-09-00856" ref-type="bibr">142</xref>]. In summary, HEV outbreaks can be prevented by improving sanitary conditions and ensuring access to clean drinking water.</p></sec><sec id="sec5-pathogens-09-00856"><title>5. Epidemiology</title><p>Taxonomically, the family <italic>Hepeviridae</italic> is divided into the genus <italic>Orthohepevirus</italic> with the species <italic>Orthohepevirus A, B, C</italic>, and <italic>D</italic>, and the genus <italic>Piscihepevirus</italic>. The species <italic>Orthohepevirus A</italic> contains eight distinct genotypes that infect humans and other mammals [<xref rid="B10-pathogens-09-00856" ref-type="bibr">10</xref>]. It is known that HEV-1 to -4 infect humans, and rare cases of human infection with other genotypes like HEV-7 have also been described [<xref rid="B11-pathogens-09-00856" ref-type="bibr">11</xref>,<xref rid="B143-pathogens-09-00856" ref-type="bibr">143</xref>]. Details on the genotypes of <italic>Orthohepevirus A</italic> including host range, transmission routes, and global distribution are summarized in <xref rid="pathogens-09-00856-t002" ref-type="table">Table 2</xref>.</p><p>Moreover, sporadic human infections with rat HEV <italic>(Orthohepevirus C</italic>) have been reported [<xref rid="B12-pathogens-09-00856" ref-type="bibr">12</xref>,<xref rid="B13-pathogens-09-00856" ref-type="bibr">13</xref>,<xref rid="B144-pathogens-09-00856" ref-type="bibr">144</xref>]. HEV epidemiology shows two differing patterns based on the global distribution of the <italic>Orthohepevirus A</italic> genotypes [<xref rid="B9-pathogens-09-00856" ref-type="bibr">9</xref>] (<xref ref-type="fig" rid="pathogens-09-00856-f002">Figure 2</xref>). HEV-1 and HEV-2 genotypes are human pathogens that are mostly transmitted via the fecal&#x02013;oral route in resource poor countries, mainly through contaminated drinking water, with several cases of vertical transmission having also been described [<xref rid="B16-pathogens-09-00856" ref-type="bibr">16</xref>]. In contrast, infections with HEV-3 and HEV-4 are autochthonous in developed countries and mainly zoonotically acquired via consumption of contaminated food, but parenteral transmission via blood transfusions have also been described [<xref rid="B145-pathogens-09-00856" ref-type="bibr">145</xref>]. Despite several HEV genotypes, only a single serotype has been reported, which simplifies seroprevalence studies, diagnosis, and vaccination [<xref rid="B146-pathogens-09-00856" ref-type="bibr">146</xref>,<xref rid="B147-pathogens-09-00856" ref-type="bibr">147</xref>,<xref rid="B148-pathogens-09-00856" ref-type="bibr">148</xref>].</p><p>The HEV-1 and HEV-2 genotypes are estimated to infect about 20 million people in resource poor countries, resulting in 3.3 million symptomatic cases and 44,000 deaths per year [<xref rid="B9-pathogens-09-00856" ref-type="bibr">9</xref>]. However, it is believed that these figures are underestimated due to lack of awareness and lack of diagnosis and serological tests [<xref rid="B150-pathogens-09-00856" ref-type="bibr">150</xref>]. HEV-1 is the main cause of significant recurrent epidemics in resource poor countries in Africa and Asia and isolated small epidemics in Latin America, as well as large outbreaks in India [<xref rid="B14-pathogens-09-00856" ref-type="bibr">14</xref>,<xref rid="B151-pathogens-09-00856" ref-type="bibr">151</xref>]. HEV-2 outbreaks were reported in 1986&#x02013;1987 from rural towns in Morelos in Mexico [<xref rid="B152-pathogens-09-00856" ref-type="bibr">152</xref>], Nigeria, Sudan, and Namibia [<xref rid="B79-pathogens-09-00856" ref-type="bibr">79</xref>,<xref rid="B153-pathogens-09-00856" ref-type="bibr">153</xref>,<xref rid="B154-pathogens-09-00856" ref-type="bibr">154</xref>,<xref rid="B155-pathogens-09-00856" ref-type="bibr">155</xref>], and the recent ones reported in Burkina Faso. Studies have shown that HEV-1 and HEV-2 infections occur most frequently in men during their adolescence (15&#x02013;30 years), and most patients experience acute self-limiting hepatitis [<xref rid="B94-pathogens-09-00856" ref-type="bibr">94</xref>,<xref rid="B100-pathogens-09-00856" ref-type="bibr">100</xref>]. In addition, HEV outbreaks were recognized among people living in refugee camps and in emergency shelters after natural disasters [<xref rid="B127-pathogens-09-00856" ref-type="bibr">127</xref>,<xref rid="B139-pathogens-09-00856" ref-type="bibr">139</xref>,<xref rid="B140-pathogens-09-00856" ref-type="bibr">140</xref>,<xref rid="B141-pathogens-09-00856" ref-type="bibr">141</xref>,<xref rid="B142-pathogens-09-00856" ref-type="bibr">142</xref>]. Few studies have reported human-to-human transmission; however, this needs to be elucidated [<xref rid="B156-pathogens-09-00856" ref-type="bibr">156</xref>].</p><p>HEV-3 and HEV-4 are zoonotically transmitted from pigs, wild boar, deer, and rabbits in developed countries [<xref rid="B157-pathogens-09-00856" ref-type="bibr">157</xref>], where pigs are the main reservoir, and autochthonous infections are caused by the consumption of undercooked meat [<xref rid="B158-pathogens-09-00856" ref-type="bibr">158</xref>] or contact with pigs and wild animals [<xref rid="B159-pathogens-09-00856" ref-type="bibr">159</xref>]. Previously, the cause of HEV-induced hepatitis was considered a disease of resource poor countries, but it has become clear that HEV is also acquired locally in industrialized regions [<xref rid="B160-pathogens-09-00856" ref-type="bibr">160</xref>,<xref rid="B161-pathogens-09-00856" ref-type="bibr">161</xref>]. A recent review and meta-analysis lists seroprevalence rates of 0.04% to 52.5% in these countries, with the highest prevalence reported from France, Poland, and Denmark [<xref rid="B162-pathogens-09-00856" ref-type="bibr">162</xref>]. HEV is much more frequent than previously thought, with an estimated &#x0003e;400.000 infections per year in Germany [<xref rid="B163-pathogens-09-00856" ref-type="bibr">163</xref>]. HEV-3 is common among pigs worldwide, which constitute the major reservoir for human infections [<xref rid="B164-pathogens-09-00856" ref-type="bibr">164</xref>,<xref rid="B165-pathogens-09-00856" ref-type="bibr">165</xref>]. HEV-4 is widely distributed in South and East Asia, where both wild and domesticated pigs serve as a reservoir [<xref rid="B10-pathogens-09-00856" ref-type="bibr">10</xref>,<xref rid="B158-pathogens-09-00856" ref-type="bibr">158</xref>,<xref rid="B166-pathogens-09-00856" ref-type="bibr">166</xref>]. Infection rates are high in people over 50 years of age [<xref rid="B4-pathogens-09-00856" ref-type="bibr">4</xref>,<xref rid="B167-pathogens-09-00856" ref-type="bibr">167</xref>,<xref rid="B168-pathogens-09-00856" ref-type="bibr">168</xref>], and seroepidemiological studies found no significant differences in HEV-IgG seropositivity according to gender [<xref rid="B169-pathogens-09-00856" ref-type="bibr">169</xref>]. However, a recent study revealed that men were more frequently infected than women [<xref rid="B170-pathogens-09-00856" ref-type="bibr">170</xref>]. Other HEV genotypes such as HEV-5 and -6 were found in wild boars, whereas HEV-7 and -8 are present in camels [<xref rid="B143-pathogens-09-00856" ref-type="bibr">143</xref>,<xref rid="B171-pathogens-09-00856" ref-type="bibr">171</xref>,<xref rid="B172-pathogens-09-00856" ref-type="bibr">172</xref>,<xref rid="B173-pathogens-09-00856" ref-type="bibr">173</xref>]. So far, only HEV-7 has shown a zoonotic potential associated with practices of camel meat consumption in the Middle East [<xref rid="B11-pathogens-09-00856" ref-type="bibr">11</xref>]. Sporadic reports of human infections with rat HEV (<italic>Orthohepevirus C</italic>) have also been reported [<xref rid="B12-pathogens-09-00856" ref-type="bibr">12</xref>,<xref rid="B13-pathogens-09-00856" ref-type="bibr">13</xref>]. HEV genotypes are selective with unique transmission patterns, pathogenesis [<xref rid="B174-pathogens-09-00856" ref-type="bibr">174</xref>,<xref rid="B175-pathogens-09-00856" ref-type="bibr">175</xref>], clinical manifestations in different patient groups, and host adaption.</p></sec><sec id="sec6-pathogens-09-00856"><title>6. Diagnosis and Clinical Aspects </title><p>As a large percentage of HEV infections do not present with symptoms, the disease often goes undiagnosed. In individuals presenting with hepatitis, symptoms are indistinguishable from those of hepatitis A. Standard diagnostic tests for hepatitis E include the detection of HEV-specific antibodies, including both anti-HEV IgM and IgG, as well as amplification of the viral genome using conventional PCR or real-time reverse transcription PCR [<xref rid="B176-pathogens-09-00856" ref-type="bibr">176</xref>]. During the last decades, WHO international standard materials have been developed to assist standardization of NAT and anti-HEV IgG detection assays [<xref rid="B177-pathogens-09-00856" ref-type="bibr">177</xref>,<xref rid="B178-pathogens-09-00856" ref-type="bibr">178</xref>]. Awareness of the need for HEV testing has been increasing over the last decade, and many countries have begun to implement HEV RNA screening in blood donations [<xref rid="B179-pathogens-09-00856" ref-type="bibr">179</xref>].</p><p>Although the main site of replication for HEV is the liver, non-hepatic replication has been shown in the brain, kidney, placenta, and others [<xref rid="B180-pathogens-09-00856" ref-type="bibr">180</xref>]. This may explain a series of different extrahepatic manifestations that can occur in infected patients. Neurological manifestations include Guillain&#x02013;Barr&#x000e9; syndrome and neuralgic amyotrophy, while kidney disorders such as cryoglobulinemia and hematological conditions have also been described in association with hepatitis E [<xref rid="B181-pathogens-09-00856" ref-type="bibr">181</xref>,<xref rid="B182-pathogens-09-00856" ref-type="bibr">182</xref>,<xref rid="B183-pathogens-09-00856" ref-type="bibr">183</xref>,<xref rid="B184-pathogens-09-00856" ref-type="bibr">184</xref>,<xref rid="B185-pathogens-09-00856" ref-type="bibr">185</xref>,<xref rid="B186-pathogens-09-00856" ref-type="bibr">186</xref>,<xref rid="B187-pathogens-09-00856" ref-type="bibr">187</xref>]. In addition, deaths due to fulminant hepatitis have been reported in 0.5 to 4% of patients, and this percentage is known to be higher in people with pre-existing liver disease [<xref rid="B188-pathogens-09-00856" ref-type="bibr">188</xref>] and among young children [<xref rid="B189-pathogens-09-00856" ref-type="bibr">189</xref>]. HEV superinfection could additionally influence the outcome and progression of HBV-related liver diseases [<xref rid="B190-pathogens-09-00856" ref-type="bibr">190</xref>]. Furthermore, severe disease outcomes may occur in pregnant women infected with HEV-1 with studies describing maternal mortality rates &#x0003e;30% within the third trimester, mainly due to fulminant hepatic failure [<xref rid="B17-pathogens-09-00856" ref-type="bibr">17</xref>]. In immunocompromised persons such as solid organ and hematopoietic stem cell transplant recipients, HEV infection may persist. Patients with chronic hepatitis E will often rapidly progress to liver cirrhosis and have an increased mortality rate [<xref rid="B158-pathogens-09-00856" ref-type="bibr">158</xref>]. There is no approved drug against HEV infection. If initial reduction of immunosuppression does not lead to HEV clearance, off-label treatment for chronic hepatitis E is indicated with ribavirin. Non-responding liver-transplant patients can be further treated with pegylated interferon alfa-2a and pegylated interferon alfa-2b [<xref rid="B168-pathogens-09-00856" ref-type="bibr">168</xref>]. Several molecules with in vitro antiviral activity against HEV have been described. Repurposed antivirals include 2&#x02032;-C-methylcytidine (2-CMC) [<xref rid="B191-pathogens-09-00856" ref-type="bibr">191</xref>], NITD008 and GPC-N114 [<xref rid="B192-pathogens-09-00856" ref-type="bibr">192</xref>], ciprofloxacin and IFN-&#x003bb; [<xref rid="B193-pathogens-09-00856" ref-type="bibr">193</xref>], and sofosbuvir [<xref rid="B194-pathogens-09-00856" ref-type="bibr">194</xref>]. Compound screening studies have revealed plant ethanol extracts from <italic>L. mauritiana</italic> [<xref rid="B195-pathogens-09-00856" ref-type="bibr">195</xref>] and <italic>L. platyphylla</italic> [<xref rid="B196-pathogens-09-00856" ref-type="bibr">196</xref>], as well as zinc [<xref rid="B197-pathogens-09-00856" ref-type="bibr">197</xref>], and the small molecule 66E2 [<xref rid="B198-pathogens-09-00856" ref-type="bibr">198</xref>] as potential antivirals. An FDA-approved drug, deptropine, a histamine H1 receptor antagonist used in asthma treatment, showed anti-HEV activity in cell culture and synergized with ribavirin [<xref rid="B199-pathogens-09-00856" ref-type="bibr">199</xref>]. Target-guided approaches include peptide conjugated phosphorodiamidate morpholino oligomers (PPMO) [<xref rid="B200-pathogens-09-00856" ref-type="bibr">200</xref>] and proteasome inhibitor MG132 [<xref rid="B201-pathogens-09-00856" ref-type="bibr">201</xref>,<xref rid="B202-pathogens-09-00856" ref-type="bibr">202</xref>] in HEV-1 cell culture, the cyclic peptide CP11, which inhibits interaction of HEV with the ESCRT [<xref rid="B203-pathogens-09-00856" ref-type="bibr">203</xref>], several inhibitors of nucleotide synthesis, including mycophenolic acid [<xref rid="B204-pathogens-09-00856" ref-type="bibr">204</xref>], Brequinar, and Leflunomide [<xref rid="B205-pathogens-09-00856" ref-type="bibr">205</xref>], and the natural compound silvestrol [<xref rid="B206-pathogens-09-00856" ref-type="bibr">206</xref>]. However, only silvestrol [<xref rid="B206-pathogens-09-00856" ref-type="bibr">206</xref>] and the hepatitis C virus polymerase inhibitor sofosbuvir [<xref rid="B194-pathogens-09-00856" ref-type="bibr">194</xref>] advanced to in vivo studies. Unfortunately, sofosbuvir monotherapy failed to prove its potency to reduce HEV viral loads in a phase II pilot trial [<xref rid="B207-pathogens-09-00856" ref-type="bibr">207</xref>]. Finally, the only developed vaccine against HEV, Hecolin<sup>&#x000ae;</sup>, is thus far only approved in China [<xref rid="B20-pathogens-09-00856" ref-type="bibr">20</xref>]. However, several other candidates based on the HEV capsid protein are currently being developed using different expression systems, such as baculovirus-infected insect cells [<xref rid="B208-pathogens-09-00856" ref-type="bibr">208</xref>], prokaryotic systems [<xref rid="B209-pathogens-09-00856" ref-type="bibr">209</xref>], expression in yeast [<xref rid="B210-pathogens-09-00856" ref-type="bibr">210</xref>,<xref rid="B211-pathogens-09-00856" ref-type="bibr">211</xref>], vectored vaccines [<xref rid="B212-pathogens-09-00856" ref-type="bibr">212</xref>], and chimeric vaccines [<xref rid="B213-pathogens-09-00856" ref-type="bibr">213</xref>,<xref rid="B214-pathogens-09-00856" ref-type="bibr">214</xref>]. So far, apart from Hecolin<sup>&#x000ae;</sup>, only two candidates have entered clinical trials [<xref rid="B215-pathogens-09-00856" ref-type="bibr">215</xref>,<xref rid="B216-pathogens-09-00856" ref-type="bibr">216</xref>]. An effective vaccine is an important step in preventing severe hepatitis E-related liver disease in risk populations such as pregnant women and immunocompromised patients.</p></sec><sec sec-type="conclusions" id="sec7-pathogens-09-00856"><title>7. Conclusions</title><p>Infection with hepatitis E virus is still an under-reported disease worldwide. However, awareness of the prevalence of this virus has grown exponentially in the last decades. Before and since its discovery, there had been numerous large-scale outbreaks in the developing world with tens of thousands of cases, demonstrating that HEV is the most common cause of viral hepatitis worldwide. While HEV-1 and HEV-2 occur mainly in waterborne epidemics in areas with insufficient hygienic conditions, sporadic cases of HEV-3 and HEV-4, which are transmitted zoonotically or via contaminated blood products in industrialized countries, have confirmed that HEV is not a health burden solely of resource poor regions. Although much effort has been put into elucidating the mechanisms of infection, replication, and pathology of the virus, many questions are still left unanswered, underlining the importance of further research on its virology. This is especially important as hepatitis E infections&#x02014;depending on the genotype&#x02014;can cause severe liver disease in risk groups such as pregnant women and immunocompromised persons. With these aspects in mind, it is clear that further research is vital to develop more effective treatment options and approved vaccination strategies.</p></sec></body><back><fn-group><fn><p><bold>Publisher&#x02019;s Note:</bold> MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group><notes><title>Author Contributions</title><p>T.P.V. and C.-T.B. contributed to the design and wrote the review. S.R.P. and D.H. wrote the first draft. J.H. and H.W. contributed to the section on discovery and history. D.T. and E.S. contributed to the section on virology. R.J. contributed to the section on outbreaks. M.S. and J.J.W. contributed to the section on epidemiology. J.H. and J.W.K.S. contributed to the chapter on diagnosis and clinical aspects. All authors have read and agreed to the published version of the manuscript.</p></notes><notes><title>Funding</title><p>This research was funded by grants from the German Federal Ministry of Health with regard to a decision of the German Bundestag by the Federal Government (CHED-project grant No: ZMVI1-2518FSB705) and (NiCaDe-project grant No: ZMVI1-2519GHP711), and grants from the German Federal Ministry of Education and Research (BMBF01DP19006A, BMBF01DP17047). D.H. is supported by the Claussen-Simon-Stiftung (Claussen-Simon Foundation; CSF) &#x0201c;Dissertation Plus&#x0201d; program, Germany, and the Fazit-Stiftung &#x0201c;Promotions Stipendium&#x0201d;.</p></notes><notes notes-type="COI-statement"><title>Conflicts of Interest</title><p>The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.</p></notes><ref-list><title>References</title><ref id="B1-pathogens-09-00856"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>D.B.</given-names></name><name><surname>Simmonds</surname><given-names>P.</given-names></name><collab>International Committee on the Taxonomy of Viruses Hepeviridae Study Group</collab><name><surname>Jameel</surname><given-names>S.</given-names></name><name><surname>Emerson</surname><given-names>S.U.</given-names></name><name><surname>Harrison</surname><given-names>T.J.</given-names></name><name><surname>Meng</surname><given-names>X.J.</given-names></name><name><surname>Okamoto</surname><given-names>H.</given-names></name><name><surname>Van der Poel</surname><given-names>W.H.M.</given-names></name><name><surname>Purdy</surname><given-names>M.A.</given-names></name></person-group><article-title>Consensus proposals for classification of the family Hepeviridae</article-title><source>J. Gen. Virol.</source><year>2014</year><volume>95</volume><fpage>2223</fpage><lpage>2232</lpage><pub-id pub-id-type="doi">10.1099/vir.0.068429-0</pub-id><?supplied-pmid 24989172?><pub-id pub-id-type="pmid">24989172</pub-id></element-citation></ref><ref id="B2-pathogens-09-00856"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Teshale</surname><given-names>E.H.</given-names></name><name><surname>Hu</surname><given-names>D.J.</given-names></name></person-group><article-title>Hepatitis E: Epidemiology and prevention</article-title><source>World J. Hepatol.</source><year>2011</year><volume>3</volume><fpage>285</fpage><lpage>291</lpage><pub-id pub-id-type="doi">10.4254/wjh.v3.i12.285</pub-id><?supplied-pmid 22216368?><pub-id pub-id-type="pmid">22216368</pub-id></element-citation></ref><ref id="B3-pathogens-09-00856"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perez-Gracia</surname><given-names>M.T.</given-names></name><name><surname>Suay-Garcia</surname><given-names>B.</given-names></name><name><surname>Mateos-Lindemann</surname><given-names>M.L.</given-names></name></person-group><article-title>Hepatitis E and pregnancy: Current state</article-title><source>Rev. Med. Virol.</source><year>2017</year><volume>27</volume><fpage>e1929</fpage><pub-id pub-id-type="doi">10.1002/rmv.1929</pub-id><?supplied-pmid 28318080?><pub-id pub-id-type="pmid">28318080</pub-id></element-citation></ref><ref id="B4-pathogens-09-00856"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dalton</surname><given-names>H.R.</given-names></name><name><surname>Stableforth</surname><given-names>W.</given-names></name><name><surname>Thurairajah</surname><given-names>P.</given-names></name><name><surname>Hazeldine</surname><given-names>S.</given-names></name><name><surname>Remnarace</surname><given-names>R.</given-names></name><name><surname>Usama</surname><given-names>W.</given-names></name><name><surname>Farrington</surname><given-names>L.</given-names></name><name><surname>Hamad</surname><given-names>N.</given-names></name><name><surname>Sieberhagen</surname><given-names>C.</given-names></name><name><surname>Ellis</surname><given-names>V.</given-names></name><etal/></person-group><article-title>Autochthonous hepatitis E in Southwest England: Natural history, complications and seasonal variation, and hepatitis E virus IgG seroprevalence in blood donors, the elderly and patients with chronic liver disease</article-title><source>Eur. J. Gastroenterol. Hepatol.</source><year>2008</year><volume>20</volume><fpage>784</fpage><lpage>790</lpage><pub-id pub-id-type="doi">10.1097/MEG.0b013e3282f5195a</pub-id><pub-id pub-id-type="pmid">18617784</pub-id></element-citation></ref><ref id="B5-pathogens-09-00856"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kamar</surname><given-names>N.</given-names></name><name><surname>Selves</surname><given-names>J.</given-names></name><name><surname>Mansuy</surname><given-names>J.M.</given-names></name><name><surname>Ouezzani</surname><given-names>L.</given-names></name><name><surname>Peron</surname><given-names>J.M.</given-names></name><name><surname>Guitard</surname><given-names>J.</given-names></name><name><surname>Cointault</surname><given-names>O.</given-names></name><name><surname>Esposito</surname><given-names>L.</given-names></name><name><surname>Abravanel</surname><given-names>F.</given-names></name><name><surname>Danjoux</surname><given-names>M.</given-names></name><etal/></person-group><article-title>Hepatitis E virus and chronic hepatitis in organ-transplant recipients</article-title><source>N. Engl. J. Med.</source><year>2008</year><volume>358</volume><fpage>811</fpage><lpage>817</lpage><pub-id pub-id-type="doi">10.1056/NEJMoa0706992</pub-id><pub-id pub-id-type="pmid">18287603</pub-id></element-citation></ref><ref id="B6-pathogens-09-00856"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bai</surname><given-names>M.J.</given-names></name><name><surname>Zhou</surname><given-names>N.</given-names></name><name><surname>Dong</surname><given-names>W.</given-names></name><name><surname>Li</surname><given-names>G.X.</given-names></name><name><surname>Cong</surname><given-names>W.</given-names></name><name><surname>Zhu</surname><given-names>X.Q.</given-names></name></person-group><article-title>Seroprevalence and risk factors of hepatitis E virus infection in cancer patients in eastern China</article-title><source>Int. J. Infect. Dis.</source><year>2018</year><volume>71</volume><fpage>42</fpage><lpage>47</lpage><pub-id pub-id-type="doi">10.1016/j.ijid.2018.04.003</pub-id><pub-id pub-id-type="pmid">29656134</pub-id></element-citation></ref><ref id="B7-pathogens-09-00856"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rivero-Juarez</surname><given-names>A.</given-names></name><name><surname>Lopez-Lopez</surname><given-names>P.</given-names></name><name><surname>Frias</surname><given-names>M.</given-names></name><name><surname>Rivero</surname><given-names>A.</given-names></name></person-group><article-title>Hepatitis E Infection in HIV-Infected Patients</article-title><source>Front. Microbiol.</source><year>2019</year><volume>10</volume><fpage>1425</fpage><pub-id pub-id-type="doi">10.3389/fmicb.2019.01425</pub-id><pub-id pub-id-type="pmid">31297100</pub-id></element-citation></ref><ref id="B8-pathogens-09-00856"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>P.</given-names></name><name><surname>Liu</surname><given-names>J.</given-names></name><name><surname>Li</surname><given-names>Y.</given-names></name><name><surname>Su</surname><given-names>J.</given-names></name><name><surname>Ma</surname><given-names>Z.</given-names></name><name><surname>Bramer</surname><given-names>W.M.</given-names></name><name><surname>Cao</surname><given-names>W.</given-names></name><name><surname>de Man</surname><given-names>R.A.</given-names></name><name><surname>Peppelenbosch</surname><given-names>M.P.</given-names></name><name><surname>Pan</surname><given-names>Q.</given-names></name></person-group><article-title>The global epidemiology of hepatitis E virus infection: A systematic review and meta-analysis</article-title><source>Liver Int.</source><year>2020</year><volume>40</volume><fpage>1516</fpage><lpage>1528</lpage><pub-id pub-id-type="doi">10.1111/liv.14468</pub-id><pub-id pub-id-type="pmid">32281721</pub-id></element-citation></ref><ref id="B9-pathogens-09-00856"><label>9.</label><element-citation publication-type="web"><person-group person-group-type="author"><collab>WHO</collab></person-group><article-title>Hepatitis E: Fact Sheet. 2020</article-title><comment>Available online: <ext-link ext-link-type="uri" xlink:href="https://www.who.int/news-room/fact-sheets/detail/hepatitis-e">https://www.who.int/news-room/fact-sheets/detail/hepatitis-e</ext-link></comment><date-in-citation content-type="access-date" iso-8601-date="2020-10-19">(accessed on 19 October 2020)</date-in-citation></element-citation></ref><ref id="B10-pathogens-09-00856"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>D.B.</given-names></name><name><surname>Izopet</surname><given-names>J.</given-names></name><name><surname>Nicot</surname><given-names>F.</given-names></name><name><surname>Simmonds</surname><given-names>P.</given-names></name><name><surname>Jameel</surname><given-names>S.</given-names></name><name><surname>Meng</surname><given-names>X.-J.</given-names></name><name><surname>Norder</surname><given-names>H.</given-names></name><name><surname>Okamoto</surname><given-names>H.</given-names></name><name><surname>van der Poel</surname><given-names>W.H.M.</given-names></name><name><surname>Reuter</surname><given-names>G.</given-names></name><etal/></person-group><article-title>Update: Proposed reference sequences for subtypes of hepatitis E virus (species Orthohepevirus A)</article-title><source>J. Gen. Virol.</source><year>2020</year><volume>101</volume><fpage>692</fpage><lpage>698</lpage><pub-id pub-id-type="doi">10.1099/jgv.0.001435</pub-id><pub-id pub-id-type="pmid">32469300</pub-id></element-citation></ref><ref id="B11-pathogens-09-00856"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>G.H.</given-names></name><name><surname>Tan</surname><given-names>B.H.</given-names></name><name><surname>Teo</surname><given-names>E.C.</given-names></name><name><surname>Lim</surname><given-names>S.G.</given-names></name><name><surname>Dan</surname><given-names>Y.Y.</given-names></name><name><surname>Wee</surname><given-names>A.</given-names></name><name><surname>Aw</surname><given-names>P.P.</given-names></name><name><surname>Zhu</surname><given-names>Y.</given-names></name><name><surname>Hibberd</surname><given-names>M.L.</given-names></name><name><surname>Tan</surname><given-names>C.K.</given-names></name><etal/></person-group><article-title>Chronic Infection With Camelid Hepatitis E Virus in a Liver Transplant Recipient Who Regularly Consumes Camel Meat and Milk</article-title><source>Gastroenterology</source><year>2016</year><volume>150</volume><fpage>355</fpage><lpage>357.e353</lpage><pub-id pub-id-type="doi">10.1053/j.gastro.2015.10.048</pub-id><pub-id pub-id-type="pmid">26551551</pub-id></element-citation></ref><ref id="B12-pathogens-09-00856"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sridhar</surname><given-names>S.</given-names></name><name><surname>Yip</surname><given-names>C.C.</given-names></name><name><surname>Wu</surname><given-names>S.</given-names></name><name><surname>Chew</surname><given-names>N.F.</given-names></name><name><surname>Leung</surname><given-names>K.H.</given-names></name><name><surname>Chan</surname><given-names>J.F.</given-names></name><name><surname>Zhao</surname><given-names>P.S.</given-names></name><name><surname>Chan</surname><given-names>W.M.</given-names></name><name><surname>Poon</surname><given-names>R.W.</given-names></name><name><surname>Tsoi</surname><given-names>H.W.</given-names></name><etal/></person-group><article-title>Transmission of rat hepatitis E virus infection to humans in Hong Kong: A clinical and epidemiological analysis</article-title><source>Hepatology</source><year>2020</year><pub-id pub-id-type="doi">10.1002/hep.31138</pub-id><?supplied-pmid 31960460?><pub-id pub-id-type="pmid">31960460</pub-id></element-citation></ref><ref id="B13-pathogens-09-00856"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andonov</surname><given-names>A.</given-names></name><name><surname>Robbins</surname><given-names>M.</given-names></name><name><surname>Borlang</surname><given-names>J.</given-names></name><name><surname>Cao</surname><given-names>J.</given-names></name><name><surname>Hatchette</surname><given-names>T.</given-names></name><name><surname>Stueck</surname><given-names>A.</given-names></name><name><surname>Deschambault</surname><given-names>Y.</given-names></name><name><surname>Murnaghan</surname><given-names>K.</given-names></name><name><surname>Varga</surname><given-names>J.</given-names></name><name><surname>Johnston</surname><given-names>L.</given-names></name></person-group><article-title>Rat Hepatitis E Virus Linked to Severe Acute Hepatitis in an Immunocompetent Patient</article-title><source>J. Infect. Dis.</source><year>2019</year><volume>220</volume><fpage>951</fpage><lpage>955</lpage><pub-id pub-id-type="doi">10.1093/infdis/jiz025</pub-id><?supplied-pmid 30649379?><pub-id pub-id-type="pmid">30649379</pub-id></element-citation></ref><ref id="B14-pathogens-09-00856"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khuroo</surname><given-names>M.S.</given-names></name><name><surname>Khuroo</surname><given-names>M.S.</given-names></name><name><surname>Khuroo</surname><given-names>N.S.</given-names></name></person-group><article-title>Transmission of Hepatitis E Virus in Developing Countries</article-title><source>Viruses</source><year>2016</year><volume>8</volume><elocation-id>253</elocation-id><pub-id pub-id-type="doi">10.3390/v8090253</pub-id><?supplied-pmid 27657112?><pub-id pub-id-type="pmid">27657112</pub-id></element-citation></ref><ref id="B15-pathogens-09-00856"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>B.</given-names></name><name><surname>Meng</surname><given-names>X.J.</given-names></name></person-group><article-title>Hepatitis E virus: Host tropism and zoonotic infection</article-title><source>Curr. Opin. Microbiol.</source><year>2020</year><volume>59</volume><fpage>8</fpage><lpage>15</lpage><pub-id pub-id-type="doi">10.1016/j.mib.2020.07.004</pub-id><pub-id pub-id-type="pmid">32810801</pub-id></element-citation></ref><ref id="B16-pathogens-09-00856"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mirazo</surname><given-names>S.</given-names></name><name><surname>Ramos</surname><given-names>N.</given-names></name><name><surname>Mainardi</surname><given-names>V.</given-names></name><name><surname>Gerona</surname><given-names>S.</given-names></name><name><surname>Arbiza</surname><given-names>J.</given-names></name></person-group><article-title>Transmission, diagnosis, and management of hepatitis E: An update</article-title><source>Hepatic Med.</source><year>2014</year><volume>6</volume><fpage>45</fpage><lpage>59</lpage><pub-id pub-id-type="doi">10.2147/HMER.S63417</pub-id></element-citation></ref><ref id="B17-pathogens-09-00856"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Patra</surname><given-names>S.</given-names></name><name><surname>Kumar</surname><given-names>A.</given-names></name><name><surname>Trivedi</surname><given-names>S.S.</given-names></name><name><surname>Puri</surname><given-names>M.</given-names></name><name><surname>Sarin</surname><given-names>S.K.</given-names></name></person-group><article-title>Maternal and fetal outcomes in pregnant women with acute hepatitis E virus infection</article-title><source>Ann. Intern. Med.</source><year>2007</year><volume>147</volume><fpage>28</fpage><lpage>33</lpage><pub-id pub-id-type="doi">10.7326/0003-4819-147-1-200707030-00005</pub-id><pub-id pub-id-type="pmid">17606958</pub-id></element-citation></ref><ref id="B18-pathogens-09-00856"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>G&#x000e9;rolami</surname><given-names>R.</given-names></name><name><surname>Moal</surname><given-names>V.</given-names></name><name><surname>Colson</surname><given-names>P.</given-names></name></person-group><article-title>Chronic hepatitis E with cirrhosis in a kidney-transplant recipient</article-title><source>N. Engl. J. Med.</source><year>2008</year><volume>358</volume><fpage>859</fpage><lpage>860</lpage><pub-id pub-id-type="doi">10.1056/NEJMc0708687</pub-id><pub-id pub-id-type="pmid">18287615</pub-id></element-citation></ref><ref id="B19-pathogens-09-00856"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haagsma</surname><given-names>E.B.</given-names></name><name><surname>van den Berg</surname><given-names>A.P.</given-names></name><name><surname>Porte</surname><given-names>R.J.</given-names></name><name><surname>Benne</surname><given-names>C.A.</given-names></name><name><surname>Vennema</surname><given-names>H.</given-names></name><name><surname>Reimerink</surname><given-names>J.H.</given-names></name><name><surname>Koopmans</surname><given-names>M.P.</given-names></name></person-group><article-title>Chronic hepatitis E virus infection in liver transplant recipients</article-title><source>Liver Transpl.</source><year>2008</year><volume>14</volume><fpage>547</fpage><lpage>553</lpage><pub-id pub-id-type="doi">10.1002/lt.21480</pub-id><pub-id pub-id-type="pmid">18383084</pub-id></element-citation></ref><ref id="B20-pathogens-09-00856"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>F.C.</given-names></name><name><surname>Zhang</surname><given-names>J.</given-names></name><name><surname>Zhang</surname><given-names>X.F.</given-names></name><name><surname>Zhou</surname><given-names>C.</given-names></name><name><surname>Wang</surname><given-names>Z.Z.</given-names></name><name><surname>Huang</surname><given-names>S.J.</given-names></name><name><surname>Wang</surname><given-names>H.</given-names></name><name><surname>Yang</surname><given-names>C.L.</given-names></name><name><surname>Jiang</surname><given-names>H.M.</given-names></name><name><surname>Cai</surname><given-names>J.P.</given-names></name><etal/></person-group><article-title>Efficacy and safety of a recombinant hepatitis E vaccine in healthy adults: A large-scale, randomised, double-blind placebo-controlled, phase 3 trial</article-title><source>Lancet</source><year>2010</year><volume>376</volume><fpage>895</fpage><lpage>902</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(10)61030-6</pub-id><pub-id pub-id-type="pmid">20728932</pub-id></element-citation></ref><ref id="B21-pathogens-09-00856"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arankalle</surname><given-names>V.A.</given-names></name><name><surname>Chadha</surname><given-names>M.S.</given-names></name><name><surname>Tsarev</surname><given-names>S.A.</given-names></name><name><surname>Emerson</surname><given-names>S.U.</given-names></name><name><surname>Risbud</surname><given-names>A.R.</given-names></name><name><surname>Banerjee</surname><given-names>K.</given-names></name><name><surname>Purcell</surname><given-names>R.H.</given-names></name></person-group><article-title>Seroepidemiology of water-borne hepatitis in India and evidence for a third enterically-transmitted hepatitis agent</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>1994</year><volume>91</volume><fpage>3428</fpage><lpage>3432</lpage><pub-id pub-id-type="doi">10.1073/pnas.91.8.3428</pub-id><pub-id pub-id-type="pmid">8159764</pub-id></element-citation></ref><ref id="B22-pathogens-09-00856"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khuroo</surname><given-names>M.S.</given-names></name></person-group><article-title>Hepatitis E: The enterically transmitted non-A, non-B hepatitis</article-title><source>Indian J. Gastroenterol.</source><year>1991</year><volume>10</volume><fpage>96</fpage><lpage>100</lpage><pub-id pub-id-type="doi">10.1101/cshperspect.a033449</pub-id><pub-id pub-id-type="pmid">1916971</pub-id></element-citation></ref><ref id="B23-pathogens-09-00856"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khuroo</surname><given-names>M.S.</given-names></name></person-group><article-title>Study of an epidemic of non-A, non-B hepatitis. Possibility of another human hepatitis virus distinct from post-transfusion non-A, non-B type</article-title><source>Am. J. Med.</source><year>1980</year><volume>68</volume><fpage>818</fpage><lpage>824</lpage><pub-id pub-id-type="doi">10.1016/0002-9343(80)90200-4</pub-id><pub-id pub-id-type="pmid">6770682</pub-id></element-citation></ref><ref id="B24-pathogens-09-00856"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Balayan</surname><given-names>M.S.</given-names></name><name><surname>Andjaparidze</surname><given-names>A.G.</given-names></name><name><surname>Savinskaya</surname><given-names>S.S.</given-names></name><name><surname>Ketiladze</surname><given-names>E.S.</given-names></name><name><surname>Braginsky</surname><given-names>D.M.</given-names></name><name><surname>Savinov</surname><given-names>A.P.</given-names></name><name><surname>Poleschuk</surname><given-names>V.F.</given-names></name></person-group><article-title>Evidence for a virus in non-A, non-B hepatitis transmitted via the fecal-oral route</article-title><source>Intervirology</source><year>1983</year><volume>20</volume><fpage>23</fpage><lpage>31</lpage><pub-id pub-id-type="doi">10.1159/000149370</pub-id><?supplied-pmid 6409836?><pub-id pub-id-type="pmid">6409836</pub-id></element-citation></ref><ref id="B25-pathogens-09-00856"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tam</surname><given-names>A.W.</given-names></name><name><surname>Smith</surname><given-names>M.M.</given-names></name><name><surname>Guerra</surname><given-names>M.E.</given-names></name><name><surname>Huang</surname><given-names>C.C.</given-names></name><name><surname>Bradley</surname><given-names>D.W.</given-names></name><name><surname>Fry</surname><given-names>K.E.</given-names></name><name><surname>Reyes</surname><given-names>G.R.</given-names></name></person-group><article-title>Hepatitis E virus (HEV): Molecular cloning and sequencing of the full-length viral genome</article-title><source>Virology</source><year>1991</year><volume>185</volume><fpage>120</fpage><lpage>131</lpage><pub-id pub-id-type="doi">10.1016/0042-6822(91)90760-9</pub-id><pub-id pub-id-type="pmid">1926770</pub-id></element-citation></ref><ref id="B26-pathogens-09-00856"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reyes</surname><given-names>G.R.</given-names></name><name><surname>Purdy</surname><given-names>M.A.</given-names></name><name><surname>Kim</surname><given-names>J.P.</given-names></name><name><surname>Luk</surname><given-names>K.C.</given-names></name><name><surname>Young</surname><given-names>L.M.</given-names></name><name><surname>Fry</surname><given-names>K.E.</given-names></name><name><surname>Bradley</surname><given-names>D.W.</given-names></name></person-group><article-title>Isolation of a cDNA from the virus responsible for enterically transmitted non-A, non-B hepatitis</article-title><source>Science</source><year>1990</year><volume>247</volume><fpage>1335</fpage><lpage>1339</lpage><pub-id pub-id-type="doi">10.1126/science.2107574</pub-id><pub-id pub-id-type="pmid">2107574</pub-id></element-citation></ref><ref id="B27-pathogens-09-00856"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mast</surname><given-names>E.E.</given-names></name><name><surname>Kuramoto</surname><given-names>I.K.</given-names></name><name><surname>Favorov</surname><given-names>M.O.</given-names></name><name><surname>Schoening</surname><given-names>V.R.</given-names></name><name><surname>Burkholder</surname><given-names>B.T.</given-names></name><name><surname>Shapiro</surname><given-names>C.N.</given-names></name><name><surname>Holland</surname><given-names>P.V.</given-names></name></person-group><article-title>Prevalence of and risk factors for antibody to hepatitis E virus seroreactivity among blood donors in Northern California</article-title><source>J. Infect. Dis.</source><year>1997</year><volume>176</volume><fpage>34</fpage><lpage>40</lpage><pub-id pub-id-type="doi">10.1086/514037</pub-id><?supplied-pmid 9207347?><pub-id pub-id-type="pmid">9207347</pub-id></element-citation></ref><ref id="B28-pathogens-09-00856"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meng</surname><given-names>X.J.</given-names></name><name><surname>Halbur</surname><given-names>P.G.</given-names></name><name><surname>Shapiro</surname><given-names>M.S.</given-names></name><name><surname>Govindarajan</surname><given-names>S.</given-names></name><name><surname>Bruna</surname><given-names>J.D.</given-names></name><name><surname>Mushahwar</surname><given-names>I.K.</given-names></name><name><surname>Purcell</surname><given-names>R.H.</given-names></name><name><surname>Emerson</surname><given-names>S.U.</given-names></name></person-group><article-title>Genetic and experimental evidence for cross-species infection by swine hepatitis E virus</article-title><source>J. Virol.</source><year>1998</year><volume>72</volume><fpage>9714</fpage><lpage>9721</lpage><pub-id pub-id-type="doi">10.1128/JVI.72.12.9714-9721.1998</pub-id><?supplied-pmid 9811705?><pub-id pub-id-type="pmid">9811705</pub-id></element-citation></ref><ref id="B29-pathogens-09-00856"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meng</surname><given-names>X.J.</given-names></name><name><surname>Purcell</surname><given-names>R.H.</given-names></name><name><surname>Halbur</surname><given-names>P.G.</given-names></name><name><surname>Lehman</surname><given-names>J.R.</given-names></name><name><surname>Webb</surname><given-names>D.M.</given-names></name><name><surname>Tsareva</surname><given-names>T.S.</given-names></name><name><surname>Haynes</surname><given-names>J.S.</given-names></name><name><surname>Thacker</surname><given-names>B.J.</given-names></name><name><surname>Emerson</surname><given-names>S.U.</given-names></name></person-group><article-title>A novel virus in swine is closely related to the human hepatitis E virus</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>1997</year><volume>94</volume><fpage>9860</fpage><lpage>9865</lpage><pub-id pub-id-type="doi">10.1073/pnas.94.18.9860</pub-id><pub-id pub-id-type="pmid">9275216</pub-id></element-citation></ref><ref id="B30-pathogens-09-00856"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bradley</surname><given-names>D.</given-names></name><name><surname>Andjaparidze</surname><given-names>A.</given-names></name><name><surname>Cook</surname><given-names>E.H.</given-names><suffix>Jr.</suffix></name><name><surname>McCaustland</surname><given-names>K.</given-names></name><name><surname>Balayan</surname><given-names>M.</given-names></name><name><surname>Stetler</surname><given-names>H.</given-names></name><name><surname>Velazquez</surname><given-names>O.</given-names></name><name><surname>Robertson</surname><given-names>B.</given-names></name><name><surname>Humphrey</surname><given-names>C.</given-names></name><name><surname>Kane</surname><given-names>M.</given-names></name><etal/></person-group><article-title>Aetiological agent of enterically transmitted non-A, non-B hepatitis</article-title><source>J. Gen. Virol.</source><year>1988</year><volume>69</volume><issue-part>Pt 3</issue-part><fpage>731</fpage><lpage>738</lpage><pub-id pub-id-type="doi">10.1099/0022-1317-69-3-731</pub-id><pub-id pub-id-type="pmid">3127543</pub-id></element-citation></ref><ref id="B31-pathogens-09-00856"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Graff</surname><given-names>J.</given-names></name><name><surname>Torian</surname><given-names>U.</given-names></name><name><surname>Nguyen</surname><given-names>H.</given-names></name><name><surname>Emerson</surname><given-names>S.U.</given-names></name></person-group><article-title>A bicistronic subgenomic mRNA encodes both the ORF2 and ORF3 proteins of hepatitis E virus</article-title><source>J. Virol.</source><year>2006</year><volume>80</volume><fpage>5919</fpage><lpage>5926</lpage><pub-id pub-id-type="doi">10.1128/JVI.00046-06</pub-id><?supplied-pmid 16731930?><pub-id pub-id-type="pmid">16731930</pub-id></element-citation></ref><ref id="B32-pathogens-09-00856"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koonin</surname><given-names>E.V.</given-names></name><name><surname>Gorbalenya</surname><given-names>A.E.</given-names></name><name><surname>Purdy</surname><given-names>M.A.</given-names></name><name><surname>Rozanov</surname><given-names>M.N.</given-names></name><name><surname>Reyes</surname><given-names>G.R.</given-names></name><name><surname>Bradley</surname><given-names>D.W.</given-names></name></person-group><article-title>Computer-assisted assignment of functional domains in the nonstructural polyprotein of hepatitis E virus: Delineation of an additional group of positive-strand RNA plant and animal viruses</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>1992</year><volume>89</volume><fpage>8259</fpage><lpage>8263</lpage><pub-id pub-id-type="doi">10.1073/pnas.89.17.8259</pub-id><?supplied-pmid 1518855?><pub-id pub-id-type="pmid">1518855</pub-id></element-citation></ref><ref id="B33-pathogens-09-00856"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Karpe</surname><given-names>Y.A.</given-names></name><name><surname>Lole</surname><given-names>K.S.</given-names></name></person-group><article-title>Deubiquitination activity associated with hepatitis E virus putative papain-like cysteine protease</article-title><source>J. Gen. Virol.</source><year>2011</year><volume>92</volume><fpage>2088</fpage><lpage>2092</lpage><pub-id pub-id-type="doi">10.1099/vir.0.033738-0</pub-id><?supplied-pmid 21653754?><pub-id pub-id-type="pmid">21653754</pub-id></element-citation></ref><ref id="B34-pathogens-09-00856"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Magden</surname><given-names>J.</given-names></name><name><surname>Takeda</surname><given-names>N.</given-names></name><name><surname>Li</surname><given-names>T.</given-names></name><name><surname>Auvinen</surname><given-names>P.</given-names></name><name><surname>Ahola</surname><given-names>T.</given-names></name><name><surname>Miyamura</surname><given-names>T.</given-names></name><name><surname>Merits</surname><given-names>A.</given-names></name><name><surname>Kaariainen</surname><given-names>L.</given-names></name></person-group><article-title>Virus-specific mRNA capping enzyme encoded by hepatitis E virus</article-title><source>J. Virol.</source><year>2001</year><volume>75</volume><fpage>6249</fpage><lpage>6255</lpage><pub-id pub-id-type="doi">10.1128/JVI.75.14.6249-6255.2001</pub-id><pub-id pub-id-type="pmid">11413290</pub-id></element-citation></ref><ref id="B35-pathogens-09-00856"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Karpe</surname><given-names>Y.A.</given-names></name><name><surname>Lole</surname><given-names>K.S.</given-names></name></person-group><article-title>RNA 5&#x02032;-triphosphatase activity of the hepatitis E virus helicase domain</article-title><source>J. Virol.</source><year>2010</year><volume>84</volume><fpage>9637</fpage><lpage>9641</lpage><pub-id pub-id-type="doi">10.1128/JVI.00492-10</pub-id><?supplied-pmid 20592074?><pub-id pub-id-type="pmid">20592074</pub-id></element-citation></ref><ref id="B36-pathogens-09-00856"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Agrawal</surname><given-names>S.</given-names></name><name><surname>Gupta</surname><given-names>D.</given-names></name><name><surname>Panda</surname><given-names>S.K.</given-names></name></person-group><article-title>The 3&#x02032; end of hepatitis E virus (HEV) genome binds specifically to the viral RNA-dependent RNA polymerase (RdRp)</article-title><source>Virology</source><year>2001</year><volume>282</volume><fpage>87</fpage><lpage>101</lpage><pub-id pub-id-type="doi">10.1006/viro.2000.0819</pub-id><?supplied-pmid 11259193?><pub-id pub-id-type="pmid">11259193</pub-id></element-citation></ref><ref id="B37-pathogens-09-00856"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parvez</surname><given-names>M.K.</given-names></name></person-group><article-title>Molecular characterization of hepatitis E virus ORF1 gene supports a papain-like cysteine protease (PCP)-domain activity</article-title><source>Virus Res.</source><year>2013</year><volume>178</volume><fpage>553</fpage><lpage>556</lpage><pub-id pub-id-type="doi">10.1016/j.virusres.2013.07.020</pub-id><pub-id pub-id-type="pmid">23978667</pub-id></element-citation></ref><ref id="B38-pathogens-09-00856"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parvez</surname><given-names>M.K.</given-names></name><name><surname>Khan</surname><given-names>A.A.</given-names></name></person-group><article-title>Molecular modeling and analysis of hepatitis E virus (HEV) papain-like cysteine protease</article-title><source>Virus Res.</source><year>2014</year><volume>179</volume><fpage>220</fpage><lpage>224</lpage><pub-id pub-id-type="doi">10.1016/j.virusres.2013.11.016</pub-id><pub-id pub-id-type="pmid">24321124</pub-id></element-citation></ref><ref id="B39-pathogens-09-00856"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>D.B.</given-names></name><name><surname>Vanek</surname><given-names>J.</given-names></name><name><surname>Ramalingam</surname><given-names>S.</given-names></name><name><surname>Johannessen</surname><given-names>I.</given-names></name><name><surname>Templeton</surname><given-names>K.</given-names></name><name><surname>Simmonds</surname><given-names>P.</given-names></name></person-group><article-title>Evolution of the hepatitis E virus hypervariable region</article-title><source>J. Gen. Virol.</source><year>2012</year><volume>93</volume><fpage>2408</fpage><lpage>2418</lpage><pub-id pub-id-type="doi">10.1099/vir.0.045351-0</pub-id><pub-id pub-id-type="pmid">22837418</pub-id></element-citation></ref><ref id="B40-pathogens-09-00856"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lhomme</surname><given-names>S.</given-names></name><name><surname>Nicot</surname><given-names>F.</given-names></name><name><surname>Jeanne</surname><given-names>N.</given-names></name><name><surname>Dimeglio</surname><given-names>C.</given-names></name><name><surname>Roulet</surname><given-names>A.</given-names></name><name><surname>Lefebvre</surname><given-names>C.</given-names></name><name><surname>Carcenac</surname><given-names>R.</given-names></name><name><surname>Manno</surname><given-names>M.</given-names></name><name><surname>Dubois</surname><given-names>M.</given-names></name><name><surname>Peron</surname><given-names>J.M.</given-names></name><etal/></person-group><article-title>Insertions and Duplications in the Polyproline Region of the Hepatitis E Virus</article-title><source>Front. Microbiol.</source><year>2020</year><volume>11</volume><fpage>1</fpage><pub-id pub-id-type="doi">10.3389/fmicb.2020.00001</pub-id><pub-id pub-id-type="pmid">32082274</pub-id></element-citation></ref><ref id="B41-pathogens-09-00856"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jameel</surname><given-names>S.</given-names></name><name><surname>Zafrullah</surname><given-names>M.</given-names></name><name><surname>Ozdener</surname><given-names>M.H.</given-names></name><name><surname>Panda</surname><given-names>S.K.</given-names></name></person-group><article-title>Expression in animal cells and characterization of the hepatitis E virus structural proteins</article-title><source>J. Virol.</source><year>1996</year><volume>70</volume><fpage>207</fpage><lpage>216</lpage><pub-id pub-id-type="doi">10.1128/JVI.70.1.207-216.1996</pub-id><pub-id pub-id-type="pmid">8523527</pub-id></element-citation></ref><ref id="B42-pathogens-09-00856"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Torresi</surname><given-names>J.</given-names></name><name><surname>Li</surname><given-names>F.</given-names></name><name><surname>Locarnini</surname><given-names>S.A.</given-names></name><name><surname>Anderson</surname><given-names>D.A.</given-names></name></person-group><article-title>Only the non-glycosylated fraction of hepatitis E virus capsid (open reading frame 2) protein is stable in mammalian cells</article-title><source>J. Gen. Virol.</source><year>1999</year><volume>80</volume><issue-part>Pt 5</issue-part><fpage>1185</fpage><lpage>1188</lpage><pub-id pub-id-type="doi">10.1099/0022-1317-80-5-1185</pub-id><pub-id pub-id-type="pmid">10355765</pub-id></element-citation></ref><ref id="B43-pathogens-09-00856"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zafrullah</surname><given-names>M.</given-names></name><name><surname>Ozdener</surname><given-names>M.H.</given-names></name><name><surname>Kumar</surname><given-names>R.</given-names></name><name><surname>Panda</surname><given-names>S.K.</given-names></name><name><surname>Jameel</surname><given-names>S.</given-names></name></person-group><article-title>Mutational analysis of glycosylation, membrane translocation, and cell surface expression of the hepatitis E virus ORF2 protein</article-title><source>J. Virol.</source><year>1999</year><volume>73</volume><fpage>4074</fpage><lpage>4082</lpage><pub-id pub-id-type="doi">10.1128/JVI.73.5.4074-4082.1999</pub-id><?supplied-pmid 10196303?><pub-id pub-id-type="pmid">10196303</pub-id></element-citation></ref><ref id="B44-pathogens-09-00856"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>Y.H.</given-names></name><name><surname>Purcell</surname><given-names>R.H.</given-names></name><name><surname>Emerson</surname><given-names>S.U.</given-names></name></person-group><article-title>A truncated ORF2 protein contains the most immunogenic site on ORF2: Antibody responses to non-vaccine sequences following challenge of vaccinated and non-vaccinated macaques with hepatitis E virus</article-title><source>Vaccine</source><year>2005</year><volume>23</volume><fpage>3157</fpage><lpage>3165</lpage><pub-id pub-id-type="doi">10.1016/j.vaccine.2004.12.020</pub-id><pub-id pub-id-type="pmid">15837215</pub-id></element-citation></ref><ref id="B45-pathogens-09-00856"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yin</surname><given-names>X.</given-names></name><name><surname>Ying</surname><given-names>D.</given-names></name><name><surname>Lhomme</surname><given-names>S.</given-names></name><name><surname>Tang</surname><given-names>Z.</given-names></name><name><surname>Walker</surname><given-names>C.M.</given-names></name><name><surname>Xia</surname><given-names>N.</given-names></name><name><surname>Zheng</surname><given-names>Z.</given-names></name><name><surname>Feng</surname><given-names>Z.</given-names></name></person-group><article-title>Origin, antigenicity, and function of a secreted form of ORF2 in hepatitis E virus infection</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>2018</year><volume>115</volume><fpage>4773</fpage><lpage>4778</lpage><pub-id pub-id-type="doi">10.1073/pnas.1721345115</pub-id><pub-id pub-id-type="pmid">29669922</pub-id></element-citation></ref><ref id="B46-pathogens-09-00856"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Montpellier</surname><given-names>C.</given-names></name><name><surname>Wychowski</surname><given-names>C.</given-names></name><name><surname>Sayed</surname><given-names>I.M.</given-names></name><name><surname>Meunier</surname><given-names>J.C.</given-names></name><name><surname>Saliou</surname><given-names>J.M.</given-names></name><name><surname>Ankavay</surname><given-names>M.</given-names></name><name><surname>Bull</surname><given-names>A.</given-names></name><name><surname>Pillez</surname><given-names>A.</given-names></name><name><surname>Abravanel</surname><given-names>F.</given-names></name><name><surname>Helle</surname><given-names>F.</given-names></name><etal/></person-group><article-title>Hepatitis E Virus Lifecycle and Identification of 3 Forms of the ORF2 Capsid Protein</article-title><source>Gastroenterology</source><year>2018</year><volume>154</volume><fpage>211</fpage><lpage>223.e218</lpage><pub-id pub-id-type="doi">10.1053/j.gastro.2017.09.020</pub-id><pub-id pub-id-type="pmid">28958858</pub-id></element-citation></ref><ref id="B47-pathogens-09-00856"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nagashima</surname><given-names>S.</given-names></name><name><surname>Takahashi</surname><given-names>M.</given-names></name><name><surname>Jirintai</surname><given-names>S.</given-names></name><name><surname>Tanaka</surname><given-names>T.</given-names></name><name><surname>Yamada</surname><given-names>K.</given-names></name><name><surname>Nishizawa</surname><given-names>T.</given-names></name><name><surname>Okamoto</surname><given-names>H.</given-names></name></person-group><article-title>A PSAP motif in the ORF3 protein of hepatitis E virus is necessary for virion release from infected cells</article-title><source>J. Gen. Virol.</source><year>2011</year><volume>92</volume><fpage>269</fpage><lpage>278</lpage><pub-id pub-id-type="doi">10.1099/vir.0.025791-0</pub-id><pub-id pub-id-type="pmid">21068219</pub-id></element-citation></ref><ref id="B48-pathogens-09-00856"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nagashima</surname><given-names>S.</given-names></name><name><surname>Takahashi</surname><given-names>M.</given-names></name><name><surname>Jirintai</surname><given-names>S.</given-names></name><name><surname>Tanaka</surname><given-names>T.</given-names></name><name><surname>Nishizawa</surname><given-names>T.</given-names></name><name><surname>Yasuda</surname><given-names>J.</given-names></name><name><surname>Okamoto</surname><given-names>H.</given-names></name></person-group><article-title>Tumour susceptibility gene 101 and the vacuolar protein sorting pathway are required for the release of hepatitis E virions</article-title><source>J. Gen. Virol.</source><year>2011</year><volume>92</volume><fpage>2838</fpage><lpage>2848</lpage><pub-id pub-id-type="doi">10.1099/vir.0.035378-0</pub-id><pub-id pub-id-type="pmid">21880841</pub-id></element-citation></ref><ref id="B49-pathogens-09-00856"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kannan</surname><given-names>H.</given-names></name><name><surname>Fan</surname><given-names>S.</given-names></name><name><surname>Patel</surname><given-names>D.</given-names></name><name><surname>Bossis</surname><given-names>I.</given-names></name><name><surname>Zhang</surname><given-names>Y.J.</given-names></name></person-group><article-title>The hepatitis E virus open reading frame 3 product interacts with microtubules and interferes with their dynamics</article-title><source>J. Virol.</source><year>2009</year><volume>83</volume><fpage>6375</fpage><lpage>6382</lpage><pub-id pub-id-type="doi">10.1128/JVI.02571-08</pub-id><?supplied-pmid 19369329?><pub-id pub-id-type="pmid">19369329</pub-id></element-citation></ref><ref id="B50-pathogens-09-00856"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nagashima</surname><given-names>S.</given-names></name><name><surname>Jirintai</surname><given-names>S.</given-names></name><name><surname>Takahashi</surname><given-names>M.</given-names></name><name><surname>Kobayashi</surname><given-names>T.</given-names></name><name><surname>Tanggis</surname></name><name><surname>Nishizawa</surname><given-names>T.</given-names></name><name><surname>Kouki</surname><given-names>T.</given-names></name><name><surname>Yashiro</surname><given-names>T.</given-names></name><name><surname>Okamoto</surname><given-names>H.</given-names></name></person-group><article-title>Hepatitis E virus egress depends on the exosomal pathway, with secretory exosomes derived from multivesicular bodies</article-title><source>J. Gen. Virol.</source><year>2014</year><volume>95</volume><fpage>2166</fpage><lpage>2175</lpage><pub-id pub-id-type="doi">10.1099/vir.0.066910-0</pub-id><?supplied-pmid 24970738?><pub-id pub-id-type="pmid">24970738</pub-id></element-citation></ref><ref id="B51-pathogens-09-00856"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gouttenoire</surname><given-names>J.</given-names></name><name><surname>Poll&#x000e1;n</surname><given-names>A.</given-names></name><name><surname>Abrami</surname><given-names>L.</given-names></name><name><surname>Oechslin</surname><given-names>N.</given-names></name><name><surname>Mauron</surname><given-names>J.</given-names></name><name><surname>Matter</surname><given-names>M.</given-names></name><name><surname>Oppliger</surname><given-names>J.</given-names></name><name><surname>Szkolnicka</surname><given-names>D.</given-names></name><name><surname>Dao Thi</surname><given-names>V.L.</given-names></name><name><surname>van der Goot</surname><given-names>F.G.</given-names></name><etal/></person-group><article-title>Palmitoylation mediates membrane association of hepatitis E virus ORF3 protein and is required for infectious particle secretion</article-title><source>PLoS Pathog.</source><year>2018</year><volume>14</volume><elocation-id>e1007471</elocation-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1007471</pub-id><pub-id pub-id-type="pmid">30532200</pub-id></element-citation></ref><ref id="B52-pathogens-09-00856"><label>52.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chandra</surname><given-names>V.</given-names></name><name><surname>Kar-Roy</surname><given-names>A.</given-names></name><name><surname>Kumari</surname><given-names>S.</given-names></name><name><surname>Mayor</surname><given-names>S.</given-names></name><name><surname>Jameel</surname><given-names>S.</given-names></name></person-group><article-title>The hepatitis E virus ORF3 protein modulates epidermal growth factor receptor trafficking, STAT3 translocation, and the acute-phase response</article-title><source>J. Virol.</source><year>2008</year><volume>82</volume><fpage>7100</fpage><lpage>7110</lpage><pub-id pub-id-type="doi">10.1128/JVI.00403-08</pub-id><?supplied-pmid 18448545?><pub-id pub-id-type="pmid">18448545</pub-id></element-citation></ref><ref id="B53-pathogens-09-00856"><label>53.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>He</surname><given-names>M.</given-names></name><name><surname>Wang</surname><given-names>M.</given-names></name><name><surname>Huang</surname><given-names>Y.</given-names></name><name><surname>Peng</surname><given-names>W.</given-names></name><name><surname>Zheng</surname><given-names>Z.</given-names></name><name><surname>Xia</surname><given-names>N.</given-names></name><name><surname>Xu</surname><given-names>J.</given-names></name><name><surname>Tian</surname><given-names>D.</given-names></name></person-group><article-title>The ORF3 Protein of Genotype 1 Hepatitis E Virus Suppresses TLR3-induced NF-kappaB Signaling via TRADD and RIP1</article-title><source>Sci. Rep.</source><year>2016</year><volume>6</volume><fpage>27597</fpage><pub-id pub-id-type="doi">10.1038/srep27597</pub-id><?supplied-pmid 27270888?><pub-id pub-id-type="pmid">27270888</pub-id></element-citation></ref><ref id="B54-pathogens-09-00856"><label>54.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>J.</given-names></name><name><surname>Wu</surname><given-names>F.</given-names></name><name><surname>Tian</surname><given-names>D.</given-names></name><name><surname>Wang</surname><given-names>J.</given-names></name><name><surname>Zheng</surname><given-names>Z.</given-names></name><name><surname>Xia</surname><given-names>N.</given-names></name></person-group><article-title>Open reading frame 3 of genotype 1 hepatitis E virus inhibits nuclear factor-kappaappa B signaling induced by tumor necrosis factor-alpha in human A549 lung epithelial cells</article-title><source>PLoS ONE</source><year>2014</year><volume>9</volume><elocation-id>e100787</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0100787</pub-id><pub-id pub-id-type="pmid">24959724</pub-id></element-citation></ref><ref id="B55-pathogens-09-00856"><label>55.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ding</surname><given-names>Q.</given-names></name><name><surname>Heller</surname><given-names>B.</given-names></name><name><surname>Capuccino</surname><given-names>J.M.</given-names></name><name><surname>Song</surname><given-names>B.</given-names></name><name><surname>Nimgaonkar</surname><given-names>I.</given-names></name><name><surname>Hrebikova</surname><given-names>G.</given-names></name><name><surname>Contreras</surname><given-names>J.E.</given-names></name><name><surname>Ploss</surname><given-names>A.</given-names></name></person-group><article-title>Hepatitis E virus ORF3 is a functional ion channel required for release of infectious particles</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>2017</year><volume>114</volume><fpage>1147</fpage><lpage>1152</lpage><pub-id pub-id-type="doi">10.1073/pnas.1614955114</pub-id><pub-id pub-id-type="pmid">28096411</pub-id></element-citation></ref><ref id="B56-pathogens-09-00856"><label>56.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nagashima</surname><given-names>S.</given-names></name><name><surname>Takahashi</surname><given-names>M.</given-names></name><name><surname>Kobayashi</surname><given-names>T.</given-names></name><name><surname>Nishizawa</surname><given-names>T.</given-names></name><name><surname>Nishiyama</surname><given-names>T.</given-names></name><name><surname>Primadharsini</surname><given-names>P.P.</given-names></name><name><surname>Okamoto</surname><given-names>H.</given-names></name></person-group><article-title>Characterization of the Quasi-Enveloped Hepatitis E Virus Particles Released by the Cellular Exosomal Pathway</article-title><source>J. Virol.</source><year>2017</year><volume>91</volume><fpage>e00822-17</fpage><pub-id pub-id-type="doi">10.1128/JVI.00822-17</pub-id><pub-id pub-id-type="pmid">28878075</pub-id></element-citation></ref><ref id="B57-pathogens-09-00856"><label>57.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marion</surname><given-names>O.</given-names></name><name><surname>Lhomme</surname><given-names>S.</given-names></name><name><surname>Nayrac</surname><given-names>M.</given-names></name><name><surname>Dubois</surname><given-names>M.</given-names></name><name><surname>Pucelle</surname><given-names>M.</given-names></name><name><surname>Requena</surname><given-names>M.</given-names></name><name><surname>Migueres</surname><given-names>M.</given-names></name><name><surname>Abravanel</surname><given-names>F.</given-names></name><name><surname>Peron</surname><given-names>J.M.</given-names></name><name><surname>Carrere</surname><given-names>N.</given-names></name><etal/></person-group><article-title>Hepatitis E virus replication in human intestinal cells</article-title><source>Gut</source><year>2019</year><volume>69</volume><fpage>901</fpage><lpage>910</lpage><pub-id pub-id-type="doi">10.1136/gutjnl-2019-319004</pub-id><?supplied-pmid 31727684?><pub-id pub-id-type="pmid">31727684</pub-id></element-citation></ref><ref id="B58-pathogens-09-00856"><label>58.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>W.</given-names></name></person-group><article-title>The action of bile salts on viruses</article-title><source>J. Pathol. Bacteriol.</source><year>1939</year><volume>48</volume><fpage>557</fpage><lpage>571</lpage><pub-id pub-id-type="doi">10.1002/path.1700480309</pub-id></element-citation></ref><ref id="B59-pathogens-09-00856"><label>59.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kalia</surname><given-names>M.</given-names></name><name><surname>Chandra</surname><given-names>V.</given-names></name><name><surname>Rahman</surname><given-names>S.A.</given-names></name><name><surname>Sehgal</surname><given-names>D.</given-names></name><name><surname>Jameel</surname><given-names>S.</given-names></name></person-group><article-title>Heparan sulfate proteoglycans are required for cellular binding of the hepatitis E virus ORF2 capsid protein and for viral infection</article-title><source>J. Virol.</source><year>2009</year><volume>83</volume><fpage>12714</fpage><lpage>12724</lpage><pub-id pub-id-type="doi">10.1128/JVI.00717-09</pub-id><pub-id pub-id-type="pmid">19812150</pub-id></element-citation></ref><ref id="B60-pathogens-09-00856"><label>60.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>Y.</given-names></name><name><surname>Emerson</surname><given-names>S.P.</given-names></name></person-group><article-title>302 Heat shock cognate protein 70 may mediate the entry of hepatitis E virus into host cells</article-title><source>J. Clin. Virol.</source><year>2006</year><volume>36</volume><fpage>S155</fpage><pub-id pub-id-type="doi">10.1016/S1386-6532(06)80480-4</pub-id></element-citation></ref><ref id="B61-pathogens-09-00856"><label>61.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shiota</surname><given-names>T.</given-names></name><name><surname>Li</surname><given-names>T.C.</given-names></name><name><surname>Nishimura</surname><given-names>Y.</given-names></name><name><surname>Yoshizaki</surname><given-names>S.</given-names></name><name><surname>Sugiyama</surname><given-names>R.</given-names></name><name><surname>Shimojima</surname><given-names>M.</given-names></name><name><surname>Saijo</surname><given-names>M.</given-names></name><name><surname>Shimizu</surname><given-names>H.</given-names></name><name><surname>Suzuki</surname><given-names>R.</given-names></name><name><surname>Wakita</surname><given-names>T.</given-names></name><etal/></person-group><article-title>Integrin alpha3 is involved in non-enveloped hepatitis E virus infection</article-title><source>Virology</source><year>2019</year><volume>536</volume><fpage>119</fpage><lpage>124</lpage><pub-id pub-id-type="doi">10.1016/j.virol.2019.07.025</pub-id><pub-id pub-id-type="pmid">31421623</pub-id></element-citation></ref><ref id="B62-pathogens-09-00856"><label>62.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Holla</surname><given-names>P.</given-names></name><name><surname>Ahmad</surname><given-names>I.</given-names></name><name><surname>Ahmed</surname><given-names>Z.</given-names></name><name><surname>Jameel</surname><given-names>S.</given-names></name></person-group><article-title>Hepatitis E virus enters liver cells through a dynamin-2, clathrin and membrane cholesterol-dependent pathway</article-title><source>Traffic</source><year>2015</year><volume>16</volume><fpage>398</fpage><lpage>416</lpage><pub-id pub-id-type="doi">10.1111/tra.12260</pub-id><pub-id pub-id-type="pmid">25615268</pub-id></element-citation></ref><ref id="B63-pathogens-09-00856"><label>63.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yin</surname><given-names>X.</given-names></name><name><surname>Ambardekar</surname><given-names>C.</given-names></name><name><surname>Lu</surname><given-names>Y.</given-names></name><name><surname>Feng</surname><given-names>Z.</given-names></name></person-group><article-title>Distinct Entry Mechanisms for Nonenveloped and Quasi-Enveloped Hepatitis E Viruses</article-title><source>J. Virol.</source><year>2016</year><volume>90</volume><fpage>4232</fpage><lpage>4242</lpage><pub-id pub-id-type="doi">10.1128/JVI.02804-15</pub-id><?supplied-pmid 26865708?><pub-id pub-id-type="pmid">26865708</pub-id></element-citation></ref><ref id="B64-pathogens-09-00856"><label>64.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Debing</surname><given-names>Y.</given-names></name><name><surname>Moradpour</surname><given-names>D.</given-names></name><name><surname>Neyts</surname><given-names>J.</given-names></name><name><surname>Gouttenoire</surname><given-names>J.</given-names></name></person-group><article-title>Update on hepatitis E virology: Implications for clinical practice</article-title><source>J. Hepatol.</source><year>2016</year><volume>65</volume><fpage>200</fpage><lpage>212</lpage><pub-id pub-id-type="doi">10.1016/j.jhep.2016.02.045</pub-id><?supplied-pmid 26966047?><pub-id pub-id-type="pmid">26966047</pub-id></element-citation></ref><ref id="B65-pathogens-09-00856"><label>65.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perttila</surname><given-names>J.</given-names></name><name><surname>Spuul</surname><given-names>P.</given-names></name><name><surname>Ahola</surname><given-names>T.</given-names></name></person-group><article-title>Early secretory pathway localization and lack of processing for hepatitis E virus replication protein pORF1</article-title><source>J. Gen. Virol.</source><year>2013</year><volume>94</volume><fpage>807</fpage><lpage>816</lpage><pub-id pub-id-type="doi">10.1099/vir.0.049577-0</pub-id><?supplied-pmid 23255617?><pub-id pub-id-type="pmid">23255617</pub-id></element-citation></ref><ref id="B66-pathogens-09-00856"><label>66.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rehman</surname><given-names>S.</given-names></name><name><surname>Kapur</surname><given-names>N.</given-names></name><name><surname>Durgapal</surname><given-names>H.</given-names></name><name><surname>Panda</surname><given-names>S.K.</given-names></name></person-group><article-title>Subcellular localization of hepatitis E virus (HEV) replicase</article-title><source>Virology</source><year>2008</year><volume>370</volume><fpage>77</fpage><lpage>92</lpage><pub-id pub-id-type="doi">10.1016/j.virol.2007.07.036</pub-id><?supplied-pmid 17904184?><pub-id pub-id-type="pmid">17904184</pub-id></element-citation></ref><ref id="B67-pathogens-09-00856"><label>67.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wissing</surname><given-names>M.H.</given-names></name><name><surname>Bruggemann</surname><given-names>Y.</given-names></name><name><surname>Steinmann</surname><given-names>E.</given-names></name><name><surname>Todt</surname><given-names>D.</given-names></name></person-group><article-title>Virus-Host Cell Interplay during Hepatitis E Virus Infection</article-title><source>Trends Microbiol.</source><year>2020</year><pub-id pub-id-type="doi">10.1016/j.tim.2020.07.002</pub-id></element-citation></ref><ref id="B68-pathogens-09-00856"><label>68.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Emerson</surname><given-names>S.U.</given-names></name><name><surname>Zhang</surname><given-names>M.</given-names></name><name><surname>Meng</surname><given-names>X.J.</given-names></name><name><surname>Nguyen</surname><given-names>H.</given-names></name><name><surname>St Claire</surname><given-names>M.</given-names></name><name><surname>Govindarajan</surname><given-names>S.</given-names></name><name><surname>Huang</surname><given-names>Y.K.</given-names></name><name><surname>Purcell</surname><given-names>R.H.</given-names></name></person-group><article-title>Recombinant hepatitis E virus genomes infectious for primates: Importance of capping and discovery of a cis-reactive element</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>2001</year><volume>98</volume><fpage>15270</fpage><lpage>15275</lpage><pub-id pub-id-type="doi">10.1073/pnas.251555098</pub-id><pub-id pub-id-type="pmid">11742081</pub-id></element-citation></ref><ref id="B69-pathogens-09-00856"><label>69.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shukla</surname><given-names>P.</given-names></name><name><surname>Nguyen</surname><given-names>H.T.</given-names></name><name><surname>Torian</surname><given-names>U.</given-names></name><name><surname>Engle</surname><given-names>R.E.</given-names></name><name><surname>Faulk</surname><given-names>K.</given-names></name><name><surname>Dalton</surname><given-names>H.R.</given-names></name><name><surname>Bendall</surname><given-names>R.P.</given-names></name><name><surname>Keane</surname><given-names>F.E.</given-names></name><name><surname>Purcell</surname><given-names>R.H.</given-names></name><name><surname>Emerson</surname><given-names>S.U.</given-names></name></person-group><article-title>Cross-species infections of cultured cells by hepatitis E virus and discovery of an infectious virus-host recombinant</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>2011</year><volume>108</volume><fpage>2438</fpage><lpage>2443</lpage><pub-id pub-id-type="doi">10.1073/pnas.1018878108</pub-id><pub-id pub-id-type="pmid">21262830</pub-id></element-citation></ref><ref id="B70-pathogens-09-00856"><label>70.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scholz</surname><given-names>J.</given-names></name><name><surname>Bachlein</surname><given-names>C.</given-names></name><name><surname>Gadicherla</surname><given-names>A.K.</given-names></name><name><surname>Falkenhagen</surname><given-names>A.</given-names></name><name><surname>Tausch</surname><given-names>S.H.</given-names></name><name><surname>Johne</surname><given-names>R.</given-names></name></person-group><article-title>Establishment of a Plasmid-Based Reverse Genetics System for the Cell Culture-Adapted Hepatitis E Virus Genotype 3c Strain 47832c</article-title><source>Pathogens</source><year>2020</year><volume>9</volume><elocation-id>157</elocation-id><pub-id pub-id-type="doi">10.3390/pathogens9030157</pub-id></element-citation></ref><ref id="B71-pathogens-09-00856"><label>71.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>C&#x000f3;rdoba</surname><given-names>L.</given-names></name><name><surname>Feagins</surname><given-names>A.R.</given-names></name><name><surname>Opriessnig</surname><given-names>T.</given-names></name><name><surname>Cossaboom</surname><given-names>C.M.</given-names></name><name><surname>Dryman</surname><given-names>B.A.</given-names></name><name><surname>Huang</surname><given-names>Y.W.</given-names></name><name><surname>Meng</surname><given-names>X.J.</given-names></name></person-group><article-title>Rescue of a genotype 4 human hepatitis E virus from cloned cDNA and characterization of intergenotypic chimeric viruses in cultured human liver cells and in pigs</article-title><source>J. Gen. Virol.</source><year>2012</year><volume>93</volume><fpage>2183</fpage><lpage>2194</lpage><pub-id pub-id-type="doi">10.1099/vir.0.043711-0</pub-id><pub-id pub-id-type="pmid">22837416</pub-id></element-citation></ref><ref id="B72-pathogens-09-00856"><label>72.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Todt</surname><given-names>D.</given-names></name><name><surname>Friesland</surname><given-names>M.</given-names></name><name><surname>Moeller</surname><given-names>N.</given-names></name><name><surname>Praditya</surname><given-names>D.</given-names></name><name><surname>Kinast</surname><given-names>V.</given-names></name><name><surname>Bruggemann</surname><given-names>Y.</given-names></name><name><surname>Knegendorf</surname><given-names>L.</given-names></name><name><surname>Burkard</surname><given-names>T.</given-names></name><name><surname>Steinmann</surname><given-names>J.</given-names></name><name><surname>Burm</surname><given-names>R.</given-names></name><etal/></person-group><article-title>Robust hepatitis E virus infection and transcriptional response in human hepatocytes</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>2020</year><volume>117</volume><fpage>1731</fpage><lpage>1741</lpage><pub-id pub-id-type="doi">10.1073/pnas.1912307117</pub-id><?supplied-pmid 31896581?><pub-id pub-id-type="pmid">31896581</pub-id></element-citation></ref><ref id="B73-pathogens-09-00856"><label>73.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Purcell</surname><given-names>R.H.</given-names></name><name><surname>Nguyen</surname><given-names>H.</given-names></name><name><surname>Shapiro</surname><given-names>M.</given-names></name><name><surname>Engle</surname><given-names>R.E.</given-names></name><name><surname>Govindarajan</surname><given-names>S.</given-names></name><name><surname>Blackwelder</surname><given-names>W.C.</given-names></name><name><surname>Wong</surname><given-names>D.C.</given-names></name><name><surname>Prieels</surname><given-names>J.P.</given-names></name><name><surname>Emerson</surname><given-names>S.U.</given-names></name></person-group><article-title>Pre-clinical immunogenicity and efficacy trial of a recombinant hepatitis E vaccine</article-title><source>Vaccine</source><year>2003</year><volume>21</volume><fpage>2607</fpage><lpage>2615</lpage><pub-id pub-id-type="doi">10.1016/S0264-410X(03)00100-2</pub-id><pub-id pub-id-type="pmid">12744897</pub-id></element-citation></ref><ref id="B74-pathogens-09-00856"><label>74.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsarev</surname><given-names>S.A.</given-names></name><name><surname>Emerson</surname><given-names>S.U.</given-names></name><name><surname>Tsareva</surname><given-names>T.S.</given-names></name><name><surname>Yarbough</surname><given-names>P.O.</given-names></name><name><surname>Lewis</surname><given-names>M.</given-names></name><name><surname>Govindarajan</surname><given-names>S.</given-names></name><name><surname>Reyes</surname><given-names>G.R.</given-names></name><name><surname>Shapiro</surname><given-names>M.</given-names></name><name><surname>Purcell</surname><given-names>R.H.</given-names></name></person-group><article-title>Variation in course of hepatitis E in experimentally infected cynomolgus monkeys</article-title><source>J. Infect. Dis.</source><year>1993</year><volume>167</volume><fpage>1302</fpage><lpage>1306</lpage><pub-id pub-id-type="doi">10.1093/infdis/167.6.1302</pub-id><?supplied-pmid 8501318?><pub-id pub-id-type="pmid">8501318</pub-id></element-citation></ref><ref id="B75-pathogens-09-00856"><label>75.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Halbur</surname><given-names>P.G.</given-names></name><name><surname>Kasorndorkbua</surname><given-names>C.</given-names></name><name><surname>Gilbert</surname><given-names>C.</given-names></name><name><surname>Guenette</surname><given-names>D.</given-names></name><name><surname>Potters</surname><given-names>M.B.</given-names></name><name><surname>Purcell</surname><given-names>R.H.</given-names></name><name><surname>Emerson</surname><given-names>S.U.</given-names></name><name><surname>Toth</surname><given-names>T.E.</given-names></name><name><surname>Meng</surname><given-names>X.J.</given-names></name></person-group><article-title>Comparative pathogenesis of infection of pigs with hepatitis E viruses recovered from a pig and a human</article-title><source>J. Clin. Microbiol.</source><year>2001</year><volume>39</volume><fpage>918</fpage><lpage>923</lpage><pub-id pub-id-type="doi">10.1128/JCM.39.3.918-923.2001</pub-id><pub-id pub-id-type="pmid">11230404</pub-id></element-citation></ref><ref id="B76-pathogens-09-00856"><label>76.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Feagins</surname><given-names>A.R.</given-names></name><name><surname>Opriessnig</surname><given-names>T.</given-names></name><name><surname>Huang</surname><given-names>Y.W.</given-names></name><name><surname>Halbur</surname><given-names>P.G.</given-names></name><name><surname>Meng</surname><given-names>X.J.</given-names></name></person-group><article-title>Cross-species infection of specific-pathogen-free pigs by a genotype 4 strain of human hepatitis E virus</article-title><source>J. Med. Virol.</source><year>2008</year><volume>80</volume><fpage>1379</fpage><lpage>1386</lpage><pub-id pub-id-type="doi">10.1002/jmv.21223</pub-id><pub-id pub-id-type="pmid">18551597</pub-id></element-citation></ref><ref id="B77-pathogens-09-00856"><label>77.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Allweiss</surname><given-names>L.</given-names></name><name><surname>Gass</surname><given-names>S.</given-names></name><name><surname>Giersch</surname><given-names>K.</given-names></name><name><surname>Groth</surname><given-names>A.</given-names></name><name><surname>Kah</surname><given-names>J.</given-names></name><name><surname>Volz</surname><given-names>T.</given-names></name><name><surname>Rapp</surname><given-names>G.</given-names></name><name><surname>Sch&#x000f6;bel</surname><given-names>A.</given-names></name><name><surname>Lohse</surname><given-names>A.W.</given-names></name><name><surname>Polywka</surname><given-names>S.</given-names></name><etal/></person-group><article-title>Human liver chimeric mice as a new model of chronic hepatitis E virus infection and preclinical drug evaluation</article-title><source>J. Hepatol.</source><year>2016</year><volume>64</volume><fpage>1033</fpage><lpage>1040</lpage><pub-id pub-id-type="doi">10.1016/j.jhep.2016.01.011</pub-id><?supplied-pmid 26805671?><pub-id pub-id-type="pmid">26805671</pub-id></element-citation></ref><ref id="B78-pathogens-09-00856"><label>78.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sayed</surname><given-names>I.M.</given-names></name><name><surname>Verhoye</surname><given-names>L.</given-names></name><name><surname>Cocquerel</surname><given-names>L.</given-names></name><name><surname>Abravanel</surname><given-names>F.</given-names></name><name><surname>Foquet</surname><given-names>L.</given-names></name><name><surname>Montpellier</surname><given-names>C.</given-names></name><name><surname>Debing</surname><given-names>Y.</given-names></name><name><surname>Farhoudi</surname><given-names>A.</given-names></name><name><surname>Wychowski</surname><given-names>C.</given-names></name><name><surname>Dubuisson</surname><given-names>J.</given-names></name><etal/></person-group><article-title>Study of hepatitis E virus infection of genotype 1 and 3 in mice with humanised liver</article-title><source>Gut</source><year>2017</year><volume>66</volume><fpage>920</fpage><lpage>929</lpage><pub-id pub-id-type="doi">10.1136/gutjnl-2015-311109</pub-id><?supplied-pmid 27006186?><pub-id pub-id-type="pmid">27006186</pub-id></element-citation></ref><ref id="B79-pathogens-09-00856"><label>79.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maila</surname><given-names>H.T.</given-names></name><name><surname>Bowyer</surname><given-names>S.M.</given-names></name><name><surname>Swanepoel</surname><given-names>R.</given-names></name></person-group><article-title>Identification of a new strain of hepatitis E virus from an outbreak in Namibia in 1995</article-title><source>J. Gen. Virol.</source><year>2004</year><volume>85</volume><fpage>89</fpage><lpage>95</lpage><pub-id pub-id-type="doi">10.1099/vir.0.19587-0</pub-id><?supplied-pmid 14718623?><pub-id pub-id-type="pmid">14718623</pub-id></element-citation></ref><ref id="B80-pathogens-09-00856"><label>80.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Viswanathan</surname><given-names>R.</given-names></name></person-group><article-title>Infectious hepatitis in Delhi (1955-56): A critical study-epidemiology. 1957</article-title><source>Natl. Med. J. India</source><year>2013</year><volume>26</volume><fpage>362</fpage><lpage>377</lpage><?supplied-pmid 25074004?><pub-id pub-id-type="pmid">25074004</pub-id></element-citation></ref><ref id="B81-pathogens-09-00856"><label>81.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Belabbes</surname><given-names>E.H.</given-names></name><name><surname>Bouguermouh</surname><given-names>A.</given-names></name><name><surname>Benatallah</surname><given-names>A.</given-names></name><name><surname>Illoul</surname><given-names>G.</given-names></name></person-group><article-title>Epidemic non-A, non-B viral hepatitis in Algeria: Strong evidence for its spreading by water</article-title><source>J. Med. Virol.</source><year>1985</year><volume>16</volume><fpage>257</fpage><lpage>263</lpage><pub-id pub-id-type="doi">10.1002/jmv.1890160306</pub-id><pub-id pub-id-type="pmid">3928807</pub-id></element-citation></ref><ref id="B82-pathogens-09-00856"><label>82.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hla</surname><given-names>M.</given-names></name><name><surname>Myint Myint</surname><given-names>S.</given-names></name><name><surname>Tun</surname><given-names>K.</given-names></name><name><surname>Thein-Maung</surname><given-names>M.</given-names></name><name><surname>Khin Maung</surname><given-names>T.</given-names></name></person-group><article-title>A clinical and epidemiological study of an epidemic of non-A non-B hepatitis in Rangoon</article-title><source>Am. J. Trop. Med. Hyg.</source><year>1985</year><volume>34</volume><fpage>1183</fpage><lpage>1189</lpage><pub-id pub-id-type="doi">10.4269/ajtmh.1985.34.1183</pub-id><pub-id pub-id-type="pmid">2939734</pub-id></element-citation></ref><ref id="B83-pathogens-09-00856"><label>83.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Isaacson</surname><given-names>M.</given-names></name><name><surname>Frean</surname><given-names>J.</given-names></name><name><surname>He</surname><given-names>J.</given-names></name><name><surname>Seriwatana</surname><given-names>J.</given-names></name><name><surname>Innis</surname><given-names>B.L.</given-names></name></person-group><article-title>An outbreak of hepatitis E in Northern Namibia, 1983</article-title><source>Am. J. Trop. Med. Hyg.</source><year>2000</year><volume>62</volume><fpage>619</fpage><lpage>625</lpage><pub-id pub-id-type="doi">10.4269/ajtmh.2000.62.619</pub-id><pub-id pub-id-type="pmid">11289674</pub-id></element-citation></ref><ref id="B84-pathogens-09-00856"><label>84.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sarthou</surname><given-names>J.L.</given-names></name><name><surname>Budkowska</surname><given-names>A.</given-names></name><name><surname>Sharma</surname><given-names>M.D.</given-names></name><name><surname>Lhuillier</surname><given-names>M.</given-names></name><name><surname>Pillot</surname><given-names>J.</given-names></name></person-group><article-title>Characterization of an antigen-antibody system associated with epidemic non-A, non-B hepatitis in West Africa and experimental transmission of an infectious agent to primates</article-title><source>Ann. Inst. Pasteur Virol.</source><year>1986</year><volume>137E</volume><fpage>225</fpage><lpage>232</lpage><pub-id pub-id-type="doi">10.1016/S0769-2617(86)80208-8</pub-id></element-citation></ref><ref id="B85-pathogens-09-00856"><label>85.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Favorov</surname><given-names>M.O.</given-names></name><name><surname>Khukhlovich</surname><given-names>P.A.</given-names></name><name><surname>Zairov</surname><given-names>G.K.</given-names></name><name><surname>Listovskaia</surname><given-names>E.K.</given-names></name><name><surname>Arakelov</surname><given-names>S.A.</given-names></name></person-group><article-title>[Clinico-epidemiological characteristics and diagnosis of viral non-A, non-B hepatitis with fecal and oral mechanisms of transmission of the infection]</article-title><source>Vopr. Virusol.</source><year>1986</year><volume>31</volume><fpage>65</fpage><lpage>69</lpage><comment>(In Russian)</comment><pub-id pub-id-type="pmid">3008441</pub-id></element-citation></ref><ref id="B86-pathogens-09-00856"><label>86.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Albetkova</surname><given-names>A.</given-names></name><name><surname>Drobeniuc</surname><given-names>J.</given-names></name><name><surname>Yashina</surname><given-names>T.</given-names></name><name><surname>Musabaev</surname><given-names>E.</given-names></name><name><surname>Robertson</surname><given-names>B.</given-names></name><name><surname>Nainan</surname><given-names>O.</given-names></name><name><surname>Favorov</surname><given-names>M.</given-names></name></person-group><article-title>Characterization of hepatitis E virus from outbreak and sporadic cases in Turkmenistan</article-title><source>J. Med. Virol.</source><year>2007</year><volume>79</volume><fpage>1696</fpage><lpage>1702</lpage><pub-id pub-id-type="doi">10.1002/jmv.20991</pub-id><?supplied-pmid 17854031?><pub-id pub-id-type="pmid">17854031</pub-id></element-citation></ref><ref id="B87-pathogens-09-00856"><label>87.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Byskov</surname><given-names>J.</given-names></name><name><surname>Wouters</surname><given-names>J.S.</given-names></name><name><surname>Sathekge</surname><given-names>T.J.</given-names></name><name><surname>Swanepoel</surname><given-names>R.</given-names></name></person-group><article-title>An outbreak of suspected water-borne epidemic non-A non-B hepatitis in northern Botswana with a high prevalence of hepatitis B carriers and hepatitis delta markers among patients</article-title><source>Trans. R. Soc. Trop. Med. Hyg.</source><year>1989</year><volume>83</volume><fpage>110</fpage><lpage>116</lpage><pub-id pub-id-type="doi">10.1016/0035-9203(89)90731-1</pub-id><pub-id pub-id-type="pmid">2513670</pub-id></element-citation></ref><ref id="B88-pathogens-09-00856"><label>88.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Velazquez</surname><given-names>O.</given-names></name><name><surname>Stetler</surname><given-names>H.C.</given-names></name><name><surname>Avila</surname><given-names>C.</given-names></name><name><surname>Ornelas</surname><given-names>G.</given-names></name><name><surname>Alvarez</surname><given-names>C.</given-names></name><name><surname>Hadler</surname><given-names>S.C.</given-names></name><name><surname>Bradley</surname><given-names>D.W.</given-names></name><name><surname>Sepulveda</surname><given-names>J.</given-names></name></person-group><article-title>Epidemic transmission of enterically transmitted non-A, non-B hepatitis in Mexico, 1986-1987</article-title><source>JAMA</source><year>1990</year><volume>263</volume><fpage>3281</fpage><lpage>3285</lpage><pub-id pub-id-type="doi">10.1001/jama.1990.03440240071018</pub-id><pub-id pub-id-type="pmid">2112204</pub-id></element-citation></ref><ref id="B89-pathogens-09-00856"><label>89.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mushahwar</surname><given-names>I.K.</given-names></name><name><surname>Dawson</surname><given-names>G.J.</given-names></name><name><surname>Bile</surname><given-names>K.M.</given-names></name><name><surname>Magnius</surname><given-names>L.O.</given-names></name></person-group><article-title>Serological studies of an enterically transmitted non-A, non-B hepatitis in Somalia</article-title><source>J. Med. Virol.</source><year>1993</year><volume>40</volume><fpage>218</fpage><lpage>221</lpage><pub-id pub-id-type="doi">10.1002/jmv.1890400309</pub-id><pub-id pub-id-type="pmid">8355020</pub-id></element-citation></ref><ref id="B90-pathogens-09-00856"><label>90.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pal</surname><given-names>P.K.</given-names></name><name><surname>Haldar</surname><given-names>A.</given-names></name><name><surname>Bhattacharya</surname><given-names>S.K.</given-names></name></person-group><article-title>An outbreak of viral hepatitis in a housing complex of north Calcutta</article-title><source>J. Commun. Dis.</source><year>1994</year><volume>26</volume><fpage>88</fpage><lpage>91</lpage><pub-id pub-id-type="pmid">7989681</pub-id></element-citation></ref><ref id="B91-pathogens-09-00856"><label>91.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsega</surname><given-names>E.</given-names></name><name><surname>Krawczynski</surname><given-names>K.</given-names></name><name><surname>Hansson</surname><given-names>B.G.</given-names></name><name><surname>Nordenfelt</surname><given-names>E.</given-names></name><name><surname>Negusse</surname><given-names>Y.</given-names></name><name><surname>Alemu</surname><given-names>W.</given-names></name><name><surname>Bahru</surname><given-names>Y.</given-names></name></person-group><article-title>Outbreak of acute hepatitis E virus infection among military personnel in northern Ethiopia</article-title><source>J. Med. Virol.</source><year>1991</year><volume>34</volume><fpage>232</fpage><lpage>236</lpage><pub-id pub-id-type="doi">10.1002/jmv.1890340407</pub-id><pub-id pub-id-type="pmid">1940876</pub-id></element-citation></ref><ref id="B92-pathogens-09-00856"><label>92.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Uchida</surname><given-names>T.</given-names></name><name><surname>Aye</surname><given-names>T.T.</given-names></name><name><surname>Ma</surname><given-names>X.</given-names></name><name><surname>Iida</surname><given-names>F.</given-names></name><name><surname>Shikata</surname><given-names>T.</given-names></name><name><surname>Ichikawa</surname><given-names>M.</given-names></name><name><surname>Rikihisa</surname><given-names>T.</given-names></name><name><surname>Win</surname><given-names>K.M.</given-names></name></person-group><article-title>An epidemic outbreak of hepatitis E in Yangon of Myanmar: Antibody assay and animal transmission of the virus</article-title><source>Acta Pathol. Jpn.</source><year>1993</year><volume>43</volume><fpage>94</fpage><lpage>98</lpage><pub-id pub-id-type="doi">10.1111/j.1440-1827.1993.tb01116.x</pub-id><?supplied-pmid 8257479?><pub-id pub-id-type="pmid">8257479</pub-id></element-citation></ref><ref id="B93-pathogens-09-00856"><label>93.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Naik</surname><given-names>S.R.</given-names></name><name><surname>Aggarwal</surname><given-names>R.</given-names></name><name><surname>Salunke</surname><given-names>P.N.</given-names></name><name><surname>Mehrotra</surname><given-names>N.N.</given-names></name></person-group><article-title>A large waterborne viral hepatitis E epidemic in Kanpur, India</article-title><source>Bull. World Health Organ.</source><year>1992</year><volume>70</volume><fpage>597</fpage><lpage>604</lpage><?supplied-pmid 1464145?><pub-id pub-id-type="pmid">1464145</pub-id></element-citation></ref><ref id="B94-pathogens-09-00856"><label>94.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhuang</surname><given-names>H.</given-names></name><name><surname>Cao</surname><given-names>X.Y.</given-names></name><name><surname>Liu</surname><given-names>C.B.</given-names></name><name><surname>Wang</surname><given-names>G.M.</given-names></name></person-group><article-title>Epidemiology of hepatitis E in China</article-title><source>Gastroenterol. Jpn.</source><year>1991</year><volume>26</volume><issue>Suppl. 3</issue><fpage>135</fpage><lpage>138</lpage><pub-id pub-id-type="doi">10.1007/BF02779283</pub-id><?supplied-pmid 1909252?><pub-id pub-id-type="pmid">1909252</pub-id></element-citation></ref><ref id="B95-pathogens-09-00856"><label>95.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bi</surname><given-names>S.L.</given-names></name><name><surname>Purdy</surname><given-names>M.A.</given-names></name><name><surname>McCaustland</surname><given-names>K.A.</given-names></name><name><surname>Margolis</surname><given-names>H.S.</given-names></name><name><surname>Bradley</surname><given-names>D.W.</given-names></name></person-group><article-title>The sequence of hepatitis E virus isolated directly from a single source during an outbreak in China</article-title><source>Virus Res.</source><year>1993</year><volume>28</volume><fpage>233</fpage><lpage>247</lpage><pub-id pub-id-type="doi">10.1016/0168-1702(93)90024-H</pub-id><pub-id pub-id-type="pmid">8346669</pub-id></element-citation></ref><ref id="B96-pathogens-09-00856"><label>96.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Corwin</surname><given-names>A.</given-names></name><name><surname>Jarot</surname><given-names>K.</given-names></name><name><surname>Lubis</surname><given-names>I.</given-names></name><name><surname>Nasution</surname><given-names>K.</given-names></name><name><surname>Suparmawo</surname><given-names>S.</given-names></name><name><surname>Sumardiati</surname><given-names>A.</given-names></name><name><surname>Widodo</surname><given-names>S.</given-names></name><name><surname>Nazir</surname><given-names>S.</given-names></name><name><surname>Orndorff</surname><given-names>G.</given-names></name><name><surname>Choi</surname><given-names>Y.</given-names></name><etal/></person-group><article-title>Two years&#x02019; investigation of epidemic hepatitis E virus transmission in West Kalimantan (Borneo), Indonesia</article-title><source>Trans. R. Soc. Trop. Med. Hyg.</source><year>1995</year><volume>89</volume><fpage>262</fpage><lpage>265</lpage><pub-id pub-id-type="doi">10.1016/0035-9203(95)90529-4</pub-id><pub-id pub-id-type="pmid">7660427</pub-id></element-citation></ref><ref id="B97-pathogens-09-00856"><label>97.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rab</surname><given-names>M.A.</given-names></name><name><surname>Bile</surname><given-names>M.K.</given-names></name><name><surname>Mubarik</surname><given-names>M.M.</given-names></name><name><surname>Asghar</surname><given-names>H.</given-names></name><name><surname>Sami</surname><given-names>Z.</given-names></name><name><surname>Siddiqi</surname><given-names>S.</given-names></name><name><surname>Dil</surname><given-names>A.S.</given-names></name><name><surname>Barzgar</surname><given-names>M.A.</given-names></name><name><surname>Chaudhry</surname><given-names>M.A.</given-names></name><name><surname>Burney</surname><given-names>M.I.</given-names></name></person-group><article-title>Water-borne hepatitis E virus epidemic in Islamabad, Pakistan: A common source outbreak traced to the malfunction of a modern water treatment plant</article-title><source>Am. J. Trop. Med. Hyg.</source><year>1997</year><volume>57</volume><fpage>151</fpage><lpage>157</lpage><pub-id pub-id-type="doi">10.4269/ajtmh.1997.57.151</pub-id><pub-id pub-id-type="pmid">9288807</pub-id></element-citation></ref><ref id="B98-pathogens-09-00856"><label>98.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Corwin</surname><given-names>A.L.</given-names></name><name><surname>Khiem</surname><given-names>H.B.</given-names></name><name><surname>Clayson</surname><given-names>E.T.</given-names></name><name><surname>Pham</surname><given-names>K.S.</given-names></name><name><surname>Vo</surname><given-names>T.T.</given-names></name><name><surname>Vu</surname><given-names>T.Y.</given-names></name><name><surname>Cao</surname><given-names>T.T.</given-names></name><name><surname>Vaughn</surname><given-names>D.</given-names></name><name><surname>Merven</surname><given-names>J.</given-names></name><name><surname>Richie</surname><given-names>T.L.</given-names></name><etal/></person-group><article-title>A waterborne outbreak of hepatitis E virus transmission in southwestern Vietnam</article-title><source>Am. J. Trop. Med. Hyg.</source><year>1996</year><volume>54</volume><fpage>559</fpage><lpage>562</lpage><pub-id pub-id-type="doi">10.4269/ajtmh.1996.54.559</pub-id><pub-id pub-id-type="pmid">8686771</pub-id></element-citation></ref><ref id="B99-pathogens-09-00856"><label>99.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Benjelloun</surname><given-names>S.</given-names></name><name><surname>Bahbouhi</surname><given-names>B.</given-names></name><name><surname>Bouchrit</surname><given-names>N.</given-names></name><name><surname>Cherkaoui</surname><given-names>L.</given-names></name><name><surname>Hda</surname><given-names>N.</given-names></name><name><surname>Mahjour</surname><given-names>J.</given-names></name><name><surname>Benslimane</surname><given-names>A.</given-names></name></person-group><article-title>Seroepidemiological study of an acute hepatitis E outbreak in Morocco</article-title><source>Res. Virol.</source><year>1997</year><volume>148</volume><fpage>279</fpage><lpage>287</lpage><pub-id pub-id-type="doi">10.1016/S0923-2516(97)88365-3</pub-id><pub-id pub-id-type="pmid">9272579</pub-id></element-citation></ref><ref id="B100-pathogens-09-00856"><label>100.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aggarwal</surname><given-names>R.</given-names></name><name><surname>Kumar</surname><given-names>R.</given-names></name><name><surname>Pal</surname><given-names>R.</given-names></name><name><surname>Naik</surname><given-names>S.</given-names></name><name><surname>Semwal</surname><given-names>S.N.</given-names></name><name><surname>Naik</surname><given-names>S.R.</given-names></name></person-group><article-title>Role of travel as a risk factor for hepatitis E virus infection in a disease-endemic area</article-title><source>Indian J. Gastroenterol.</source><year>2002</year><volume>21</volume><fpage>14</fpage><lpage>18</lpage><pub-id pub-id-type="pmid">11871830</pub-id></element-citation></ref><ref id="B101-pathogens-09-00856"><label>101.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sedyaningsih-Mamahit</surname><given-names>E.R.</given-names></name><name><surname>Larasati</surname><given-names>R.P.</given-names></name><name><surname>Laras</surname><given-names>K.</given-names></name><name><surname>Sidemen</surname><given-names>A.</given-names></name><name><surname>Sukri</surname><given-names>N.</given-names></name><name><surname>Sabaruddin</surname><given-names>N.</given-names></name><name><surname>Didi</surname><given-names>S.</given-names></name><name><surname>Saragih</surname><given-names>J.M.</given-names></name><name><surname>Myint</surname><given-names>K.S.</given-names></name><name><surname>Endy</surname><given-names>T.P.</given-names></name><etal/></person-group><article-title>First documented outbreak of hepatitis E virus transmission in Java, Indonesia</article-title><source>Trans. R. Soc. Trop. Med. Hyg.</source><year>2002</year><volume>96</volume><fpage>398</fpage><lpage>404</lpage><pub-id pub-id-type="doi">10.1016/S0035-9203(02)90373-1</pub-id><pub-id pub-id-type="pmid">12497976</pub-id></element-citation></ref><ref id="B102-pathogens-09-00856"><label>102.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bryan</surname><given-names>J.P.</given-names></name><name><surname>Iqbal</surname><given-names>M.</given-names></name><name><surname>Tsarev</surname><given-names>S.</given-names></name><name><surname>Malik</surname><given-names>I.A.</given-names></name><name><surname>Duncan</surname><given-names>J.F.</given-names></name><name><surname>Ahmed</surname><given-names>A.</given-names></name><name><surname>Khan</surname><given-names>A.</given-names></name><name><surname>Khan</surname><given-names>A.</given-names></name><name><surname>Rafiqui</surname><given-names>A.R.</given-names></name><name><surname>Purcell</surname><given-names>R.H.</given-names></name><etal/></person-group><article-title>Epidemic of hepatitis E in a military unit in Abbotrabad, Pakistan</article-title><source>Am. J. Trop. Med. Hyg.</source><year>2002</year><volume>67</volume><fpage>662</fpage><lpage>668</lpage><pub-id pub-id-type="doi">10.4269/ajtmh.2002.67.662</pub-id><?supplied-pmid 12518859?><pub-id pub-id-type="pmid">12518859</pub-id></element-citation></ref><ref id="B103-pathogens-09-00856"><label>103.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Banerjee</surname><given-names>A.</given-names></name><name><surname>Sahni</surname><given-names>A.K.</given-names></name><name><surname>Rajiva</surname></name><name><surname>Nagendra</surname><given-names>A.</given-names></name><name><surname>Saiprasad</surname><given-names>G.S.</given-names></name></person-group><article-title>Outbreak of Viral Hepatitis E in a Regimental Training Centre</article-title><source>Med. J. Armed Forces India</source><year>2005</year><volume>61</volume><fpage>326</fpage><lpage>329</lpage><pub-id pub-id-type="doi">10.1016/S0377-1237(05)80055-3</pub-id><pub-id pub-id-type="pmid">27407798</pub-id></element-citation></ref><ref id="B104-pathogens-09-00856"><label>104.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goumba</surname><given-names>A.I.</given-names></name><name><surname>Konamna</surname><given-names>X.</given-names></name><name><surname>Komas</surname><given-names>N.P.</given-names></name></person-group><article-title>Clinical and epidemiological aspects of a hepatitis E outbreak in Bangui, Central African Republic</article-title><source>BMC Infect. Dis.</source><year>2011</year><volume>11</volume><elocation-id>93</elocation-id><pub-id pub-id-type="doi">10.1186/1471-2334-11-93</pub-id><?supplied-pmid 21492477?><pub-id pub-id-type="pmid">21492477</pub-id></element-citation></ref><ref id="B105-pathogens-09-00856"><label>105.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rayis</surname><given-names>D.A.</given-names></name><name><surname>Jumaa</surname><given-names>A.M.</given-names></name><name><surname>Gasim</surname><given-names>G.I.</given-names></name><name><surname>Karsany</surname><given-names>M.S.</given-names></name><name><surname>Adam</surname><given-names>I.</given-names></name></person-group><article-title>An outbreak of hepatitis E and high maternal mortality at Port Sudan, Eastern Sudan</article-title><source>Pathog. Glob. Health</source><year>2013</year><volume>107</volume><fpage>66</fpage><lpage>68</lpage><pub-id pub-id-type="doi">10.1179/2047773213Y.0000000076</pub-id><pub-id pub-id-type="pmid">23683332</pub-id></element-citation></ref><ref id="B106-pathogens-09-00856"><label>106.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Swain</surname><given-names>S.K.</given-names></name><name><surname>Baral</surname><given-names>P.</given-names></name><name><surname>Hutin</surname><given-names>Y.J.</given-names></name><name><surname>Rao</surname><given-names>T.V.</given-names></name><name><surname>Murhekar</surname><given-names>M.</given-names></name><name><surname>Gupte</surname><given-names>M.D.</given-names></name></person-group><article-title>A hepatitis E outbreak caused by a temporary interruption in a municipal water treatment system, Baripada, Orissa, India, 2004</article-title><source>Trans. R. Soc. Trop. Med. Hyg.</source><year>2010</year><volume>104</volume><fpage>66</fpage><lpage>69</lpage><pub-id pub-id-type="doi">10.1016/j.trstmh.2009.07.020</pub-id><?supplied-pmid 19716576?><pub-id pub-id-type="pmid">19716576</pub-id></element-citation></ref><ref id="B107-pathogens-09-00856"><label>107.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rec</surname><given-names>W.E.</given-names></name></person-group><article-title>Hepatitis E, Chad</article-title><source>Wkly. Epidemiol. Rec.</source><year>2004</year><volume>79</volume><fpage>313</fpage><pub-id pub-id-type="pmid">15382402</pub-id></element-citation></ref><ref id="B108-pathogens-09-00856"><label>108.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Al-Nasrawi</surname><given-names>K.K.</given-names></name><name><surname>Al Diwan</surname><given-names>J.K.</given-names></name><name><surname>Al-Hadithi</surname><given-names>T.S.</given-names></name><name><surname>Saleh</surname><given-names>A.M.</given-names></name></person-group><article-title>Viral hepatitis E outbreak in Al-Sadr city, Baghdad, Iraq</article-title><source>East. Mediterr. Health J.</source><year>2010</year><volume>16</volume><fpage>1128</fpage><lpage>1132</lpage><pub-id pub-id-type="doi">10.26719/2010.16.11.1128</pub-id><pub-id pub-id-type="pmid">21218735</pub-id></element-citation></ref><ref id="B109-pathogens-09-00856"><label>109.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sarguna</surname><given-names>P.</given-names></name><name><surname>Rao</surname><given-names>A.</given-names></name><name><surname>Sudha Ramana</surname><given-names>K.N.</given-names></name></person-group><article-title>Outbreak of acute viral hepatitis due to hepatitis E virus in Hyderabad</article-title><source>Indian J. Med. Microbiol.</source><year>2007</year><volume>25</volume><fpage>378</fpage><lpage>382</lpage><pub-id pub-id-type="doi">10.4103/0255-0857.37343</pub-id><pub-id pub-id-type="pmid">18087089</pub-id></element-citation></ref><ref id="B110-pathogens-09-00856"><label>110.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guthmann</surname><given-names>J.P.</given-names></name><name><surname>Klovstad</surname><given-names>H.</given-names></name><name><surname>Boccia</surname><given-names>D.</given-names></name><name><surname>Hamid</surname><given-names>N.</given-names></name><name><surname>Pinoges</surname><given-names>L.</given-names></name><name><surname>Nizou</surname><given-names>J.Y.</given-names></name><name><surname>Tatay</surname><given-names>M.</given-names></name><name><surname>Diaz</surname><given-names>F.</given-names></name><name><surname>Moren</surname><given-names>A.</given-names></name><name><surname>Grais</surname><given-names>R.F.</given-names></name><etal/></person-group><article-title>A large outbreak of hepatitis E among a displaced population in Darfur, Sudan, 2004: The role of water treatment methods</article-title><source>Clin. Infect. Dis.</source><year>2006</year><volume>42</volume><fpage>1685</fpage><lpage>1691</lpage><pub-id pub-id-type="doi">10.1086/504321</pub-id><pub-id pub-id-type="pmid">16705572</pub-id></element-citation></ref><ref id="B111-pathogens-09-00856"><label>111.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boccia</surname><given-names>D.</given-names></name><name><surname>Guthmann</surname><given-names>J.P.</given-names></name><name><surname>Klovstad</surname><given-names>H.</given-names></name><name><surname>Hamid</surname><given-names>N.</given-names></name><name><surname>Tatay</surname><given-names>M.</given-names></name><name><surname>Ciglenecki</surname><given-names>I.</given-names></name><name><surname>Nizou</surname><given-names>J.Y.</given-names></name><name><surname>Nicand</surname><given-names>E.</given-names></name><name><surname>Guerin</surname><given-names>P.J.</given-names></name></person-group><article-title>High mortality associated with an outbreak of hepatitis E among displaced persons in Darfur, Sudan</article-title><source>Clin. Infect. Dis.</source><year>2006</year><volume>42</volume><fpage>1679</fpage><lpage>1684</lpage><pub-id pub-id-type="doi">10.1086/504322</pub-id><pub-id pub-id-type="pmid">16705571</pub-id></element-citation></ref><ref id="B112-pathogens-09-00856"><label>112.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khuroo</surname><given-names>M.S.</given-names></name><name><surname>Khuroo</surname><given-names>M.S.</given-names></name></person-group><article-title>Seroepidemiology of a second epidemic of hepatitis E in a population that had recorded first epidemic 30 years before and has been under surveillance since then</article-title><source>Hepatol. Int.</source><year>2010</year><volume>4</volume><fpage>494</fpage><lpage>499</lpage><pub-id pub-id-type="doi">10.1007/s12072-009-9159-5</pub-id><?supplied-pmid 20827406?><pub-id pub-id-type="pmid">20827406</pub-id></element-citation></ref><ref id="B113-pathogens-09-00856"><label>113.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shata</surname><given-names>M.T.</given-names></name><name><surname>Daef</surname><given-names>E.A.</given-names></name><name><surname>Zaki</surname><given-names>M.E.</given-names></name><name><surname>Abdelwahab</surname><given-names>S.F.</given-names></name><name><surname>Marzuuk</surname><given-names>N.M.</given-names></name><name><surname>Sobhy</surname><given-names>M.</given-names></name><name><surname>Rafaat</surname><given-names>M.</given-names></name><name><surname>Abdelbaki</surname><given-names>L.</given-names></name><name><surname>Nafeh</surname><given-names>M.A.</given-names></name><name><surname>Hashem</surname><given-names>M.</given-names></name><etal/></person-group><article-title>Protective role of humoral immune responses during an outbreak of hepatitis E in Egypt</article-title><source>Trans. R. Soc. Trop. Med. Hyg.</source><year>2012</year><volume>106</volume><fpage>613</fpage><lpage>618</lpage><pub-id pub-id-type="doi">10.1016/j.trstmh.2012.07.004</pub-id><?supplied-pmid 22938992?><pub-id pub-id-type="pmid">22938992</pub-id></element-citation></ref><ref id="B114-pathogens-09-00856"><label>114.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gerbi</surname><given-names>G.B.</given-names></name><name><surname>Williams</surname><given-names>R.</given-names></name><name><surname>Bakamutumaho</surname><given-names>B.</given-names></name><name><surname>Liu</surname><given-names>S.</given-names></name><name><surname>Downing</surname><given-names>R.</given-names></name><name><surname>Drobeniuc</surname><given-names>J.</given-names></name><name><surname>Kamili</surname><given-names>S.</given-names></name><name><surname>Xu</surname><given-names>F.</given-names></name><name><surname>Holmberg</surname><given-names>S.D.</given-names></name><name><surname>Teshale</surname><given-names>E.H.</given-names></name></person-group><article-title>Hepatitis E as a cause of acute jaundice syndrome in northern Uganda, 2010-2012</article-title><source>Am. J. Trop. Med. Hyg.</source><year>2015</year><volume>92</volume><fpage>411</fpage><lpage>414</lpage><pub-id pub-id-type="doi">10.4269/ajtmh.14-0196</pub-id><pub-id pub-id-type="pmid">25448237</pub-id></element-citation></ref><ref id="B115-pathogens-09-00856"><label>115.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vivek</surname><given-names>R.</given-names></name><name><surname>Nihal</surname><given-names>L.</given-names></name><name><surname>Illiayaraja</surname><given-names>J.</given-names></name><name><surname>Reddy</surname><given-names>P.K.</given-names></name><name><surname>Sarkar</surname><given-names>R.</given-names></name><name><surname>Eapen</surname><given-names>C.E.</given-names></name><name><surname>Kang</surname><given-names>G.</given-names></name></person-group><article-title>Investigation of an epidemic of Hepatitis E in Nellore in south India</article-title><source>Trop. Med. Int. Health</source><year>2010</year><volume>15</volume><fpage>1333</fpage><lpage>1339</lpage><pub-id pub-id-type="doi">10.1111/j.1365-3156.2010.02624.x</pub-id><pub-id pub-id-type="pmid">20955497</pub-id></element-citation></ref><ref id="B116-pathogens-09-00856"><label>116.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Teshale</surname><given-names>E.H.</given-names></name><name><surname>Howard</surname><given-names>C.M.</given-names></name><name><surname>Grytdal</surname><given-names>S.P.</given-names></name><name><surname>Handzel</surname><given-names>T.R.</given-names></name><name><surname>Barry</surname><given-names>V.</given-names></name><name><surname>Kamili</surname><given-names>S.</given-names></name><name><surname>Drobeniuc</surname><given-names>J.</given-names></name><name><surname>Okware</surname><given-names>S.</given-names></name><name><surname>Downing</surname><given-names>R.</given-names></name><name><surname>Tappero</surname><given-names>J.W.</given-names></name><etal/></person-group><article-title>Hepatitis E epidemic, Uganda</article-title><source>Emerg. Infect. Dis.</source><year>2010</year><volume>16</volume><fpage>126</fpage><lpage>129</lpage><pub-id pub-id-type="doi">10.3201/eid1601.090764</pub-id><pub-id pub-id-type="pmid">20031058</pub-id></element-citation></ref><ref id="B117-pathogens-09-00856"><label>117.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Teshale</surname><given-names>E.H.</given-names></name><name><surname>Grytdal</surname><given-names>S.P.</given-names></name><name><surname>Howard</surname><given-names>C.</given-names></name><name><surname>Barry</surname><given-names>V.</given-names></name><name><surname>Kamili</surname><given-names>S.</given-names></name><name><surname>Drobeniuc</surname><given-names>J.</given-names></name><name><surname>Hill</surname><given-names>V.R.</given-names></name><name><surname>Okware</surname><given-names>S.</given-names></name><name><surname>Hu</surname><given-names>D.J.</given-names></name><name><surname>Holmberg</surname><given-names>S.D.</given-names></name></person-group><article-title>Evidence of person-to-person transmission of hepatitis E virus during a large outbreak in Northern Uganda</article-title><source>Clin. Infect. Dis.</source><year>2010</year><volume>50</volume><fpage>1006</fpage><lpage>1010</lpage><pub-id pub-id-type="doi">10.1086/651077</pub-id><?supplied-pmid 20178415?><pub-id pub-id-type="pmid">20178415</pub-id></element-citation></ref><ref id="B118-pathogens-09-00856"><label>118.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Howard</surname><given-names>C.M.</given-names></name><name><surname>Handzel</surname><given-names>T.</given-names></name><name><surname>Hill</surname><given-names>V.R.</given-names></name><name><surname>Grytdal</surname><given-names>S.P.</given-names></name><name><surname>Blanton</surname><given-names>C.</given-names></name><name><surname>Kamili</surname><given-names>S.</given-names></name><name><surname>Drobeniuc</surname><given-names>J.</given-names></name><name><surname>Hu</surname><given-names>D.</given-names></name><name><surname>Teshale</surname><given-names>E.</given-names></name></person-group><article-title>Novel risk factors associated with hepatitis E virus infection in a large outbreak in northern Uganda: Results from a case-control study and environmental analysis</article-title><source>Am. J. Trop. Med. Hyg.</source><year>2010</year><volume>83</volume><fpage>1170</fpage><lpage>1173</lpage><pub-id pub-id-type="doi">10.4269/ajtmh.2010.10-0384</pub-id><pub-id pub-id-type="pmid">21036857</pub-id></element-citation></ref><ref id="B119-pathogens-09-00856"><label>119.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gurley</surname><given-names>E.S.</given-names></name><name><surname>Hossain</surname><given-names>M.J.</given-names></name><name><surname>Paul</surname><given-names>R.C.</given-names></name><name><surname>Sazzad</surname><given-names>H.M.</given-names></name><name><surname>Islam</surname><given-names>M.S.</given-names></name><name><surname>Parveen</surname><given-names>S.</given-names></name><name><surname>Faruque</surname><given-names>L.I.</given-names></name><name><surname>Husain</surname><given-names>M.</given-names></name><name><surname>Ara</surname><given-names>K.</given-names></name><name><surname>Jahan</surname><given-names>Y.</given-names></name><etal/></person-group><article-title>Outbreak of hepatitis E in urban Bangladesh resulting in maternal and perinatal mortality</article-title><source>Clin. Infect. Dis.</source><year>2014</year><volume>59</volume><fpage>658</fpage><lpage>665</lpage><pub-id pub-id-type="doi">10.1093/cid/ciu383</pub-id><pub-id pub-id-type="pmid">24855146</pub-id></element-citation></ref><ref id="B120-pathogens-09-00856"><label>120.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cummings</surname><given-names>M.J.</given-names></name><name><surname>Wamala</surname><given-names>J.F.</given-names></name><name><surname>Komakech</surname><given-names>I.</given-names></name><name><surname>Lukwago</surname><given-names>L.</given-names></name><name><surname>Malimbo</surname><given-names>M.</given-names></name><name><surname>Omeke</surname><given-names>M.E.</given-names></name><name><surname>Mayer</surname><given-names>D.</given-names></name><name><surname>Bakamutumaho</surname><given-names>B.</given-names></name></person-group><article-title>Hepatitis E in Karamoja, Uganda, 2009-2012: Epidemiology and challenges to control in a setting of semi-nomadic pastoralism</article-title><source>Trans. R. Soc. Trop. Med. Hyg.</source><year>2014</year><volume>108</volume><fpage>648</fpage><lpage>655</lpage><pub-id pub-id-type="doi">10.1093/trstmh/tru123</pub-id><pub-id pub-id-type="pmid">25092862</pub-id></element-citation></ref><ref id="B121-pathogens-09-00856"><label>121.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harun-Or-Rashid</surname><given-names>M.</given-names></name><name><surname>Akbar</surname><given-names>S.M.</given-names></name><name><surname>Takahashi</surname><given-names>K.</given-names></name><name><surname>Al-Mahtab</surname><given-names>M.</given-names></name><name><surname>Khan</surname><given-names>M.S.</given-names></name><name><surname>Alim</surname><given-names>M.A.</given-names></name><name><surname>Ekram</surname><given-names>A.R.</given-names></name><name><surname>Khan</surname><given-names>M.M.</given-names></name><name><surname>Arai</surname><given-names>M.</given-names></name><name><surname>Mishiro</surname><given-names>S.</given-names></name></person-group><article-title>Epidemiological and molecular analyses of a non-seasonal outbreak of acute icteric hepatitis E in Bangladesh</article-title><source>J. Med. Virol.</source><year>2013</year><volume>85</volume><fpage>1369</fpage><lpage>1376</lpage><pub-id pub-id-type="doi">10.1002/jmv.23601</pub-id><pub-id pub-id-type="pmid">23703666</pub-id></element-citation></ref><ref id="B122-pathogens-09-00856"><label>122.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Majumdar</surname><given-names>M.</given-names></name><name><surname>Singh</surname><given-names>M.P.</given-names></name><name><surname>Pujhari</surname><given-names>S.K.</given-names></name><name><surname>Bhatia</surname><given-names>D.</given-names></name><name><surname>Chawla</surname><given-names>Y.</given-names></name><name><surname>Ratho</surname><given-names>R.K.</given-names></name></person-group><article-title>Hepatitis E virus antigen detection as an early diagnostic marker: Report from India</article-title><source>J. Med. Virol.</source><year>2013</year><volume>85</volume><fpage>823</fpage><lpage>827</lpage><pub-id pub-id-type="doi">10.1002/jmv.23529</pub-id><?supplied-pmid 23408566?><pub-id pub-id-type="pmid">23408566</pub-id></element-citation></ref><ref id="B123-pathogens-09-00856"><label>123.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Karna</surname><given-names>R.</given-names></name><name><surname>Hazam</surname><given-names>R.K.</given-names></name><name><surname>Borkakoti</surname><given-names>J.</given-names></name><name><surname>Kumar</surname><given-names>A.</given-names></name><name><surname>Kar</surname><given-names>P.</given-names></name></person-group><article-title>A 5-year Single-Center Experience of Hepatitis E Virus Infection During Pregnancy</article-title><source>J. Clin. Exp. Hepatol.</source><year>2020</year><volume>10</volume><fpage>135</fpage><lpage>138</lpage><pub-id pub-id-type="doi">10.1016/j.jceh.2019.09.003</pub-id><?supplied-pmid 32189928?><pub-id pub-id-type="pmid">32189928</pub-id></element-citation></ref><ref id="B124-pathogens-09-00856"><label>124.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tambe</surname><given-names>M.</given-names></name><name><surname>Patil</surname><given-names>S.M.D.</given-names></name><name><surname>Bhagwat</surname><given-names>V.</given-names></name></person-group><article-title>Investigation of an Outbreak of Hepatitis &#x02019;E&#x02019; in a Rural Area of Dhule District in Maharashtra</article-title><source>JKIMSU</source><year>2015</year><volume>4</volume><fpage>109</fpage><lpage>114</lpage></element-citation></ref><ref id="B125-pathogens-09-00856"><label>125.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ahmed</surname><given-names>J.A.</given-names></name><name><surname>Moturi</surname><given-names>E.</given-names></name><name><surname>Spiegel</surname><given-names>P.</given-names></name><name><surname>Schilperoord</surname><given-names>M.</given-names></name><name><surname>Burton</surname><given-names>W.</given-names></name><name><surname>Kassim</surname><given-names>N.H.</given-names></name><name><surname>Mohamed</surname><given-names>A.</given-names></name><name><surname>Ochieng</surname><given-names>M.</given-names></name><name><surname>Nderitu</surname><given-names>L.</given-names></name><name><surname>Navarro-Colorado</surname><given-names>C.</given-names></name><etal/></person-group><article-title>Hepatitis E outbreak, Dadaab refugee camp, Kenya, 2012</article-title><source>Emerg. Infect. Dis.</source><year>2013</year><volume>19</volume><fpage>1010</fpage><lpage>1012</lpage><pub-id pub-id-type="doi">10.3201/eid1906.130275</pub-id><pub-id pub-id-type="pmid">23735820</pub-id></element-citation></ref><ref id="B126-pathogens-09-00856"><label>126.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tricou</surname><given-names>V.</given-names></name><name><surname>Bouscaillou</surname><given-names>J.</given-names></name><name><surname>Laghoe-Nguembe</surname><given-names>G.L.</given-names></name><name><surname>Bere</surname><given-names>A.</given-names></name><name><surname>Konamna</surname><given-names>X.</given-names></name><name><surname>Selekon</surname><given-names>B.</given-names></name><name><surname>Nakoune</surname><given-names>E.</given-names></name><name><surname>Kazanji</surname><given-names>M.</given-names></name><name><surname>Komas</surname><given-names>N.P.</given-names></name></person-group><article-title>Hepatitis E virus outbreak associated with rainfall in the Central African Republic in 2008&#x02013;2009</article-title><source>BMC Infect. Dis.</source><year>2020</year><volume>20</volume><elocation-id>260</elocation-id><pub-id pub-id-type="doi">10.1186/s12879-020-04961-4</pub-id><pub-id pub-id-type="pmid">32245368</pub-id></element-citation></ref><ref id="B127-pathogens-09-00856"><label>127.</label><element-citation publication-type="journal"><person-group person-group-type="author"><collab>Center for Global Health, CDC</collab></person-group><article-title>Prevention. Investigation of hepatitis E outbreak among refugees - Upper Nile, South Sudan, 2012&#x02013;2013</article-title><source>MMWR Morb. Mortal Wkly. Rep.</source><year>2013</year><volume>62</volume><fpage>581</fpage><lpage>586</lpage><pub-id pub-id-type="pmid">23884344</pub-id></element-citation></ref><ref id="B128-pathogens-09-00856"><label>128.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Awsathi</surname><given-names>S.</given-names></name><name><surname>Rawat</surname><given-names>V.</given-names></name><name><surname>Rawat</surname><given-names>C.M.</given-names></name><name><surname>Semwal</surname><given-names>V.</given-names></name><name><surname>Bartwal</surname><given-names>S.J.</given-names></name></person-group><article-title>Epidemiological investigation of the jaundice outbreak in lalkuan, nainital district, uttarakhand</article-title><source>Indian J. Community Med.</source><year>2014</year><volume>39</volume><fpage>94</fpage><lpage>97</lpage><pub-id pub-id-type="doi">10.4103/0970-0218.132725</pub-id><pub-id pub-id-type="pmid">24963225</pub-id></element-citation></ref><ref id="B129-pathogens-09-00856"><label>129.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maurice</surname><given-names>D.</given-names></name><name><surname>Abassora</surname><given-names>M.</given-names></name><name><surname>Marcelin</surname><given-names>N.</given-names></name><name><surname>Richard</surname><given-names>N.</given-names></name></person-group><article-title>First documented outbreak of Hepatitis E in Northern Cameroon</article-title><source>Ann. Trop. Med. PH</source><year>2013</year><volume>6</volume><fpage>682</fpage><lpage>683</lpage><pub-id pub-id-type="doi">10.4103/1755-6783.140266</pub-id></element-citation></ref><ref id="B130-pathogens-09-00856"><label>130.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khan</surname><given-names>A.I.</given-names></name><name><surname>Salimuzzaman</surname><given-names>M.</given-names></name><name><surname>Islam</surname><given-names>M.T.</given-names></name><name><surname>Afrad</surname><given-names>M.H.</given-names></name><name><surname>Shirin</surname><given-names>T.</given-names></name><name><surname>Jony</surname><given-names>M.H.K.</given-names></name><name><surname>Alam</surname><given-names>M.A.</given-names></name><name><surname>Rahman</surname><given-names>M.</given-names></name><name><surname>Flora</surname><given-names>M.S.</given-names></name><name><surname>Qadri</surname><given-names>F.</given-names></name></person-group><article-title>Nationwide Hospital-Based Seroprevalence of Hepatitis A and Hepatitis E Virus in Bangladesh</article-title><source>Ann. Glob. Health</source><year>2020</year><volume>86</volume><fpage>29</fpage><pub-id pub-id-type="doi">10.5334/aogh.2574</pub-id><pub-id pub-id-type="pmid">32211299</pub-id></element-citation></ref><ref id="B131-pathogens-09-00856"><label>131.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goel</surname><given-names>A.</given-names></name><name><surname>Padmaprakash</surname><given-names>K.V.</given-names></name><name><surname>Benjamin</surname><given-names>M.</given-names></name><name><surname>Katiyar</surname><given-names>H.</given-names></name><name><surname>Aggarwal</surname><given-names>R.</given-names></name></person-group><article-title>Temporal profile of HEV RNA concentration in blood and stool from patients with acute uncomplicated hepatitis E in a region with genotype 1 predominance</article-title><source>J. Viral. Hepat.</source><year>2020</year><volume>27</volume><fpage>631</fpage><lpage>637</lpage><pub-id pub-id-type="doi">10.1111/jvh.13266</pub-id><pub-id pub-id-type="pmid">31997507</pub-id></element-citation></ref><ref id="B132-pathogens-09-00856"><label>132.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spina</surname><given-names>A.</given-names></name><name><surname>Lenglet</surname><given-names>A.</given-names></name><name><surname>Beversluis</surname><given-names>D.</given-names></name><name><surname>de Jong</surname><given-names>M.</given-names></name><name><surname>Vernier</surname><given-names>L.</given-names></name><name><surname>Spencer</surname><given-names>C.</given-names></name><name><surname>Andayi</surname><given-names>F.</given-names></name><name><surname>Kamau</surname><given-names>C.</given-names></name><name><surname>Vollmer</surname><given-names>S.</given-names></name><name><surname>Hogema</surname><given-names>B.</given-names></name><etal/></person-group><article-title>A large outbreak of Hepatitis E virus genotype 1 infection in an urban setting in Chad likely linked to household level transmission factors, 2016&#x02013;2017</article-title><source>PLoS ONE</source><year>2017</year><volume>12</volume><elocation-id>e0188240</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0188240</pub-id><?supplied-pmid 29176816?><pub-id pub-id-type="pmid">29176816</pub-id></element-citation></ref><ref id="B133-pathogens-09-00856"><label>133.</label><element-citation publication-type="book"><person-group person-group-type="author"><collab>WHO</collab></person-group><source>Weekly Bulletin on Outbreaks and Other Emergencies</source><publisher-name>WHO</publisher-name><publisher-loc>Geneva, Switzerland</publisher-loc><year>2017</year></element-citation></ref><ref id="B134-pathogens-09-00856"><label>134.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Paul</surname><given-names>R.C.</given-names></name><name><surname>Nazneen</surname><given-names>A.</given-names></name><name><surname>Banik</surname><given-names>K.C.</given-names></name><name><surname>Sumon</surname><given-names>S.A.</given-names></name><name><surname>Paul</surname><given-names>K.K.</given-names></name><name><surname>Akram</surname><given-names>A.</given-names></name><name><surname>Uzzaman</surname><given-names>M.S.</given-names></name><name><surname>Iqbal</surname><given-names>T.</given-names></name><name><surname>Tejada-Strop</surname><given-names>A.</given-names></name><name><surname>Kamili</surname><given-names>S.</given-names></name><etal/></person-group><article-title>Hepatitis E as a cause of adult hospitalization in Bangladesh: Results from an acute jaundice surveillance study in six tertiary hospitals, 2014&#x02013;2017</article-title><source>PLoS Negl. Trop. Dis.</source><year>2020</year><volume>14</volume><elocation-id>e0007586</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pntd.0007586</pub-id><pub-id pub-id-type="pmid">31961861</pub-id></element-citation></ref><ref id="B135-pathogens-09-00856"><label>135.</label><element-citation publication-type="book"><person-group person-group-type="author"><collab>WHO</collab></person-group><source>Weekly Bulletin on Outbreaks and Other Emergencies</source><publisher-name>WHO</publisher-name><publisher-loc>Geneva, Switzerland</publisher-loc><year>2018</year></element-citation></ref><ref id="B136-pathogens-09-00856"><label>136.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Salman</surname><given-names>M.</given-names></name><name><surname>Ul Mustafa</surname><given-names>Z.</given-names></name><name><surname>Asif</surname><given-names>N.</given-names></name></person-group><article-title>Hepatitis E outbreak in the province of Punjab, Pakistan: A call for action</article-title><source>Infect. Dis. (Lond.)</source><year>2019</year><volume>51</volume><fpage>633</fpage><lpage>634</lpage><pub-id pub-id-type="doi">10.1080/23744235.2019.1632473</pub-id><?supplied-pmid 31240982?><pub-id pub-id-type="pmid">31240982</pub-id></element-citation></ref><ref id="B137-pathogens-09-00856"><label>137.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bustamante</surname><given-names>N.D.</given-names></name><name><surname>Matyenyika</surname><given-names>S.R.</given-names></name><name><surname>Miller</surname><given-names>L.A.</given-names></name><name><surname>Goers</surname><given-names>M.</given-names></name><name><surname>Katjiuanjo</surname><given-names>P.</given-names></name><name><surname>Ndiitodino</surname><given-names>K.</given-names></name><name><surname>Ndevaetela</surname><given-names>E.E.</given-names></name><name><surname>Kaura</surname><given-names>U.</given-names></name><name><surname>Nyarko</surname><given-names>K.M.</given-names></name><name><surname>Kahuika-Crentsil</surname><given-names>L.</given-names></name><etal/></person-group><article-title>Notes from the Field: Nationwide Hepatitis E Outbreak Concentrated in Informal Settlements-Namibia, 2017&#x02013;2020</article-title><source>MMWR Morb. Mortal. Wkly. Rep.</source><year>2020</year><volume>69</volume><fpage>355</fpage><lpage>357</lpage><pub-id pub-id-type="doi">10.15585/mmwr.mm6912a6</pub-id><pub-id pub-id-type="pmid">32214080</pub-id></element-citation></ref><ref id="B138-pathogens-09-00856"><label>138.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carratala</surname><given-names>A.</given-names></name><name><surname>Joost</surname><given-names>S.</given-names></name></person-group><article-title>Population density and water balance influence the global occurrence of hepatitis E epidemics</article-title><source>Sci. Rep.</source><year>2019</year><volume>9</volume><fpage>10042</fpage><pub-id pub-id-type="doi">10.1038/s41598-019-46475-3</pub-id><?supplied-pmid 31296895?><pub-id pub-id-type="pmid">31296895</pub-id></element-citation></ref><ref id="B139-pathogens-09-00856"><label>139.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hakim</surname><given-names>M.S.</given-names></name><name><surname>Wang</surname><given-names>W.</given-names></name><name><surname>Bramer</surname><given-names>W.M.</given-names></name><name><surname>Geng</surname><given-names>J.</given-names></name><name><surname>Huang</surname><given-names>F.</given-names></name><name><surname>de Man</surname><given-names>R.A.</given-names></name><name><surname>Peppelenbosch</surname><given-names>M.P.</given-names></name><name><surname>Pan</surname><given-names>Q.</given-names></name></person-group><article-title>The global burden of hepatitis E outbreaks: A systematic review</article-title><source>Liver Int.</source><year>2017</year><volume>37</volume><fpage>19</fpage><lpage>31</lpage><pub-id pub-id-type="doi">10.1111/liv.13237</pub-id></element-citation></ref><ref id="B140-pathogens-09-00856"><label>140.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lagare</surname><given-names>A.</given-names></name><name><surname>Ibrahim</surname><given-names>A.</given-names></name><name><surname>Ousmane</surname><given-names>S.</given-names></name><name><surname>Issaka</surname><given-names>B.</given-names></name><name><surname>Zaneidou</surname><given-names>M.</given-names></name><name><surname>Kadade</surname><given-names>G.</given-names></name><name><surname>Testa</surname><given-names>J.</given-names></name></person-group><article-title>Outbreak of Hepatitis E Virus Infection in Displaced Persons Camps in Diffa Region, Niger, 2017</article-title><source>Am. J. Trop. Med. Hyg.</source><year>2018</year><volume>99</volume><fpage>1055</fpage><lpage>1057</lpage><pub-id pub-id-type="doi">10.4269/ajtmh.17-0950</pub-id><pub-id pub-id-type="pmid">30062983</pub-id></element-citation></ref><ref id="B141-pathogens-09-00856"><label>141.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Azman</surname><given-names>A.S.</given-names></name><name><surname>Bouhenia</surname><given-names>M.</given-names></name><name><surname>Iyer</surname><given-names>A.S.</given-names></name><name><surname>Rumunu</surname><given-names>J.</given-names></name><name><surname>Laku</surname><given-names>R.L.</given-names></name><name><surname>Wamala</surname><given-names>J.F.</given-names></name><name><surname>Rodriguez-Barraquer</surname><given-names>I.</given-names></name><name><surname>Lessler</surname><given-names>J.</given-names></name><name><surname>Gignoux</surname><given-names>E.</given-names></name><name><surname>Luquero</surname><given-names>F.J.</given-names></name><etal/></person-group><article-title>High Hepatitis E Seroprevalence Among Displaced Persons in South Sudan</article-title><source>Am. J. Trop. Med. Hyg.</source><year>2017</year><volume>96</volume><fpage>1296</fpage><lpage>1301</lpage><pub-id pub-id-type="doi">10.4269/ajtmh.16-0620</pub-id><pub-id pub-id-type="pmid">28719276</pub-id></element-citation></ref><ref id="B142-pathogens-09-00856"><label>142.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guerrero-Latorre</surname><given-names>L.</given-names></name><name><surname>Carratala</surname><given-names>A.</given-names></name><name><surname>Rodriguez-Manzano</surname><given-names>J.</given-names></name><name><surname>Calgua</surname><given-names>B.</given-names></name><name><surname>Hundesa</surname><given-names>A.</given-names></name><name><surname>Girones</surname><given-names>R.</given-names></name></person-group><article-title>Occurrence of water-borne enteric viruses in two settlements based in Eastern Chad: Analysis of hepatitis E virus, hepatitis A virus and human adenovirus in water sources</article-title><source>J. Water Health</source><year>2011</year><volume>9</volume><fpage>515</fpage><lpage>524</lpage><pub-id pub-id-type="doi">10.2166/wh.2011.126</pub-id><pub-id pub-id-type="pmid">21976198</pub-id></element-citation></ref><ref id="B143-pathogens-09-00856"><label>143.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Woo</surname><given-names>P.C.</given-names></name><name><surname>Lau</surname><given-names>S.K.</given-names></name><name><surname>Teng</surname><given-names>J.L.</given-names></name><name><surname>Tsang</surname><given-names>A.K.</given-names></name><name><surname>Joseph</surname><given-names>M.</given-names></name><name><surname>Wong</surname><given-names>E.Y.</given-names></name><name><surname>Tang</surname><given-names>Y.</given-names></name><name><surname>Sivakumar</surname><given-names>S.</given-names></name><name><surname>Xie</surname><given-names>J.</given-names></name><name><surname>Bai</surname><given-names>R.</given-names></name><etal/></person-group><article-title>New hepatitis E virus genotype in camels, the Middle East</article-title><source>Emerg. Infect. Dis.</source><year>2014</year><volume>20</volume><fpage>1044</fpage><lpage>1048</lpage><pub-id pub-id-type="doi">10.3201/eid2006.140140</pub-id><pub-id pub-id-type="pmid">24856611</pub-id></element-citation></ref><ref id="B144-pathogens-09-00856"><label>144.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sridhar</surname><given-names>S.</given-names></name><name><surname>Yip</surname><given-names>C.C.Y.</given-names></name><name><surname>Wu</surname><given-names>S.</given-names></name><name><surname>Cai</surname><given-names>J.</given-names></name><name><surname>Zhang</surname><given-names>A.J.</given-names></name><name><surname>Leung</surname><given-names>K.H.</given-names></name><name><surname>Chung</surname><given-names>T.W.H.</given-names></name><name><surname>Chan</surname><given-names>J.F.W.</given-names></name><name><surname>Chan</surname><given-names>W.M.</given-names></name><name><surname>Teng</surname><given-names>J.L.L.</given-names></name><etal/></person-group><article-title>Rat Hepatitis E Virus as Cause of Persistent Hepatitis after Liver Transplant</article-title><source>Emerg. Infect. Dis.</source><year>2018</year><volume>24</volume><fpage>2241</fpage><lpage>2250</lpage><pub-id pub-id-type="doi">10.3201/eid2412.180937</pub-id><pub-id pub-id-type="pmid">30457530</pub-id></element-citation></ref><ref id="B145-pathogens-09-00856"><label>145.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pischke</surname><given-names>S.</given-names></name><name><surname>Hiller</surname><given-names>J.</given-names></name><name><surname>Lutgehetmann</surname><given-names>M.</given-names></name><name><surname>Polywka</surname><given-names>S.</given-names></name><name><surname>Rybczynski</surname><given-names>M.</given-names></name><name><surname>Ayuk</surname><given-names>F.</given-names></name><name><surname>Lohse</surname><given-names>A.W.</given-names></name></person-group><article-title>Blood-borne Hepatitis E Virus Transmission: A Relevant Risk for Immunosuppressed Patients</article-title><source>Clin. Infect. Dis.</source><year>2016</year><volume>63</volume><fpage>569</fpage><lpage>570</lpage><pub-id pub-id-type="doi">10.1093/cid/ciw309</pub-id><?supplied-pmid 27178472?><pub-id pub-id-type="pmid">27178472</pub-id></element-citation></ref><ref id="B146-pathogens-09-00856"><label>146.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gu</surname><given-names>Y.</given-names></name><name><surname>Tang</surname><given-names>X.</given-names></name><name><surname>Zhang</surname><given-names>X.</given-names></name><name><surname>Song</surname><given-names>C.</given-names></name><name><surname>Zheng</surname><given-names>M.</given-names></name><name><surname>Wang</surname><given-names>K.</given-names></name><name><surname>Zhang</surname><given-names>J.</given-names></name><name><surname>Ng</surname><given-names>M.H.</given-names></name><name><surname>Hew</surname><given-names>C.L.</given-names></name><name><surname>Li</surname><given-names>S.</given-names></name><etal/></person-group><article-title>Structural basis for the neutralization of hepatitis E virus by a cross-genotype antibody</article-title><source>Cell Res.</source><year>2015</year><volume>25</volume><fpage>604</fpage><lpage>620</lpage><pub-id pub-id-type="doi">10.1038/cr.2015.34</pub-id><pub-id pub-id-type="pmid">25793314</pub-id></element-citation></ref><ref id="B147-pathogens-09-00856"><label>147.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>J.</given-names></name><name><surname>Shih</surname><given-names>J.W.</given-names></name><name><surname>Wu</surname><given-names>T.</given-names></name><name><surname>Li</surname><given-names>S.W.</given-names></name><name><surname>Xia</surname><given-names>N.S.</given-names></name></person-group><article-title>Development of the hepatitis E vaccine: From bench to field</article-title><source>Semin. Liver Dis.</source><year>2013</year><volume>33</volume><fpage>79</fpage><lpage>88</lpage><pub-id pub-id-type="doi">10.1055/s-0033-1338116</pub-id><?supplied-pmid 23564392?><pub-id pub-id-type="pmid">23564392</pub-id></element-citation></ref><ref id="B148-pathogens-09-00856"><label>148.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>X.</given-names></name><name><surname>Chen</surname><given-names>P.</given-names></name><name><surname>Lin</surname><given-names>H.</given-names></name><name><surname>Hao</surname><given-names>X.</given-names></name><name><surname>Liang</surname><given-names>Z.</given-names></name></person-group><article-title>Hepatitis E virus: Current epidemiology and vaccine</article-title><source>Hum. Vaccines immunother.</source><year>2016</year><volume>12</volume><fpage>2603</fpage><lpage>2610</lpage><pub-id pub-id-type="doi">10.1080/21645515.2016.1184806</pub-id></element-citation></ref><ref id="B149-pathogens-09-00856"><label>149.</label><element-citation publication-type="web"><person-group person-group-type="author"><name><surname>Shorthouse</surname><given-names>D.P.</given-names></name></person-group><article-title>SimpleMappr, An Online Tool to Produce Publication-Quality Point Maps. 2010</article-title><comment>Available online: <ext-link ext-link-type="uri" xlink:href="http://www.simplemappr.net">http://www.simplemappr.net</ext-link></comment><date-in-citation content-type="access-date" iso-8601-date="2020-09-17">(accessed on 17 September 2020)</date-in-citation></element-citation></ref><ref id="B150-pathogens-09-00856"><label>150.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Webb</surname><given-names>G.W.</given-names></name><name><surname>Dalton</surname><given-names>H.R.</given-names></name></person-group><article-title>Hepatitis E: An underestimated emerging threat</article-title><source>Ther. Adv. Infect. Dis.</source><year>2019</year><volume>6</volume><fpage>2049936119837162</fpage><pub-id pub-id-type="doi">10.1177/2049936119837162</pub-id><?supplied-pmid 30984394?><pub-id pub-id-type="pmid">30984394</pub-id></element-citation></ref><ref id="B151-pathogens-09-00856"><label>151.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khuroo</surname><given-names>M.S.</given-names></name><name><surname>Khuroo</surname><given-names>M.S.</given-names></name><name><surname>Khuroo</surname><given-names>N.S.</given-names></name></person-group><article-title>Hepatitis E: Discovery, global impact, control and cure</article-title><source>World J. Gastroenterol.</source><year>2016</year><volume>22</volume><fpage>7030</fpage><lpage>7045</lpage><pub-id pub-id-type="doi">10.3748/wjg.v22.i31.7030</pub-id><pub-id pub-id-type="pmid">27610014</pub-id></element-citation></ref><ref id="B152-pathogens-09-00856"><label>152.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>C.C.</given-names></name><name><surname>Nguyen</surname><given-names>D.</given-names></name><name><surname>Fernandez</surname><given-names>J.</given-names></name><name><surname>Yun</surname><given-names>K.Y.</given-names></name><name><surname>Fry</surname><given-names>K.E.</given-names></name><name><surname>Bradley</surname><given-names>D.W.</given-names></name><name><surname>Tam</surname><given-names>A.W.</given-names></name><name><surname>Reyes</surname><given-names>G.R.</given-names></name></person-group><article-title>Molecular cloning and sequencing of the Mexico isolate of hepatitis E virus (HEV)</article-title><source>Virology</source><year>1992</year><volume>191</volume><fpage>550</fpage><lpage>558</lpage><pub-id pub-id-type="doi">10.1016/0042-6822(92)90230-M</pub-id><pub-id pub-id-type="pmid">1448913</pub-id></element-citation></ref><ref id="B153-pathogens-09-00856"><label>153.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dimeglio</surname><given-names>C.</given-names></name><name><surname>Kania</surname><given-names>D.</given-names></name><name><surname>Mantono</surname><given-names>J.M.</given-names></name><name><surname>Kagone</surname><given-names>T.</given-names></name><name><surname>Zida</surname><given-names>S.</given-names></name><name><surname>Tassembedo</surname><given-names>S.</given-names></name><name><surname>Dicko</surname><given-names>A.</given-names></name><name><surname>Tinto</surname><given-names>B.</given-names></name><name><surname>Yaro</surname><given-names>S.</given-names></name><name><surname>Hien</surname><given-names>H.</given-names></name><etal/></person-group><article-title>Hepatitis E Virus Infections among Patients with Acute Febrile Jaundice in Burkina Faso</article-title><source>Viruses</source><year>2019</year><volume>11</volume><elocation-id>554</elocation-id><pub-id pub-id-type="doi">10.3390/v11060554</pub-id></element-citation></ref><ref id="B154-pathogens-09-00856"><label>154.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Buisson</surname><given-names>Y.</given-names></name><name><surname>Grandadam</surname><given-names>M.</given-names></name><name><surname>Nicand</surname><given-names>E.</given-names></name><name><surname>Cheval</surname><given-names>P.</given-names></name><name><surname>van Cuyck-Gandre</surname><given-names>H.</given-names></name><name><surname>Innis</surname><given-names>B.</given-names></name><name><surname>Rehel</surname><given-names>P.</given-names></name><name><surname>Coursaget</surname><given-names>P.</given-names></name><name><surname>Teyssou</surname><given-names>R.</given-names></name><name><surname>Tsarev</surname><given-names>S.</given-names></name></person-group><article-title>Identification of a novel hepatitis E virus in Nigeria</article-title><source>J. Gen. Virol.</source><year>2000</year><volume>81</volume><fpage>903</fpage><lpage>909</lpage><pub-id pub-id-type="doi">10.1099/0022-1317-81-4-903</pub-id><?supplied-pmid 10725415?><pub-id pub-id-type="pmid">10725415</pub-id></element-citation></ref><ref id="B155-pathogens-09-00856"><label>155.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nicand</surname><given-names>E.</given-names></name><name><surname>Armstrong</surname><given-names>G.L.</given-names></name><name><surname>Enouf</surname><given-names>V.</given-names></name><name><surname>Guthmann</surname><given-names>J.P.</given-names></name><name><surname>Guerin</surname><given-names>J.P.</given-names></name><name><surname>Caron</surname><given-names>M.</given-names></name><name><surname>Nizou</surname><given-names>J.Y.</given-names></name><name><surname>Andraghetti</surname><given-names>R.</given-names></name></person-group><article-title>Genetic heterogeneity of hepatitis E virus in Darfur, Sudan, and neighboring Chad</article-title><source>J. Med. Virol.</source><year>2005</year><volume>77</volume><fpage>519</fpage><lpage>521</lpage><pub-id pub-id-type="doi">10.1002/jmv.20487</pub-id><?supplied-pmid 16254969?><pub-id pub-id-type="pmid">16254969</pub-id></element-citation></ref><ref id="B156-pathogens-09-00856"><label>156.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aggarwal</surname><given-names>R.</given-names></name><name><surname>Naik</surname><given-names>S.R.</given-names></name></person-group><article-title>Hepatitis E: Intrafamilial transmission versus waterborne spread</article-title><source>J. Hepatol.</source><year>1994</year><volume>21</volume><fpage>718</fpage><lpage>723</lpage><pub-id pub-id-type="doi">10.1016/S0168-8278(94)80229-7</pub-id><pub-id pub-id-type="pmid">7890884</pub-id></element-citation></ref><ref id="B157-pathogens-09-00856"><label>157.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kamar</surname><given-names>N.</given-names></name><name><surname>Dalton</surname><given-names>H.R.</given-names></name><name><surname>Abravanel</surname><given-names>F.</given-names></name><name><surname>Izopet</surname><given-names>J.</given-names></name></person-group><article-title>Hepatitis E virus infection</article-title><source>Clin. Microbiol. Rev.</source><year>2014</year><volume>27</volume><fpage>116</fpage><lpage>138</lpage><pub-id pub-id-type="doi">10.1128/CMR.00057-13</pub-id><?supplied-pmid 24396139?><pub-id pub-id-type="pmid">24396139</pub-id></element-citation></ref><ref id="B158-pathogens-09-00856"><label>158.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lu</surname><given-names>L.</given-names></name><name><surname>Li</surname><given-names>C.</given-names></name><name><surname>Hagedorn</surname><given-names>C.H.</given-names></name></person-group><article-title>Phylogenetic analysis of global hepatitis E virus sequences: Genetic diversity, subtypes and zoonosis</article-title><source>Rev. Med. Virol.</source><year>2006</year><volume>16</volume><fpage>5</fpage><lpage>36</lpage><pub-id pub-id-type="doi">10.1002/rmv.482</pub-id><?supplied-pmid 16175650?><pub-id pub-id-type="pmid">16175650</pub-id></element-citation></ref><ref id="B159-pathogens-09-00856"><label>159.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Adlhoch</surname><given-names>C.</given-names></name><name><surname>Avellon</surname><given-names>A.</given-names></name><name><surname>Baylis</surname><given-names>S.A.</given-names></name><name><surname>Ciccaglione</surname><given-names>A.R.</given-names></name><name><surname>Couturier</surname><given-names>E.</given-names></name><name><surname>de Sousa</surname><given-names>R.</given-names></name><name><surname>Epstein</surname><given-names>J.</given-names></name><name><surname>Ethelberg</surname><given-names>S.</given-names></name><name><surname>Faber</surname><given-names>M.</given-names></name><name><surname>Feher</surname><given-names>A.</given-names></name><etal/></person-group><article-title>Hepatitis E virus: Assessment of the epidemiological situation in humans in Europe, 2014/15</article-title><source>J. Clin. Virol.</source><year>2016</year><volume>82</volume><fpage>9</fpage><lpage>16</lpage><pub-id pub-id-type="doi">10.1016/j.jcv.2016.06.010</pub-id><pub-id pub-id-type="pmid">27393938</pub-id></element-citation></ref><ref id="B160-pathogens-09-00856"><label>160.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aspinall</surname><given-names>E.J.</given-names></name><name><surname>Couturier</surname><given-names>E.</given-names></name><name><surname>Faber</surname><given-names>M.</given-names></name><name><surname>Said</surname><given-names>B.</given-names></name><name><surname>Ijaz</surname><given-names>S.</given-names></name><name><surname>Tavoschi</surname><given-names>L.</given-names></name><name><surname>Takkinen</surname><given-names>J.</given-names></name><name><surname>Adlhoch</surname><given-names>C.</given-names></name><name><surname>The Country</surname><given-names>E.</given-names></name></person-group><article-title>Hepatitis E virus infection in Europe: Surveillance and descriptive epidemiology of confirmed cases, 2005 to 2015</article-title><source>Eurosurveillance</source><year>2017</year><volume>22</volume><fpage>30561</fpage><pub-id pub-id-type="doi">10.2807/1560-7917.ES.2017.22.26.30561</pub-id></element-citation></ref><ref id="B161-pathogens-09-00856"><label>161.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yapa</surname><given-names>C.M.</given-names></name><name><surname>Furlong</surname><given-names>C.</given-names></name><name><surname>Rosewell</surname><given-names>A.</given-names></name><name><surname>Ward</surname><given-names>K.A.</given-names></name><name><surname>Adamson</surname><given-names>S.</given-names></name><name><surname>Shadbolt</surname><given-names>C.</given-names></name><name><surname>Kok</surname><given-names>J.</given-names></name><name><surname>Tracy</surname><given-names>S.L.</given-names></name><name><surname>Bowden</surname><given-names>S.</given-names></name><name><surname>Smedley</surname><given-names>E.J.</given-names></name><etal/></person-group><article-title>First reported outbreak of locally acquired hepatitis E virus infection in Australia</article-title><source>Med. J. Aust.</source><year>2016</year><volume>204</volume><fpage>274</fpage><pub-id pub-id-type="doi">10.5694/mja15.00955</pub-id><pub-id pub-id-type="pmid">27078603</pub-id></element-citation></ref><ref id="B162-pathogens-09-00856"><label>162.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wilhelm</surname><given-names>B.</given-names></name><name><surname>Waddell</surname><given-names>L.</given-names></name><name><surname>Greig</surname><given-names>J.</given-names></name><name><surname>Young</surname><given-names>I.</given-names></name></person-group><article-title>Systematic review and meta-analysis of the seroprevalence of hepatitis E virus in the general population across non-endemic countries</article-title><source>PLoS ONE</source><year>2019</year><volume>14</volume><elocation-id>e0216826</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0216826</pub-id><pub-id pub-id-type="pmid">31173594</pub-id></element-citation></ref><ref id="B163-pathogens-09-00856"><label>163.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Faber</surname><given-names>M.</given-names></name><name><surname>Willrich</surname><given-names>N.</given-names></name><name><surname>Schemmerer</surname><given-names>M.</given-names></name><name><surname>Rauh</surname><given-names>C.</given-names></name><name><surname>Kuhnert</surname><given-names>R.</given-names></name><name><surname>Stark</surname><given-names>K.</given-names></name><name><surname>Wenzel</surname><given-names>J.J.</given-names></name></person-group><article-title>Hepatitis E virus seroprevalence, seroincidence and seroreversion in the German adult population</article-title><source>J. Viral Hepat.</source><year>2018</year><volume>25</volume><fpage>752</fpage><lpage>758</lpage><pub-id pub-id-type="doi">10.1111/jvh.12868</pub-id><pub-id pub-id-type="pmid">29377436</pub-id></element-citation></ref><ref id="B164-pathogens-09-00856"><label>164.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sooryanarain</surname><given-names>H.</given-names></name><name><surname>Meng</surname><given-names>X.J.</given-names></name></person-group><article-title>Swine hepatitis E virus: Cross-species infection, pork safety and chronic infection</article-title><source>Virus Res.</source><year>2020</year><volume>284</volume><fpage>197985</fpage><pub-id pub-id-type="doi">10.1016/j.virusres.2020.197985</pub-id><pub-id pub-id-type="pmid">32333941</pub-id></element-citation></ref><ref id="B165-pathogens-09-00856"><label>165.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pavio</surname><given-names>N.</given-names></name><name><surname>Doceul</surname><given-names>V.</given-names></name><name><surname>Bagdassarian</surname><given-names>E.</given-names></name><name><surname>Johne</surname><given-names>R.</given-names></name></person-group><article-title>Recent knowledge on hepatitis E virus in Suidae reservoirs and transmission routes to human</article-title><source>Vet. Res.</source><year>2017</year><volume>48</volume><fpage>78</fpage><pub-id pub-id-type="doi">10.1186/s13567-017-0483-9</pub-id><pub-id pub-id-type="pmid">29157309</pub-id></element-citation></ref><ref id="B166-pathogens-09-00856"><label>166.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>Y.M.</given-names></name><name><surname>Dong</surname><given-names>S.J.</given-names></name><name><surname>Si</surname><given-names>F.S.</given-names></name><name><surname>Yu</surname><given-names>R.S.</given-names></name><name><surname>Li</surname><given-names>Z.</given-names></name><name><surname>Yu</surname><given-names>X.M.</given-names></name><name><surname>Zou</surname><given-names>S.X.</given-names></name></person-group><article-title>Swine and human hepatitis E virus (HEV) infection in China</article-title><source>J. Clin. Virol.</source><year>2011</year><volume>52</volume><fpage>155</fpage><lpage>157</lpage><pub-id pub-id-type="doi">10.1016/j.jcv.2011.06.023</pub-id><?supplied-pmid 21831705?><pub-id pub-id-type="pmid">21831705</pub-id></element-citation></ref><ref id="B167-pathogens-09-00856"><label>167.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dalton</surname><given-names>H.R.</given-names></name><name><surname>Fellows</surname><given-names>H.J.</given-names></name><name><surname>Gane</surname><given-names>E.J.</given-names></name><name><surname>Wong</surname><given-names>P.</given-names></name><name><surname>Gerred</surname><given-names>S.</given-names></name><name><surname>Schroeder</surname><given-names>B.</given-names></name><name><surname>Croxson</surname><given-names>M.C.</given-names></name><name><surname>Garkavenko</surname><given-names>O.</given-names></name></person-group><article-title>Hepatitis E in new zealand</article-title><source>J. Gastroenterol. Hepatol.</source><year>2007</year><volume>22</volume><fpage>1236</fpage><lpage>1240</lpage><pub-id pub-id-type="doi">10.1111/j.1440-1746.2007.04894.x</pub-id><?supplied-pmid 17489963?><pub-id pub-id-type="pmid">17489963</pub-id></element-citation></ref><ref id="B168-pathogens-09-00856"><label>168.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dalton</surname><given-names>H.R.</given-names></name><name><surname>Kamar</surname><given-names>N.</given-names></name><name><surname>Baylis</surname><given-names>S.A.</given-names></name><name><surname>Moradpour</surname><given-names>D.</given-names></name><name><surname>Wedemeyer</surname><given-names>H.</given-names></name><name><surname>Negro</surname><given-names>F.</given-names></name></person-group><article-title>EASL Clinical Practice Guidelines on hepatitis E virus infection</article-title><source>J. Hepatol.</source><year>2018</year><volume>68</volume><fpage>1256</fpage><lpage>1271</lpage><pub-id pub-id-type="doi">10.1016/j.jhep.2018.03.005</pub-id><pub-id pub-id-type="pmid">29609832</pub-id></element-citation></ref><ref id="B169-pathogens-09-00856"><label>169.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Faber</surname><given-names>M.S.</given-names></name><name><surname>Wenzel</surname><given-names>J.J.</given-names></name><name><surname>Jilg</surname><given-names>W.</given-names></name><name><surname>Thamm</surname><given-names>M.</given-names></name><name><surname>Hohle</surname><given-names>M.</given-names></name><name><surname>Stark</surname><given-names>K.</given-names></name></person-group><article-title>Hepatitis E virus seroprevalence among adults, Germany</article-title><source>Emerg. Infect. Dis.</source><year>2012</year><volume>18</volume><fpage>1654</fpage><lpage>1657</lpage><pub-id pub-id-type="doi">10.3201/eid1810.111756</pub-id><pub-id pub-id-type="pmid">23018055</pub-id></element-citation></ref><ref id="B170-pathogens-09-00856"><label>170.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mahrt</surname><given-names>H.</given-names></name><name><surname>Schemmerer</surname><given-names>M.</given-names></name><name><surname>Behrens</surname><given-names>G.</given-names></name><name><surname>Leitzmann</surname><given-names>M.</given-names></name><name><surname>Jilg</surname><given-names>W.</given-names></name><name><surname>Wenzel</surname><given-names>J.J.</given-names></name></person-group><article-title>Continuous decline of hepatitis E virus seroprevalence in southern Germany despite increasing notifications, 2003&#x02013;2015</article-title><source>Emerg. Microbes Infect.</source><year>2018</year><volume>7</volume><fpage>133</fpage><pub-id pub-id-type="doi">10.1038/s41426-018-0136-8</pub-id><?supplied-pmid 30042475?><pub-id pub-id-type="pmid">30042475</pub-id></element-citation></ref><ref id="B171-pathogens-09-00856"><label>171.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takahashi</surname><given-names>M.</given-names></name><name><surname>Nishizawa</surname><given-names>T.</given-names></name><name><surname>Sato</surname><given-names>H.</given-names></name><name><surname>Sato</surname><given-names>Y.</given-names></name><name><surname>Jirintai</surname></name><name><surname>Nagashima</surname><given-names>S.</given-names></name><name><surname>Okamoto</surname><given-names>H.</given-names></name></person-group><article-title>Analysis of the full-length genome of a hepatitis E virus isolate obtained from a wild boar in Japan that is classifiable into a novel genotype</article-title><source>J. Gen. Virol.</source><year>2011</year><volume>92</volume><fpage>902</fpage><lpage>908</lpage><pub-id pub-id-type="doi">10.1099/vir.0.029470-0</pub-id><pub-id pub-id-type="pmid">21228128</pub-id></element-citation></ref><ref id="B172-pathogens-09-00856"><label>172.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Woo</surname><given-names>P.C.</given-names></name><name><surname>Lau</surname><given-names>S.K.</given-names></name><name><surname>Teng</surname><given-names>J.L.</given-names></name><name><surname>Cao</surname><given-names>K.Y.</given-names></name><name><surname>Wernery</surname><given-names>U.</given-names></name><name><surname>Schountz</surname><given-names>T.</given-names></name><name><surname>Chiu</surname><given-names>T.H.</given-names></name><name><surname>Tsang</surname><given-names>A.K.</given-names></name><name><surname>Wong</surname><given-names>P.C.</given-names></name><name><surname>Wong</surname><given-names>E.Y.</given-names></name><etal/></person-group><article-title>New Hepatitis E Virus Genotype in Bactrian Camels, Xinjiang, China, 2013</article-title><source>Emerg. Infect. Dis.</source><year>2016</year><volume>22</volume><fpage>2219</fpage><lpage>2221</lpage><pub-id pub-id-type="doi">10.3201/eid2212.160979</pub-id><pub-id pub-id-type="pmid">27869607</pub-id></element-citation></ref><ref id="B173-pathogens-09-00856"><label>173.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takahashi</surname><given-names>M.</given-names></name><name><surname>Nishizawa</surname><given-names>T.</given-names></name><name><surname>Sato</surname><given-names>Y.</given-names></name><name><surname>Miyazaki</surname><given-names>S.</given-names></name><name><surname>Aikawa</surname><given-names>T.</given-names></name><name><surname>Ashida</surname><given-names>K.</given-names></name><name><surname>Tamaru</surname><given-names>T.</given-names></name><name><surname>Oguro</surname><given-names>K.</given-names></name><name><surname>Hayakawa</surname><given-names>F.</given-names></name><name><surname>Matsuoka</surname><given-names>H.</given-names></name><etal/></person-group><article-title>Prevalence and genotype/subtype distribution of hepatitis E virus (HEV) among wild boars in Japan: Identification of a genotype 5 HEV strain</article-title><source>Virus Res.</source><year>2020</year><volume>287</volume><fpage>198106</fpage><pub-id pub-id-type="doi">10.1016/j.virusres.2020.198106</pub-id><pub-id pub-id-type="pmid">32777387</pub-id></element-citation></ref><ref id="B174-pathogens-09-00856"><label>174.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kamar</surname><given-names>N.</given-names></name><name><surname>Bendall</surname><given-names>R.</given-names></name><name><surname>Legrand-Abravanel</surname><given-names>F.</given-names></name><name><surname>Xia</surname><given-names>N.S.</given-names></name><name><surname>Ijaz</surname><given-names>S.</given-names></name><name><surname>Izopet</surname><given-names>J.</given-names></name><name><surname>Dalton</surname><given-names>H.R.</given-names></name></person-group><article-title>Hepatitis, E</article-title><source>Lancet</source><year>2012</year><volume>379</volume><fpage>2477</fpage><lpage>2488</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(11)61849-7</pub-id><pub-id pub-id-type="pmid">22549046</pub-id></element-citation></ref><ref id="B175-pathogens-09-00856"><label>175.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lhomme</surname><given-names>S.</given-names></name><name><surname>Marion</surname><given-names>O.</given-names></name><name><surname>Abravanel</surname><given-names>F.</given-names></name><name><surname>Chapuy-Regaud</surname><given-names>S.</given-names></name><name><surname>Kamar</surname><given-names>N.</given-names></name><name><surname>Izopet</surname><given-names>J.</given-names></name></person-group><article-title>Hepatitis E Pathogenesis</article-title><source>Viruses</source><year>2016</year><volume>8</volume><elocation-id>212</elocation-id><pub-id pub-id-type="doi">10.3390/v8080212</pub-id><?supplied-pmid 27527210?><pub-id pub-id-type="pmid">27527210</pub-id></element-citation></ref><ref id="B176-pathogens-09-00856"><label>176.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jothikumar</surname><given-names>N.</given-names></name><name><surname>Cromeans</surname><given-names>T.L.</given-names></name><name><surname>Robertson</surname><given-names>B.H.</given-names></name><name><surname>Meng</surname><given-names>X.J.</given-names></name><name><surname>Hill</surname><given-names>V.R.</given-names></name></person-group><article-title>A broadly reactive one-step real-time RT-PCR assay for rapid and sensitive detection of hepatitis E virus</article-title><source>J. Virol. Methods</source><year>2006</year><volume>131</volume><fpage>65</fpage><lpage>71</lpage><pub-id pub-id-type="doi">10.1016/j.jviromet.2005.07.004</pub-id><?supplied-pmid 16125257?><pub-id pub-id-type="pmid">16125257</pub-id></element-citation></ref><ref id="B177-pathogens-09-00856"><label>177.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baylis</surname><given-names>S.A.</given-names></name><name><surname>Hanschmann</surname><given-names>K.M.</given-names></name><name><surname>Blumel</surname><given-names>J.</given-names></name><name><surname>Nubling</surname><given-names>C.M.</given-names></name><name><surname>Group</surname><given-names>H.E.V.C.S.</given-names></name></person-group><article-title>Standardization of hepatitis E virus (HEV) nucleic acid amplification technique-based assays: An initial study to evaluate a panel of HEV strains and investigate laboratory performance</article-title><source>J. Clin. Microbiol.</source><year>2011</year><volume>49</volume><fpage>1234</fpage><lpage>1239</lpage><pub-id pub-id-type="doi">10.1128/JCM.02578-10</pub-id><?supplied-pmid 21307208?><pub-id pub-id-type="pmid">21307208</pub-id></element-citation></ref><ref id="B178-pathogens-09-00856"><label>178.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ferguson</surname><given-names>M.</given-names></name><name><surname>Walker</surname><given-names>D.</given-names></name><name><surname>Mast</surname><given-names>E.</given-names></name><name><surname>Fields</surname><given-names>H.</given-names></name></person-group><article-title>Report of a collaborative study to assess the suitability of a reference reagent for antibodies to hepatitis E virus</article-title><source>Biologicals</source><year>2002</year><volume>30</volume><fpage>43</fpage><lpage>48</lpage><pub-id pub-id-type="doi">10.1006/biol.2001.0315</pub-id><pub-id pub-id-type="pmid">11846429</pub-id></element-citation></ref><ref id="B179-pathogens-09-00856"><label>179.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boland</surname><given-names>F.</given-names></name><name><surname>Martinez</surname><given-names>A.</given-names></name><name><surname>Pomeroy</surname><given-names>L.</given-names></name><name><surname>O&#x02019;Flaherty</surname><given-names>N.</given-names></name></person-group><article-title>Blood Donor Screening for Hepatitis E Virus in the European Union</article-title><source>Transfus. Med. Hemother.</source><year>2019</year><volume>46</volume><fpage>95</fpage><lpage>103</lpage><pub-id pub-id-type="doi">10.1159/000499121</pub-id><pub-id pub-id-type="pmid">31191195</pub-id></element-citation></ref><ref id="B180-pathogens-09-00856"><label>180.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pischke</surname><given-names>S.</given-names></name><name><surname>Hartl</surname><given-names>J.</given-names></name><name><surname>Pas</surname><given-names>S.D.</given-names></name><name><surname>Lohse</surname><given-names>A.W.</given-names></name><name><surname>Jacobs</surname><given-names>B.C.</given-names></name><name><surname>Van der Eijk</surname><given-names>A.A.</given-names></name></person-group><article-title>Hepatitis E virus: Infection beyond the liver?</article-title><source>J. Hepatol.</source><year>2017</year><volume>66</volume><fpage>1082</fpage><lpage>1095</lpage><pub-id pub-id-type="doi">10.1016/j.jhep.2016.11.016</pub-id><pub-id pub-id-type="pmid">27913223</pub-id></element-citation></ref><ref id="B181-pathogens-09-00856"><label>181.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van den Berg</surname><given-names>B.</given-names></name><name><surname>van der Eijk</surname><given-names>A.A.</given-names></name><name><surname>Pas</surname><given-names>S.D.</given-names></name><name><surname>Hunter</surname><given-names>J.G.</given-names></name><name><surname>Madden</surname><given-names>R.G.</given-names></name><name><surname>Tio-Gillen</surname><given-names>A.P.</given-names></name><name><surname>Dalton</surname><given-names>H.R.</given-names></name><name><surname>Jacobs</surname><given-names>B.C.</given-names></name></person-group><article-title>Guillain-Barr&#x000e9; syndrome associated with preceding hepatitis E virus infection</article-title><source>Neurology</source><year>2014</year><volume>82</volume><fpage>491</fpage><lpage>497</lpage><pub-id pub-id-type="doi">10.1212/WNL.0000000000000111</pub-id><pub-id pub-id-type="pmid">24415572</pub-id></element-citation></ref><ref id="B182-pathogens-09-00856"><label>182.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stevens</surname><given-names>O.</given-names></name><name><surname>Claeys</surname><given-names>K.G.</given-names></name><name><surname>Poesen</surname><given-names>K.</given-names></name><name><surname>Saegeman</surname><given-names>V.</given-names></name><name><surname>Van Damme</surname><given-names>P.</given-names></name></person-group><article-title>Diagnostic Challenges and Clinical Characteristics of Hepatitis E Virus-Associated Guillain-Barr&#x000e9; Syndrome</article-title><source>JAMA Neurol.</source><year>2017</year><volume>74</volume><fpage>26</fpage><lpage>33</lpage><pub-id pub-id-type="doi">10.1001/jamaneurol.2016.3541</pub-id><pub-id pub-id-type="pmid">27820624</pub-id></element-citation></ref><ref id="B183-pathogens-09-00856"><label>183.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Eijk</surname><given-names>J.J.</given-names></name><name><surname>Madden</surname><given-names>R.G.</given-names></name><name><surname>van der Eijk</surname><given-names>A.A.</given-names></name><name><surname>Hunter</surname><given-names>J.G.</given-names></name><name><surname>Reimerink</surname><given-names>J.H.</given-names></name><name><surname>Bendall</surname><given-names>R.P.</given-names></name><name><surname>Pas</surname><given-names>S.D.</given-names></name><name><surname>Ellis</surname><given-names>V.</given-names></name><name><surname>van Alfen</surname><given-names>N.</given-names></name><name><surname>Beynon</surname><given-names>L.</given-names></name><etal/></person-group><article-title>Neuralgic amyotrophy and hepatitis E virus infection</article-title><source>Neurology</source><year>2014</year><volume>82</volume><fpage>498</fpage><lpage>503</lpage><pub-id pub-id-type="doi">10.1212/WNL.0000000000000112</pub-id><pub-id pub-id-type="pmid">24401685</pub-id></element-citation></ref><ref id="B184-pathogens-09-00856"><label>184.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kamar</surname><given-names>N.</given-names></name><name><surname>Weclawiak</surname><given-names>H.</given-names></name><name><surname>Guilbeau-Frugier</surname><given-names>C.</given-names></name><name><surname>Legrand-Abravanel</surname><given-names>F.</given-names></name><name><surname>Cointault</surname><given-names>O.</given-names></name><name><surname>Ribes</surname><given-names>D.</given-names></name><name><surname>Esposito</surname><given-names>L.</given-names></name><name><surname>Cardeau-Desangles</surname><given-names>I.</given-names></name><name><surname>Guitard</surname><given-names>J.</given-names></name><name><surname>Sallusto</surname><given-names>F.</given-names></name><etal/></person-group><article-title>Hepatitis E virus and the kidney in solid-organ transplant patients</article-title><source>Transplantation</source><year>2012</year><volume>93</volume><fpage>617</fpage><lpage>623</lpage><pub-id pub-id-type="doi">10.1097/TP.0b013e318245f14c</pub-id><pub-id pub-id-type="pmid">22298032</pub-id></element-citation></ref><ref id="B185-pathogens-09-00856"><label>185.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Masood</surname><given-names>I.</given-names></name><name><surname>Rafiq</surname><given-names>A.</given-names></name><name><surname>Majid</surname><given-names>Z.</given-names></name></person-group><article-title>Hepatitis E presenting with thrombocytopaenia</article-title><source>Trop. Dr.</source><year>2014</year><volume>44</volume><fpage>219</fpage><lpage>220</lpage><pub-id pub-id-type="doi">10.1177/0049475514521610</pub-id><?supplied-pmid 24472742?><pub-id pub-id-type="pmid">24472742</pub-id></element-citation></ref><ref id="B186-pathogens-09-00856"><label>186.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ahmad</surname><given-names>B.S.</given-names></name><name><surname>Ahmad</surname><given-names>A.</given-names></name><name><surname>Jamil</surname><given-names>S.</given-names></name><name><surname>Abubakar Mohsin Ehsanullah</surname><given-names>S.A.</given-names></name><name><surname>Munir</surname><given-names>A.</given-names></name></person-group><article-title>Severe haemolysis and renal failure precipitated by hepatitis E virus in G6PD Deficient patient: A case report</article-title><source>J. Pak. Med. Assoc.</source><year>2018</year><volume>68</volume><fpage>1397</fpage><lpage>1399</lpage><?supplied-pmid 30317274?><pub-id pub-id-type="pmid">30317274</pub-id></element-citation></ref><ref id="B187-pathogens-09-00856"><label>187.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abid</surname><given-names>S.</given-names></name><name><surname>Khan</surname><given-names>A.H.</given-names></name></person-group><article-title>Severe hemolysis and renal failure in glucose-6-phosphate dehydrogenase deficient patients with hepatitis E</article-title><source>Am. J. Gastroenterol.</source><year>2002</year><volume>97</volume><fpage>1544</fpage><lpage>1547</lpage><pub-id pub-id-type="doi">10.1111/j.1572-0241.2002.05740.x</pub-id><?supplied-pmid 12094881?><pub-id pub-id-type="pmid">12094881</pub-id></element-citation></ref><ref id="B188-pathogens-09-00856"><label>188.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Acharya</surname><given-names>S.K.</given-names></name><name><surname>Sharma</surname><given-names>P.K.</given-names></name><name><surname>Singh</surname><given-names>R.</given-names></name><name><surname>Mohanty</surname><given-names>S.K.</given-names></name><name><surname>Madan</surname><given-names>K.</given-names></name><name><surname>Kumar Jha</surname><given-names>J.</given-names></name><name><surname>Panda</surname><given-names>S.K.</given-names></name></person-group><article-title>Hepatitis E virus (HEV) infection in patients with cirrhosis is associated with rapid decompensation and death</article-title><source>J. Hepatol.</source><year>2007</year><volume>46</volume><fpage>387</fpage><lpage>394</lpage><pub-id pub-id-type="doi">10.1016/j.jhep.2006.09.016</pub-id><?supplied-pmid 17125878?><pub-id pub-id-type="pmid">17125878</pub-id></element-citation></ref><ref id="B189-pathogens-09-00856"><label>189.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sharapov</surname><given-names>M.B.</given-names></name><name><surname>Favorov</surname><given-names>M.O.</given-names></name><name><surname>Yashina</surname><given-names>T.L.</given-names></name><name><surname>Brown</surname><given-names>M.S.</given-names></name><name><surname>Onischenko</surname><given-names>G.G.</given-names></name><name><surname>Margolis</surname><given-names>H.S.</given-names></name><name><surname>Chorba</surname><given-names>T.L.</given-names></name></person-group><article-title>Acute viral hepatitis morbidity and mortality associated with hepatitis E virus infection: Uzbekistan surveillance data</article-title><source>BMC Infect. Dis.</source><year>2009</year><volume>9</volume><elocation-id>35</elocation-id><pub-id pub-id-type="doi">10.1186/1471-2334-9-35</pub-id><?supplied-pmid 19320984?><pub-id pub-id-type="pmid">19320984</pub-id></element-citation></ref><ref id="B190-pathogens-09-00856"><label>190.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoan</surname><given-names>N.X.</given-names></name><name><surname>Tong</surname><given-names>H.V.</given-names></name><name><surname>Hecht</surname><given-names>N.</given-names></name><name><surname>Sy</surname><given-names>B.T.</given-names></name><name><surname>Marcinek</surname><given-names>P.</given-names></name><name><surname>Meyer</surname><given-names>C.G.</given-names></name><name><surname>Song le</surname><given-names>H.</given-names></name><name><surname>Toan</surname><given-names>N.L.</given-names></name><name><surname>Kurreck</surname><given-names>J.</given-names></name><name><surname>Kremsner</surname><given-names>P.G.</given-names></name><etal/></person-group><article-title>Hepatitis E Virus Superinfection and Clinical Progression in Hepatitis B Patients</article-title><source>EBioMedicine</source><year>2015</year><volume>2</volume><fpage>2080</fpage><lpage>2086</lpage><pub-id pub-id-type="doi">10.1016/j.ebiom.2015.11.020</pub-id><pub-id pub-id-type="pmid">26844288</pub-id></element-citation></ref><ref id="B191-pathogens-09-00856"><label>191.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qu</surname><given-names>C.</given-names></name><name><surname>Xu</surname><given-names>L.</given-names></name><name><surname>Yin</surname><given-names>Y.</given-names></name><name><surname>Peppelenbosch</surname><given-names>M.P.</given-names></name><name><surname>Pan</surname><given-names>Q.</given-names></name><name><surname>Wang</surname><given-names>W.</given-names></name></person-group><article-title>Nucleoside analogue 2&#x02032;-C-methylcytidine inhibits hepatitis E virus replication but antagonizes ribavirin</article-title><source>Arch. Virol.</source><year>2017</year><volume>162</volume><fpage>2989</fpage><lpage>2996</lpage><pub-id pub-id-type="doi">10.1007/s00705-017-3444-8</pub-id><?supplied-pmid 28623406?><pub-id pub-id-type="pmid">28623406</pub-id></element-citation></ref><ref id="B192-pathogens-09-00856"><label>192.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Netzler</surname><given-names>N.E.</given-names></name><name><surname>Enosi Tuipulotu</surname><given-names>D.</given-names></name><name><surname>Vasudevan</surname><given-names>S.G.</given-names></name><name><surname>Mackenzie</surname><given-names>J.M.</given-names></name><name><surname>White</surname><given-names>P.A.</given-names></name></person-group><article-title>Antiviral Candidates for Treating Hepatitis E Virus Infection</article-title><source>Antimicrob. Agents Chemother.</source><year>2019</year><volume>63</volume><fpage>e00003-19</fpage><pub-id pub-id-type="doi">10.1128/AAC.00003-19</pub-id><pub-id pub-id-type="pmid">30885901</pub-id></element-citation></ref><ref id="B193-pathogens-09-00856"><label>193.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nishiyama</surname><given-names>T.</given-names></name><name><surname>Kobayashi</surname><given-names>T.</given-names></name><name><surname>Jirintai</surname><given-names>S.</given-names></name><name><surname>Kii</surname><given-names>I.</given-names></name><name><surname>Nagashima</surname><given-names>S.</given-names></name><name><surname>Prathiwi Primadharsini</surname><given-names>P.</given-names></name><name><surname>Nishizawa</surname><given-names>T.</given-names></name><name><surname>Okamoto</surname><given-names>H.</given-names></name></person-group><article-title>Screening of novel drugs for inhibiting hepatitis E virus replication</article-title><source>J. Virol. Methods</source><year>2019</year><volume>270</volume><fpage>1</fpage><lpage>11</lpage><pub-id pub-id-type="doi">10.1016/j.jviromet.2019.04.017</pub-id><pub-id pub-id-type="pmid">31004661</pub-id></element-citation></ref><ref id="B194-pathogens-09-00856"><label>194.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dao Thi</surname><given-names>V.L.</given-names></name><name><surname>Debing</surname><given-names>Y.</given-names></name><name><surname>Wu</surname><given-names>X.</given-names></name><name><surname>Rice</surname><given-names>C.M.</given-names></name><name><surname>Neyts</surname><given-names>J.</given-names></name><name><surname>Moradpour</surname><given-names>D.</given-names></name><name><surname>Gouttenoire</surname><given-names>J.</given-names></name></person-group><article-title>Sofosbuvir Inhibits Hepatitis E Virus Replication In Vitro and Results in an Additive Effect When Combined With Ribavirin</article-title><source>Gastroenterology</source><year>2016</year><volume>150</volume><fpage>82</fpage><lpage>85.e84</lpage><pub-id pub-id-type="doi">10.1053/j.gastro.2015.09.011</pub-id><pub-id pub-id-type="pmid">26408347</pub-id></element-citation></ref><ref id="B195-pathogens-09-00856"><label>195.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jin</surname><given-names>S.E.</given-names></name><name><surname>Kim</surname><given-names>J.E.</given-names></name><name><surname>Kim</surname><given-names>S.Y.</given-names></name><name><surname>Park</surname><given-names>B.J.</given-names></name><name><surname>Song</surname><given-names>Y.J.</given-names></name></person-group><article-title>An ethanol extract of Lysimachia mauritiana exhibits inhibitory activity against hepatitis E virus genotype 3 replication</article-title><source>J. Microbiol.</source><year>2017</year><volume>55</volume><fpage>984</fpage><lpage>988</lpage><pub-id pub-id-type="doi">10.1007/s12275-017-7477-1</pub-id><pub-id pub-id-type="pmid">29214492</pub-id></element-citation></ref><ref id="B196-pathogens-09-00856"><label>196.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname><given-names>G.</given-names></name><name><surname>Parveen</surname><given-names>A.</given-names></name><name><surname>Kim</surname><given-names>J.E.</given-names></name><name><surname>Cho</surname><given-names>K.H.</given-names></name><name><surname>Kim</surname><given-names>S.Y.</given-names></name><name><surname>Park</surname><given-names>B.J.</given-names></name><name><surname>Song</surname><given-names>Y.J.</given-names></name></person-group><article-title>Spicatoside A derived from Liriope platyphylla root ethanol extract inhibits hepatitis E virus genotype 3 replication in vitro</article-title><source>Sci. Rep.</source><year>2019</year><volume>9</volume><fpage>4397</fpage><pub-id pub-id-type="doi">10.1038/s41598-019-39488-5</pub-id><pub-id pub-id-type="pmid">30867434</pub-id></element-citation></ref><ref id="B197-pathogens-09-00856"><label>197.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaushik</surname><given-names>N.</given-names></name><name><surname>Subramani</surname><given-names>C.</given-names></name><name><surname>Anang</surname><given-names>S.</given-names></name><name><surname>Muthumohan</surname><given-names>R.</given-names></name><name><surname>Shalimar</surname></name><name><surname>Nayak</surname><given-names>B.</given-names></name><name><surname>Ranjith-Kumar</surname><given-names>C.T.</given-names></name><name><surname>Surjit</surname><given-names>M.</given-names></name></person-group><article-title>Zinc Salts Block Hepatitis E Virus Replication by Inhibiting the Activity of Viral RNA-Dependent RNA Polymerase</article-title><source>J. Virol.</source><year>2017</year><volume>91</volume><pub-id pub-id-type="doi">10.1128/JVI.00754-17</pub-id></element-citation></ref><ref id="B198-pathogens-09-00856"><label>198.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Madhvi</surname><given-names>A.</given-names></name><name><surname>Hingane</surname><given-names>S.</given-names></name><name><surname>Srivastav</surname><given-names>R.</given-names></name><name><surname>Joshi</surname><given-names>N.</given-names></name><name><surname>Subramani</surname><given-names>C.</given-names></name><name><surname>Muthumohan</surname><given-names>R.</given-names></name><name><surname>Khasa</surname><given-names>R.</given-names></name><name><surname>Varshney</surname><given-names>S.</given-names></name><name><surname>Kalia</surname><given-names>M.</given-names></name><name><surname>Vrati</surname><given-names>S.</given-names></name><etal/></person-group><article-title>A screen for novel hepatitis C virus RdRp inhibitor identifies a broad-spectrum antiviral compound</article-title><source>Sci. Rep.</source><year>2017</year><volume>7</volume><fpage>5816</fpage><pub-id pub-id-type="doi">10.1038/s41598-017-04449-3</pub-id><pub-id pub-id-type="pmid">28725041</pub-id></element-citation></ref><ref id="B199-pathogens-09-00856"><label>199.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qu</surname><given-names>C.</given-names></name><name><surname>Li</surname><given-names>Y.</given-names></name><name><surname>Li</surname><given-names>Y.</given-names></name><name><surname>Yu</surname><given-names>P.</given-names></name><name><surname>Li</surname><given-names>P.</given-names></name><name><surname>Donkers</surname><given-names>J.M.</given-names></name><name><surname>van de Graaf</surname><given-names>S.F.J.</given-names></name><name><surname>de Man</surname><given-names>R.A.</given-names></name><name><surname>Peppelenbosch</surname><given-names>M.P.</given-names></name><name><surname>Pan</surname><given-names>Q.</given-names></name></person-group><article-title>FDA-drug screening identifies deptropine inhibiting hepatitis E virus involving the NF-&#x003ba;B-RIPK1-caspase axis</article-title><source>Antiviral Res.</source><year>2019</year><volume>170</volume><fpage>104588</fpage><pub-id pub-id-type="doi">10.1016/j.antiviral.2019.104588</pub-id><?supplied-pmid 31415805?><pub-id pub-id-type="pmid">31415805</pub-id></element-citation></ref><ref id="B200-pathogens-09-00856"><label>200.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nan</surname><given-names>Y.</given-names></name><name><surname>Ma</surname><given-names>Z.</given-names></name><name><surname>Kannan</surname><given-names>H.</given-names></name><name><surname>Stein</surname><given-names>D.A.</given-names></name><name><surname>Iversen</surname><given-names>P.I.</given-names></name><name><surname>Meng</surname><given-names>X.J.</given-names></name><name><surname>Zhang</surname><given-names>Y.J.</given-names></name></person-group><article-title>Inhibition of hepatitis E virus replication by peptide-conjugated morpholino oligomers</article-title><source>Antivir. Res.</source><year>2015</year><volume>120</volume><fpage>134</fpage><lpage>139</lpage><pub-id pub-id-type="doi">10.1016/j.antiviral.2015.06.006</pub-id><pub-id pub-id-type="pmid">26086884</pub-id></element-citation></ref><ref id="B201-pathogens-09-00856"><label>201.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Karpe</surname><given-names>Y.A.</given-names></name><name><surname>Meng</surname><given-names>X.J.</given-names></name></person-group><article-title>Hepatitis E virus replication requires an active ubiquitin-proteasome system</article-title><source>J. Virol.</source><year>2012</year><volume>86</volume><fpage>5948</fpage><lpage>5952</lpage><pub-id pub-id-type="doi">10.1128/JVI.07039-11</pub-id><?supplied-pmid 22438536?><pub-id pub-id-type="pmid">22438536</pub-id></element-citation></ref><ref id="B202-pathogens-09-00856"><label>202.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>L.</given-names></name><name><surname>Zhou</surname><given-names>X.</given-names></name><name><surname>Peppelenbosch</surname><given-names>M.P.</given-names></name><name><surname>Pan</surname><given-names>Q.</given-names></name></person-group><article-title>Inhibition of hepatitis E virus replication by proteasome inhibitor is nonspecific</article-title><source>Arch. Virol.</source><year>2015</year><volume>160</volume><fpage>435</fpage><lpage>439</lpage><pub-id pub-id-type="doi">10.1007/s00705-014-2303-0</pub-id><pub-id pub-id-type="pmid">25476751</pub-id></element-citation></ref><ref id="B203-pathogens-09-00856"><label>203.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anang</surname><given-names>S.</given-names></name><name><surname>Kaushik</surname><given-names>N.</given-names></name><name><surname>Hingane</surname><given-names>S.</given-names></name><name><surname>Kumari</surname><given-names>A.</given-names></name><name><surname>Gupta</surname><given-names>J.</given-names></name><name><surname>Asthana</surname><given-names>S.</given-names></name><name><surname>Shalimar</surname></name><name><surname>Nayak</surname><given-names>B.</given-names></name><name><surname>Ranjith-Kumar</surname><given-names>C.T.</given-names></name><name><surname>Surjit</surname><given-names>M.</given-names></name></person-group><article-title>Potent Inhibition of Hepatitis E Virus Release by a Cyclic Peptide Inhibitor of the Interaction between Viral Open Reading Frame 3 Protein and Host Tumor Susceptibility Gene 101</article-title><source>J. Virol.</source><year>2018</year><volume>92</volume><fpage>e00684-18</fpage><pub-id pub-id-type="doi">10.1128/JVI.00684-18</pub-id><?supplied-pmid 30068652?><pub-id pub-id-type="pmid">30068652</pub-id></element-citation></ref><ref id="B204-pathogens-09-00856"><label>204.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Zhou</surname><given-names>X.</given-names></name><name><surname>Debing</surname><given-names>Y.</given-names></name><name><surname>Chen</surname><given-names>K.</given-names></name><name><surname>Van Der Laan</surname><given-names>L.J.</given-names></name><name><surname>Neyts</surname><given-names>J.</given-names></name><name><surname>Janssen</surname><given-names>H.L.</given-names></name><name><surname>Metselaar</surname><given-names>H.J.</given-names></name><name><surname>Peppelenbosch</surname><given-names>M.P.</given-names></name><name><surname>Pan</surname><given-names>Q.</given-names></name></person-group><article-title>Calcineurin inhibitors stimulate and mycophenolic acid inhibits replication of hepatitis E virus</article-title><source>Gastroenterology</source><year>2014</year><volume>146</volume><fpage>1775</fpage><lpage>1783</lpage><pub-id pub-id-type="doi">10.1053/j.gastro.2014.02.036</pub-id><pub-id pub-id-type="pmid">24582714</pub-id></element-citation></ref><ref id="B205-pathogens-09-00856"><label>205.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Wang</surname><given-names>W.</given-names></name><name><surname>Xu</surname><given-names>L.</given-names></name><name><surname>Zhou</surname><given-names>X.</given-names></name><name><surname>Shokrollahi</surname><given-names>E.</given-names></name><name><surname>Felczak</surname><given-names>K.</given-names></name><name><surname>van der Laan</surname><given-names>L.J.</given-names></name><name><surname>Pankiewicz</surname><given-names>K.W.</given-names></name><name><surname>Sprengers</surname><given-names>D.</given-names></name><name><surname>Raat</surname><given-names>N.J.</given-names></name><etal/></person-group><article-title>Cross Talk between Nucleotide Synthesis Pathways with Cellular Immunity in Constraining Hepatitis E Virus Replication</article-title><source>Antimicrob. Agents Chemother.</source><year>2016</year><volume>60</volume><fpage>2834</fpage><lpage>2848</lpage><pub-id pub-id-type="doi">10.1128/AAC.02700-15</pub-id><?supplied-pmid 26926637?><pub-id pub-id-type="pmid">26926637</pub-id></element-citation></ref><ref id="B206-pathogens-09-00856"><label>206.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Todt</surname><given-names>D.</given-names></name><name><surname>Moeller</surname><given-names>N.</given-names></name><name><surname>Praditya</surname><given-names>D.</given-names></name><name><surname>Kinast</surname><given-names>V.</given-names></name><name><surname>Friesland</surname><given-names>M.</given-names></name><name><surname>Engelmann</surname><given-names>M.</given-names></name><name><surname>Verhoye</surname><given-names>L.</given-names></name><name><surname>Sayed</surname><given-names>I.M.</given-names></name><name><surname>Behrendt</surname><given-names>P.</given-names></name><name><surname>Dao Thi</surname><given-names>V.L.</given-names></name><etal/></person-group><article-title>The natural compound silvestrol inhibits hepatitis E virus (HEV) replication in vitro and in vivo</article-title><source>Antivir. Res.</source><year>2018</year><volume>157</volume><fpage>151</fpage><lpage>158</lpage><pub-id pub-id-type="doi">10.1016/j.antiviral.2018.07.010</pub-id><?supplied-pmid 30036559?><pub-id pub-id-type="pmid">30036559</pub-id></element-citation></ref><ref id="B207-pathogens-09-00856"><label>207.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cornberg</surname><given-names>M.</given-names></name><name><surname>Pischke</surname><given-names>S.</given-names></name><name><surname>Muller</surname><given-names>T.</given-names></name><name><surname>Behrendt</surname><given-names>P.</given-names></name><name><surname>Piecha</surname><given-names>F.</given-names></name><name><surname>Benckert</surname><given-names>J.</given-names></name><name><surname>Todt</surname><given-names>D.</given-names></name><name><surname>Steinmann</surname><given-names>E.</given-names></name><name><surname>Papkalla</surname><given-names>A.</given-names></name><name><surname>von Karpowitz</surname><given-names>M.</given-names></name><etal/></person-group><article-title>Sofosbuvir monotherapy fails to achieve HEV RNA elimination in patients with chronic hepatitis E&#x02014;The HepNet SofE pilot study</article-title><source>J. Hepatol.</source><year>2020</year><volume>73</volume><fpage>696</fpage><lpage>699</lpage><pub-id pub-id-type="doi">10.1016/j.jhep.2020.05.020</pub-id><?supplied-pmid 32624195?><pub-id pub-id-type="pmid">32624195</pub-id></element-citation></ref><ref id="B208-pathogens-09-00856"><label>208.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shrestha</surname><given-names>M.P.</given-names></name><name><surname>Scott</surname><given-names>R.M.</given-names></name><name><surname>Joshi</surname><given-names>D.M.</given-names></name><name><surname>Mammen</surname><given-names>M.P.</given-names><suffix>Jr.</suffix></name><name><surname>Thapa</surname><given-names>G.B.</given-names></name><name><surname>Thapa</surname><given-names>N.</given-names></name><name><surname>Myint</surname><given-names>K.S.</given-names></name><name><surname>Fourneau</surname><given-names>M.</given-names></name><name><surname>Kuschner</surname><given-names>R.A.</given-names></name><name><surname>Shrestha</surname><given-names>S.K.</given-names></name><etal/></person-group><article-title>Safety and efficacy of a recombinant hepatitis E vaccine</article-title><source>N. Engl. J. Med.</source><year>2007</year><volume>356</volume><fpage>895</fpage><lpage>903</lpage><pub-id pub-id-type="doi">10.1056/NEJMoa061847</pub-id><pub-id pub-id-type="pmid">17329696</pub-id></element-citation></ref><ref id="B209-pathogens-09-00856"><label>209.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dong</surname><given-names>C.</given-names></name><name><surname>Meng</surname><given-names>J.H.</given-names></name></person-group><article-title>[Expression, purification and immunogenicity of a novel hepatitis E virus-like particle]</article-title><source>Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi</source><year>2006</year><volume>22</volume><fpage>339</fpage><lpage>342</lpage><pub-id pub-id-type="pmid">16643795</pub-id></element-citation></ref><ref id="B210-pathogens-09-00856"><label>210.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Su</surname><given-names>C.X.</given-names></name><name><surname>Gu</surname><given-names>M.R.</given-names></name><name><surname>Zhang</surname><given-names>P.</given-names></name><name><surname>Jin</surname><given-names>Z.J.</given-names></name><name><surname>Meng</surname><given-names>F.H.</given-names></name><name><surname>Chen</surname><given-names>E.J.</given-names></name><name><surname>Yang</surname><given-names>Z.</given-names></name><name><surname>Liu</surname><given-names>Y.</given-names></name><name><surname>Wang</surname><given-names>Y.C.</given-names></name></person-group><article-title>[Expression of ORF2 protein of HEV genotype IV in Hansenula polymorpha]</article-title><source>Sheng Wu Gong Cheng Xue Bao</source><year>2007</year><volume>23</volume><fpage>73</fpage><lpage>78</lpage><pub-id pub-id-type="pmid">17366891</pub-id></element-citation></ref><ref id="B211-pathogens-09-00856"><label>211.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tong</surname><given-names>Y.</given-names></name><name><surname>Zhan</surname><given-names>M.</given-names></name><name><surname>Lu</surname><given-names>J.</given-names></name><name><surname>Bai</surname><given-names>Y.</given-names></name><name><surname>Bi</surname><given-names>S.</given-names></name></person-group><article-title>[Immunogenicity of recombinant HEV ORF2 protein expressed in pichia pastoris]</article-title><source>Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi</source><year>2002</year><volume>16</volume><fpage>23</fpage><lpage>26</lpage><pub-id pub-id-type="pmid">11986739</pub-id></element-citation></ref><ref id="B212-pathogens-09-00856"><label>212.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jim&#x000e9;nez de Oya</surname><given-names>N.</given-names></name><name><surname>Escribano-Romero</surname><given-names>E.</given-names></name><name><surname>Bl&#x000e1;zquez</surname><given-names>A.B.</given-names></name><name><surname>Lorenzo</surname><given-names>M.</given-names></name><name><surname>Mart&#x000ed;n-Acebes</surname><given-names>M.A.</given-names></name><name><surname>Blasco</surname><given-names>R.</given-names></name><name><surname>Saiz</surname><given-names>J.C.</given-names></name></person-group><article-title>Characterization of hepatitis E virus recombinant ORF2 proteins expressed by vaccinia viruses</article-title><source>J. Virol.</source><year>2012</year><volume>86</volume><fpage>7880</fpage><lpage>7886</lpage><pub-id pub-id-type="doi">10.1128/JVI.00610-12</pub-id><pub-id pub-id-type="pmid">22593167</pub-id></element-citation></ref><ref id="B213-pathogens-09-00856"><label>213.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xiang</surname><given-names>K.</given-names></name><name><surname>Kusov</surname><given-names>Y.</given-names></name><name><surname>Ying</surname><given-names>G.</given-names></name><name><surname>Yan</surname><given-names>W.</given-names></name><name><surname>Shan</surname><given-names>Y.</given-names></name><name><surname>Jinyuan</surname><given-names>W.</given-names></name><name><surname>Na</surname><given-names>Y.</given-names></name><name><surname>Yan</surname><given-names>Z.</given-names></name><name><surname>Hongjun</surname><given-names>L.</given-names></name><name><surname>Maosheng</surname><given-names>S.</given-names></name></person-group><article-title>A Recombinant HAV Expressing a Neutralization Epitope of HEV Induces Immune Response against HAV and HEV in Mice</article-title><source>Viruses</source><year>2017</year><volume>9</volume><elocation-id>260</elocation-id><pub-id pub-id-type="doi">10.3390/v9090260</pub-id></element-citation></ref><ref id="B214-pathogens-09-00856"><label>214.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gao</surname><given-names>Y.</given-names></name><name><surname>Su</surname><given-names>Q.</given-names></name><name><surname>Yi</surname><given-names>Y.</given-names></name><name><surname>Jia</surname><given-names>Z.</given-names></name><name><surname>Wang</surname><given-names>H.</given-names></name><name><surname>Lu</surname><given-names>X.</given-names></name><name><surname>Qiu</surname><given-names>F.</given-names></name><name><surname>Bi</surname><given-names>S.</given-names></name></person-group><article-title>Enhanced mucosal immune responses induced by a combined candidate mucosal vaccine based on Hepatitis A virus and Hepatitis E virus structural proteins linked to tuftsin</article-title><source>PLoS ONE</source><year>2015</year><volume>10</volume><elocation-id>e0123400</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0123400</pub-id><pub-id pub-id-type="pmid">25875115</pub-id></element-citation></ref><ref id="B215-pathogens-09-00856"><label>215.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andrews</surname><given-names>J.</given-names></name></person-group><article-title>U.S. Military sponsored vaccine trials and la resistance in Nepal</article-title><source>Am. J. Bioeth.</source><year>2005</year><volume>5</volume><fpage>W1</fpage><lpage>W3</lpage><pub-id pub-id-type="doi">10.1080/15265160591002962</pub-id><?supplied-pmid 16006352?><pub-id pub-id-type="pmid">16006352</pub-id></element-citation></ref><ref id="B216-pathogens-09-00856"><label>216.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cao</surname><given-names>Y.F.</given-names></name><name><surname>Tao</surname><given-names>H.</given-names></name><name><surname>Hu</surname><given-names>Y.M.</given-names></name><name><surname>Shi</surname><given-names>C.B.</given-names></name><name><surname>Wu</surname><given-names>X.</given-names></name><name><surname>Liang</surname><given-names>Q.</given-names></name><name><surname>Chi</surname><given-names>C.P.</given-names></name><name><surname>Li</surname><given-names>L.</given-names></name><name><surname>Liang</surname><given-names>Z.L.</given-names></name><name><surname>Meng</surname><given-names>J.H.</given-names></name><etal/></person-group><article-title>A phase 1 randomized open-label clinical study to evaluate the safety and tolerability of a novel recombinant hepatitis E vaccine</article-title><source>Vaccine</source><year>2017</year><volume>35</volume><fpage>5073</fpage><lpage>5080</lpage><pub-id pub-id-type="doi">10.1016/j.vaccine.2017.05.072</pub-id><?supplied-pmid 28803715?><pub-id pub-id-type="pmid">28803715</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="pathogens-09-00856-f001" orientation="portrait" position="float"><label>Figure 1</label><caption><p>Genome arrangement of hepatitis E virus (HEV) and steps of viral genome replication.</p></caption><graphic xlink:href="pathogens-09-00856-g001"/></fig><fig id="pathogens-09-00856-f002" orientation="portrait" position="float"><label>Figure 2</label><caption><p>Global HEV genotype distribution. Different colors on the map indicate the distribution of HEV genotypes (HEV-1 through -4) across the globe. The figure was created using SimpleMappr, an online tool to produce publication-quality point maps [<xref rid="B149-pathogens-09-00856" ref-type="bibr">149</xref>].</p></caption><graphic xlink:href="pathogens-09-00856-g002"/></fig><table-wrap id="pathogens-09-00856-t001" orientation="portrait" position="float"><object-id pub-id-type="pii">pathogens-09-00856-t001_Table 1</object-id><label>Table 1</label><caption><p>Reported HEV outbreaks.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Year(s)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Country</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Mode of Transmission</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Reported</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Ref.</th></tr></thead><tbody><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1955&#x02013;1956</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">India </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Waterborne </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">29,300</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B80-pathogens-09-00856" ref-type="bibr">80</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1978&#x02013;1979</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Kashmir </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Waterborne </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x0003e;270</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B23-pathogens-09-00856" ref-type="bibr">23</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1980&#x02013;1981</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Algeria</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Sewage contamination&#x02014;river water</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">788</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B81-pathogens-09-00856" ref-type="bibr">81</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1982</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Myanmar</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Waterborne </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">399</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B82-pathogens-09-00856" ref-type="bibr">82</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1983</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Namibia</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Waterborne </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">hundreds</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B79-pathogens-09-00856" ref-type="bibr">79</xref>,<xref rid="B83-pathogens-09-00856" ref-type="bibr">83</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1983&#x02013;1984</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cote d&#x02019;Ivoire</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Waterborne </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">623</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B84-pathogens-09-00856" ref-type="bibr">84</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1985</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Turkmenistan</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Waterborne </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">16,175</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B85-pathogens-09-00856" ref-type="bibr">85</xref>,<xref rid="B86-pathogens-09-00856" ref-type="bibr">86</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1985</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Botswana</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Fecal contamination of water</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">273</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B87-pathogens-09-00856" ref-type="bibr">87</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1986</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Mexico </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Contaminated well water </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x0003e;200</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B88-pathogens-09-00856" ref-type="bibr">88</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1988</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Somalia</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Waterborne </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">106</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B89-pathogens-09-00856" ref-type="bibr">89</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1988&#x02013;1989</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">India </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Contaminated drinking water</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">53</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B90-pathogens-09-00856" ref-type="bibr">90</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1988&#x02013;1989</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ethiopia </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">After monsoon rains </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x0003e;750</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B91-pathogens-09-00856" ref-type="bibr">91</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1989</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Myanmar</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Contamination&#x02014;water supply by feces</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">93</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B92-pathogens-09-00856" ref-type="bibr">92</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1991</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">India </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Contaminated river water (Ganges) </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">79,000 <sup>1</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B93-pathogens-09-00856" ref-type="bibr">93</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1991</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">China</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Waterborne </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">119,000</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B94-pathogens-09-00856" ref-type="bibr">94</xref>,<xref rid="B95-pathogens-09-00856" ref-type="bibr">95</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1991</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Indonesia</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Waterborne </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1688 <sup>1</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B96-pathogens-09-00856" ref-type="bibr">96</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1993&#x02013;1994</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Pakistan</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Waterborne </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3827</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B97-pathogens-09-00856" ref-type="bibr">97</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1994</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Vietnam </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">After heavy rains </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x0003e;300</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B98-pathogens-09-00856" ref-type="bibr">98</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1994</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Morocco</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Fecal contamination of drinking water</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">73</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B99-pathogens-09-00856" ref-type="bibr">99</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1995&#x02013;1996</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Namibia</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Waterborne </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x0003e;600</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B79-pathogens-09-00856" ref-type="bibr">79</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1998</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">India </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Waterborne</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">82</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B100-pathogens-09-00856" ref-type="bibr">100</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1998</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Indonesia</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Waterborne </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">472</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B101-pathogens-09-00856" ref-type="bibr">101</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1998</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Pakistan</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Fecal contamination&#x02014;water system</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">104</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B102-pathogens-09-00856" ref-type="bibr">102</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2002</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">India </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Contaminated water</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">185</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B103-pathogens-09-00856" ref-type="bibr">103</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2004</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Central African Republic</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Rainy season</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">213</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B104-pathogens-09-00856" ref-type="bibr">104</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2004</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Sudan</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Safe water insufficient </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x0003e;2600</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B105-pathogens-09-00856" ref-type="bibr">105</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2004</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">India </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Drinking untreated raw river water</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">538</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B106-pathogens-09-00856" ref-type="bibr">106</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2004</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Chad</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Waterborne </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1442 <sup>1</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B107-pathogens-09-00856" ref-type="bibr">107</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2005</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Iraq</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Waterborne </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">268 <sup>1</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B108-pathogens-09-00856" ref-type="bibr">108</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2005</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">India </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Contaminated drinking water</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">429</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B109-pathogens-09-00856" ref-type="bibr">109</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2006</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Sudan</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Waterborne </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2621</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B110-pathogens-09-00856" ref-type="bibr">110</xref>,<xref rid="B111-pathogens-09-00856" ref-type="bibr">111</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2007&#x02013;2008</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">India </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Fecal contamination of water resources</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">64</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B112-pathogens-09-00856" ref-type="bibr">112</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2007&#x02013;2008</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Egypt</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Waterborne </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">28</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B113-pathogens-09-00856" ref-type="bibr">113</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2007&#x02013;2009</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Uganda</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Waterborne </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">146</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B114-pathogens-09-00856" ref-type="bibr">114</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2008</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">India </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Sewage contamination of the river</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">23,915 <sup>1</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B115-pathogens-09-00856" ref-type="bibr">115</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2008</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Uganda</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Substantial person-to-person </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x0003e;10,000</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B116-pathogens-09-00856" ref-type="bibr">116</xref>,<xref rid="B117-pathogens-09-00856" ref-type="bibr">117</xref>,<xref rid="B118-pathogens-09-00856" ref-type="bibr">118</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2008&#x02013;2009</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Bangladesh</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Sewage contamination&#x02014;municipal water </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4751 <sup>1</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B119-pathogens-09-00856" ref-type="bibr">119</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2009&#x02013;2012</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Uganda</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Contaminated water</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">987</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B120-pathogens-09-00856" ref-type="bibr">120</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2010</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Bangladesh</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Waterborne </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">200</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B121-pathogens-09-00856" ref-type="bibr">121</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2010</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">India </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Waterborne </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">102</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B122-pathogens-09-00856" ref-type="bibr">122</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2005&#x02013;2010</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">India</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Waterborne</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">442</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B123-pathogens-09-00856" ref-type="bibr">123</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2010&#x02013;2011</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Sudan</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Waterborne </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">39</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B105-pathogens-09-00856" ref-type="bibr">105</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2012</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">India </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Fecal contamination of drinking water</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">180</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B124-pathogens-09-00856" ref-type="bibr">124</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2012</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Kenya</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Waterborne </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">131</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B125-pathogens-09-00856" ref-type="bibr">125</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2008&#x02013;2012</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Central African Republic</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Waterborne</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">745</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B126-pathogens-09-00856" ref-type="bibr">126</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2012&#x02013;2013</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">South Sudan</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Waterborne </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5080 <sup>1</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B127-pathogens-09-00856" ref-type="bibr">127</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2013</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">India </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Sewage contamination of drinking water</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">240</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B128-pathogens-09-00856" ref-type="bibr">128</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2013</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cameroon</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Waterborne </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">33</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B129-pathogens-09-00856" ref-type="bibr">129</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2014&#x02013;2015</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Bangladesh</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Waterborne</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">103</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B130-pathogens-09-00856" ref-type="bibr">130</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2014&#x02013;2016</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">India</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Waterborne</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">17</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B131-pathogens-09-00856" ref-type="bibr">131</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2016&#x02013;2017</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Chad</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Waterborne </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1293</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B132-pathogens-09-00856" ref-type="bibr">132</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2017&#x02013;2018</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Nigeria</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Contamination of drinking water</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1376</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B133-pathogens-09-00856" ref-type="bibr">133</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2014&#x02013;2017</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Bangladesh</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Waterborne</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">661</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B134-pathogens-09-00856" ref-type="bibr">134</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2018</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Central African Republic</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Waterborne</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">149</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B135-pathogens-09-00856" ref-type="bibr">135</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2018</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">South Sudan</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Waterborne</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">161</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B135-pathogens-09-00856" ref-type="bibr">135</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2019</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Pakistan</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Waterborne</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">300</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B136-pathogens-09-00856" ref-type="bibr">136</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2017&#x02013;2020</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Namibia</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Waterborne</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">7247</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B137-pathogens-09-00856" ref-type="bibr">137</xref>]</td></tr></tbody></table><table-wrap-foot><fn><p><sup>1</sup> Numbers based on reported estimates.</p></fn></table-wrap-foot></table-wrap><table-wrap id="pathogens-09-00856-t002" orientation="portrait" position="float"><object-id pub-id-type="pii">pathogens-09-00856-t002_Table 2</object-id><label>Table 2</label><caption><p>Details on <italic>Orthohepevirus A</italic> genotypes.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Genotype <sup>1</sup><break/>(Subtypes)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Host</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Transmission Route</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Global Distribution <sup>1</sup></th></tr></thead><tbody><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HEV-1<break/>(1a&#x02013;1g)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Human, primates</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Fecal&#x02013;oral via contaminated drinking water</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Mainly resource poor regions in <break/>India, Pakistan, Bangladesh, Myanmar, China, Mongolia, Morocco, Chad, Nigeria</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HEV-2<break/>(2a, 2b)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Human, primates</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Fecal&#x02013;oral via contaminated drinking water</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Mainly resource poor regions in <break/>Mexico, Nigeria</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HEV-3<break/>(3a&#x02013;3m, 3ra)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Human, pig, wild boar, deer, mongoose, rabbit (3ra), hare (3ra), rodents</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Zoonotic via consumption or contact of/with contaminated foodstuffs; parenteral via contaminated blood donations</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Mainly in industrialized countries such as<break/>USA, Canada, China, Japan, South Korea, India, Singapore, UK, Germany, France, Italy, Spain, Sweden, Switzerland, Netherlands, Denmark, Hungary </td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HEV-4<break/>(4a&#x02013;4i)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Human, pig, wild boar, cow, goat, yak, Rhesus monkey</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Zoonotic via consumption or contact of/with contaminated foodstuffs; parenteral via contaminated blood donations</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Mainly in Asian countries such as<break/>China, Mongolia, Japan, South Korea, Taiwan, Cambodia, India</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HEV-5<break/>(5a)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Wild boar</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Unavailable</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Japan</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HEV-6<break/>(6a)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Wild boar</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Unavailable</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Japan</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HEV-7<break/>(7a)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Human, dromedary camel</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Zoonotic, likely via consumption of camel meat</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">UAE</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HEV-8<break/>(8a)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Bactrian camel</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Unavailable</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">China</td></tr></tbody></table><table-wrap-foot><fn><p><sup>1</sup> Information according to the International Committee on Taxonomy of Viruses (ICTV) as of September 2020 and Smith et al. 2020 [<xref rid="B10-pathogens-09-00856" ref-type="bibr">10</xref>].</p></fn></table-wrap-foot></table-wrap></floats-group></article>